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Abstract 
Keywords: Kangaroo Island, propolis, metabolomics, 1H-NMR 
Introduction: Propolis, a sticky substance produced by bees from plant resins, has a long 
history of safe use medicinally. Kangaroo Island, SA (KI) lacks many introduced European 
plants bees preferentially collect resin from; consequentially, propolis from KI is produced 
from resinous native plants. Several identiﬁably reproducible pure-source KI propolis types 
exist. Research into medical use of compounds from KI native plants is limited. 
Metabolomics is a growing ﬁeld of interest in natural products chemistry, including beehive 
products. Metabolomic and similarity-scoring assessment of KI propolis, through statistical 
evaluation of 1D 1H-NMR ﬁngerprints, provides an entry point for research into medical use 
of KI native plant compounds. Many avenues to product discovery in pharmaceutical 
chemistry are suffering diminishing returns: metabolomics-guided natural products 
assessment has the potential for further identiﬁcation of novel therapeutic compounds from 
resinous plants. 
Aim: To assess and identify, via metabolomic investigation of NMR ﬁngerprints, major 
propolis types on KI, and to produce, from this, similarity-scoring tools for assessment of 
propolis samples. 
Method: KI propolis samples, identiﬁed as pure-source by TLC, and resinous KI plants were 
analysed by 1H-NMR and HPLC. Data points of interest were normalised and binned to form 
individual sample ‘ﬁngerprints’. Data from these ﬁngerprints were analysed by hierarchical 
clustering and principal component analysis (PCA) to conﬁrm provisionally-identiﬁed pure-
source propolis types and identify subtypes within propolis and resinous plant species. From 
this, calculator tools were created to score similarity (out of 1000) of 1H-NMR ﬁngerprints to 
the average spectrum of pure-source propolis types, as well as to calculated mixtures of these 
  xxii 
 
average spectra. Assessment of the chemistry of two major KI propolis types identiﬁed (CP- 
and F-type) was made by fractionation and NMR, with one compound, 
6,8-diprenyleriodictyol, isolated from CP-type propolis in quantity, submitted for epigenetic 
and other biological assays. 
Results: Source resinous plants were demonstrated, through hierarchical clustering and PCA, 
to cluster with propolis types arising from these sources, with closely related plants and sub-
chemotypes clustering separately, conﬁrming speciﬁcity. A number of previously-identiﬁed 
pure-source propolis types and known botanical sources were shown to have very high 
similarity (> 800/1000) to the expected propolis type. Calculator tools were observed to 
accurately predict the content of mixed propolis samples to within ± 10%. A number of 
methylﬂavanones, and two novel terminally-hydroxylated prenyldihydrochalcones were 
isolated from F-type propolis. 6,8-diprenyleriodictyol demonstrated a range of promising 
activity in biological assays.  
Conclusion: Metabolomic evaluation of 1H-NMR ﬁngerprints can reliably identify and 
assess pure-source KI propolis and identify botanical origin of source resins. Similarity 
scoring calculators can accurately identify mixed-source propolis samples. KI propolis types 
are a rich source of pharmaceutically-interesting ﬂavanones and related compounds, many of 
which are prenylated. 6,8-diprenyleriodictyol displays strong anti-inﬂammatory and 
anticancer activity, especially against Burkitt’s lymphoma. A number of possible epigenetic 
pathways for this activity were observed. 
  
 
 
 
 
 
Chapter One 
A Review of Propolis Literature 
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1.1 General introduction and history 
 
Figure 1: Propolis, as deposited on propolis mats within the hive for commercial harvesting. Propolis 
of this colour and texture is typical of the south coast of Kangaroo Island, SA. 
ropolis (pronounced /ˈprɒpəlɪs/) (3), referred to historically as bee glue (4), is a 
sticky resinous substance produced by various species of bees, especially the 
European honey bee, Apis mellifera (5), from resins from a variety of plants but 
most notably from trees of genus Populus, the poplars (6). These resins are mixed with 
beeswax and utilised for structural support in the margins of the hive and as a general 
antiseptic (7). It is this antiseptic nature that accounts for the interest in, and use of, propolis 
pharmaceutically. 
The etymology reﬂects these roles, being a direct transliteration of the Hellenistic Greek 
name for the substance (πρόπολις) (5), which despite also having the meaning of ‘suburb’ (5), 
can be read as pro- (for) polis (the city), with the inferred sense of ‘in defence of the hive’ 
(8). It has also been suggested that this is a corruption of προμαλάσσω (‘promalasso’: that 
P 
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which is softened beforehand, that made supple by rubbing or kneading) (5), but these tidy 
folk etymologies by analogy are generally spurious (9). 
As the age of the name suggests, propolis has a very long history of use and research, 
certainly in Europe and potentially in the Near East, with possible mentions of propolis 
identiﬁed almost as early as mentions of beekeeping (10). The Ancient Egyptians appear to 
have known and used the product; indeed, it has even (perhaps fancifully) been suggested 
that the practice of mummiﬁcation was inﬂuenced by the known behaviour of bees in 
embalming corpses of large hive invaders, such as mice, in propolis (11). 
The Ancient Hebrews have been construed as using propolis, with several mentions of tzori 
(translated in the King James Bible as ‘balm’) in the Torah1. Several authors have identiﬁed 
this famous Balm of Gilead as propolis, some citing Maimonides (5, 12). Tzori itself, 
however, is usually held to have been the resin of a plant: most probably either Commiphora 
gileadensis or Pistacia lentiscus (12). Identiﬁcation as propolis appears, on the balance of 
evidence, a probable act of wishful thinking by propolis researchers – especially as the claim 
that tzori is the word in Modern Hebrew for propolis is not backed up by any external 
sources2. Nevertheless, this claim can be found (in oddly similar wording) in many papers 
and theses on propolis (5, 13-16). 
Turning again to the Greeks, propolis was noted by a number of authors. Aristotle, in 
Historia Animalium, gave an apparent description of propolis that bears quoting at length: 
  
                                                 
1 Jer. 8:22, 46:11, 51:8 
2 Indeed, the Modern Hebrew for propolis (סילופורפ, ‘prvpvlys’) would also appear to be a direct transliteration 
of the Greek. 
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When the hive has been delivered to them [bees] clean and empty, they build their 
waxen cells, bringing in the juice of all kinds of ﬂowers and the ‘tears’ or exuding 
sap of trees, such as willows and elms and such others as are particularly given to 
the exudation of gum. With this material they besmear the groundwork, to provide 
against attacks of other creatures; the bee-keepers call this stuff ‘stop-wax’. They 
also with the same material narrow by side-building the entrances to the hive if 
they are too wide. 
[…] 
At the entry to the hive the aperture of the doorway is smeared with mitys; this 
substance is a deep black, and is a sort of dross or residual by-product of wax; it 
has a pungent odour, and is a cure for bruises and suppurating sores. (17) 
Clearly, the ancients already were reasonably familiar with sources, production and 
characteristics of propolis, despite some confusion as to differences between beeswax and 
propolis. Two early fathers of western medicine, Hippocrates and Dioscorides, are known to 
have used propolis in their cures (5), Dioscorides stating that: 
The yellow bee-glue that has a sweet scent and resembles styrax3 should be 
chosen, and which is soft, excessively dry, and easy to spread (like mastic4). It is 
extremely warm and attractive, and draws out thorns and splinters. The smoke 
from it (inhaled) helps old coughs, and it is applied to take away lichen 
[dermatitis]. It is found around the mouths of hives, being similar in nature to 
wax. (18) 
                                                 
3 A resin obtained from wounded bark of trees of Liquidambar spp. 
4 Interestingly, with regards to the tzori controversy, mastic is the resin of the plant Pistacia lentiscus. 
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Knowledge of propolis as a healing agent continued with the Romans. Marcus Terentius 
Varro mentions propolis brieﬂy in De re Rustica, as does the famous healer and 
encyclopaedist Celsus in De Medicina (5). Pliny’s encyclopaedia, Naturalis Historia, 
mentions bees and beekeeping in detail in Book XI and echoes Aristotle’s description of the 
physical nature of propolis: 
… [bees] extract bee-glue from the tears of those trees which distil glutinous 
substances, the juices, gums, and resins, namely, of the willow, the elm, and the 
reed. With these substances, as well as others of a more bitter nature, they ﬁrst 
line the whole inside of the hive, as a sort of protection against the greedy 
propensities of other small insects, as they are well aware that they are about to 
form that which will prove an object of attraction to them. Having done this, they 
employ similar substances in narrowing the entrance to the hive, if otherwise too 
wide. (19) 
The propolis is produced from the sweet gum of the vine or the poplar, and is of a 
denser consistency, the juices of ﬂowers being added to it. Still, however, it 
cannot be properly termed wax, but rather the foundation of the honey-combs; by 
means of it all inlets are stopped up, which might, otherwise, serve for the 
admission of cold or other injurious inﬂuences; it has also a strong odour … (20) 
Pliny in a later book expounds how propolis is “remarkable for its utility in medicine” (20): 
This substance has the property of extracting stings and all foreign bodies from 
the ﬂesh, dispersing tumours, ripening indurations, allaying pains of the sinews, 
and cicatrizing ulcers of the most obstinate nature. (21) 
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The Islamic World also utilised propolis. Not only did Avicenna describe the healing powers 
of propolis (5), but a passing reference in the Koran has historically been inferred as referring 
to propolis, alongside other bee products: “From [the bee’s] belly comes forth a syrup [or 
juice/liquid] of different hues, a cure for men. Surely in this there is a sign for those who 
would take thought” (22). 
Further aﬁeld, independently of Western knowledge, the Inca utilised propolis as an 
antipyretic (8), other South Americans as an antacid (23) and sub-Saharan Africans also 
utilised propolis medically (24, 25). Propolis, known as Feng Jiao, also has a long history of 
use in traditional Chinese medicine (26). 
Sadly, along with much other knowledge from the ancient world, the healing properties of 
propolis were generally forgotten in Western Europe after the fall of Rome (5). Patchy 
mentions of propolis use for dental conditions appear; propolis studies and use remained 
strongest in the folk medicine of Eastern Europe (even to this day, propolis apparently has the 
sobriquet of ‘Russian Penicillin’) (5). It was not until the re-availability of ancient texts 
during the early Renaissance that propolis returned with force to the western pharmacopoeia 
and to medical study (5). 
Propolis is often claimed in the literature to be mentioned in the English herbal of John 
Gerard, The History of Plants (1597) (15), and also Nicholas Culpeper’s Complete Herbal 
(1653) (5). However, the ungulent populeon they mention, although broadly interpreted as 
propolis by some, is rather an ointment made directly from buds of the poplar tree and lard, 
with other herbs (27, 28). This ointment had wide circulation in early modern times (29). The 
conﬂation of this historical cure with propolis proper has, apparently, been present in the 
literature since at least the 1940s (30). 
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Apart from medicinal and cosmeceutical use, which is further detailed below, propolis has a 
limited range of other applications. Notably, it was once used as a constituent of varnishes for 
musical instruments; this is (again, perhaps fancifully) reputed to play a role in the unique 
sound qualities of Stradivarius violins (31). Propolis is still a constituent of some violin 
rosins, especially Italian recipes, used for increasing friction between strings and bow 
immediately prior to playing (31); and also used in musical instrument repair, especially 
accordions (32). Propolis has been suggested as a meat and ﬁsh preservative (33-36), a 
treatment against wax moth in the hive (37), and an antimicrobial additive to food packaging 
(38, 39), with mixed success5. 
More unusually, Ukrainian propolis has been shown to form an effective near-infrared 
photodetector when applied in a ﬁlm to various semiconducting materials (40, 41), and, in 
addition, one study has demonstrated inhibition of carbon steel corrosion in aqueous solutions 
by water extracts of Egyptian propolis (42). 
1.2 Physical nature of propolis 
Bulk propolis is generally hard and brittle at room temperature, becoming tacky with 
handling or heating (15). Melting point generally varies from 60-70°C but can be as high as 
100°C (15). Colour varies, with a usual range from yellow to brown (15), however red (43), 
green (44), and even transparent propolis types have been reported (45). Most propolis has an 
aromatic and overall pleasant odour (46), such that it is occasionally used as ﬂavouring or in 
perfumery (47). Taste, however, is generally unpleasant and bitter (34, 48). 
                                                 
5 For instance, Bernardi et al. (2013) note that though “It is possible to prepare Italian-type salami using propolis 
as a replacement for the synthetic antioxidant sodium erythorbate” downsides include “strong residual 
uncharacteristic ﬂavour that was unpleasant”, concluding “further research is needed … to mitigate the strong 
aroma of propolis”. 
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A usual breakdown of propolis components, commonly cited in papers, is 50% plant resins, 
30% waxes, 10% essential oils and volatiles, and 1% amino acids with the balance made up 
of various impurities (46), such as dead bees, pollen and wood (47). However, it has been 
suggested that a more accurate determination of volatiles over most propolis is in the lower 
range 1-3% (49). 
More unusually, when suitable plant resins are absent, honey bees have been reported to 
collect paints, caulking agents and even asphalt for propolis (50). Another unusual propolis 
type is geopropolis, produced by many species of stingless bees (most notably Melipona 
spp.), which partially consists of clay or soil (8, 51, 52). 
1.3 Collection, manufacture and use of propolis by bees 
 
Figure 2: The Ligurian honey bee, Apis mellifera ligustica, here seen collecting plant resins from the 
Kangaroo Thorn, Acacia paradoxa, on Kangaroo Island for use in propolis. 
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Propolis collection is only observed by insects of the family Apidae, the bees6, and primarily 
by one species: Apis mellifera, the western or European honey bee, and its associated 
subspecies and hybrids (24). No other honey bees of genus Apis are known to produce 
propolis in quantity (5), despite known plant resin collection by A. dorsata, A. ﬂorea and A. 
cerana for structural and ant-resistance purposes (53, 54). By contrast, numerous species of 
stingless bees (tribe Meliponini) of genera Lepidotrigona (55), Melipona (51, 56), 
Scaptotrigona (57), Tetragonula (55, 58-60), Tetrigona (59), and Trigona (61), amongst 
others, are known to produce propolis. This stingless bee propolis is often termed cerumen7 
in the literature (60, 62). 
Dedicated bees make trips to collect plant resins for propolis. These bees often are directly 
involved in applying the resins to the hive surface, unlike other resources collected by bees 
which are distributed to user bees at the entrance of the hive. Collection rates of resin are 
driven primarily by direct need for propolis in the hive (63). Bees collect plant resins from a 
variety of locations on suitable plants (e.g. ﬁgures 2 and 11); collection from plant wounds, 
ﬂowers, leaves and buds have all been observed (6). Resins are removed via mastication with 
the mandibles, wetted with saliva or possibly small quantities of nectar (64) and transferred to 
the corbiculae (‘pollen baskets’) on the hind legs, or carried in the mandibles, for transport 
back to the hive (63, 65). A collection period of approximately 7 minutes per collection ﬂight 
is typical (66), with a maximum collection range of roughly 8-11 km (although preferentially 
< 2 km) from the hive (67, 68). Beehives of A. mellifera will produce about 150-200 g of 
propolis per year; certain subspecies can produce notably more or less (6). 
                                                 
6 A non-bee species, Timia apicalis, a member of the Ulidiidae family of picture-winged ﬂies, is named in 
Kustiawan et al. (2014) as producing propolis. In context, this is a clear error for Trigona apicalis. 
7 Also a medical term for earwax, certainly appropriate given the typical colour, texture and ﬂavour of propolis. 
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How bees detect and select suitable resins is uncertain, however it is known that bees can 
associate colours, both exact and approximate, and taste with pollen and nectar sources (69, 
70). Bees can also discriminately select ﬂowers and plant resin sources depending on the 
odour arising from a small subset of all terpenes produced by plants, with subtle variations in 
overall terpenes not reducing collection habits (71). It would seem likely a combination of all 
the senses to form a ‘ﬁngerprint’ of suitable plants is used for selection (54). Certainly, bees 
are observed to discriminately collect resins from particular species, even if other closely-
related resinous plants are available (72-74). Furthermore, collector bees will collect 
primarily from plants whose odour they are familiar with, either from the hive or previous 
successful collection ﬂights, even if other bees communicate successful collection of other 
resins by waggle-dances (75). In circumstances where this remembered source is 
unobtainable, more attention is given to the waggle-dances (76). As such, bees display “a 
remarkably conservative attitude … against exploration” (77) and will tend to produce a 
chemically-consistent propolis within an individual hive, with change of source slow (76). 
An open question in propolis research is the degree of chemical change the exposure to bee 
saliva induces in propolis. Infrared (IR) comparison of Chinese propolis, sourced by bees 
from the poplar, and poplar bud resin showed no difference in ﬂavonoid composition, but 
marked differences in long-chain alkyl constituents (78). Rapid enzymatic degradation of 
salicin, an alcoholic β-glucoside, from poplar resin collected by bees, even in propolis 
collected from the hive on the same day of production, has been noted and proposed as a 
marker for propolis adulteration (79). Against these results, however, should be noted a 
number of studies showing near perfect matching of chromatographic proﬁles between 
propolis and source plant resins (66, 80-82). The consensus position developing would be 
that any chemical change is minor, especially with regard to pharmaceutically relevant 
components of propolis (83). 
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Bees utilise propolis in a number of ways. In wild hives, a propolis envelope is used to line 
the hive; this would seem to offer structural support for the comb as well as waterprooﬁng 
(84). By contrast, in the majority of stingless bees the entirety of the hive is produced from 
cerumen of various formulations, not just the lining (85). Propolis is utilised as a direct 
physical barrier to some hive pests; being applied by bees to immobilise ants, sticking to ant 
cuticle far more readily than to bee mandibles (64), and also for encapsulating or 
mummifying small hive beetles (Aethina tumida) (86, 87). It certainly has an anti-infective 
role; hives with propolis lining were observed to have an increased rate of colony survival, 
increased colony size in spring, lower bacterial load and lower transcription levels of 
immunogenic genes in individual bees, suggesting a healthier hive overall (88, 89). In 
addition, a relationship between higher production of propolis and both higher honey 
production and increased rates of hygienic behaviour (such as removal of dead brood) has 
been demonstrated (90). Bees have even been observed to increase rates of propolis 
production in response to fungal infection of hives, suggesting propolis is not produced 
merely as a prophylactic but also as a directed cure (91). 
1.4 Chemical variability of propolis 
1.4.1 Early research 
One of the earliest investigations into the chemical constituents of propolis was by French 
pharmacist Nicholas Vauquelin in 1803. Vauquelin prepared 57 g of dry ethanolic extract 
from 100 g of raw propolis, and distilled from it an unidentiﬁed white, sweet-smelling oil, 
most probably a terpene mixture (92). 
In 1814, Huber visually conﬁrmed poplars as a resin source: observing resin collection from 
branches “that had very large buds coated both on the outside and inside with a viscous, 
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reddish and odoriferous sap” by bees within 15 minutes of these branches being placed before 
hives (93). 
Further research did not commence in earnest until the early 20th century. Early European 
research focussed on simple fractionation of propolis extracts, later identifying and isolating 
various compounds from fractions, including vanillin, cinnamic acid and cinnamyl alcohol, 
and the ﬂavone chrysin (5). Total analysis of available propolis demonstrated a non-conifer 
resinous source, with constituents in “fairly constant percentage” (94). The ﬁrst study to 
chemically conﬁrm poplar bud resin as a source of propolis was performed in 1927 by G. A. 
Rösch (95). 
A series of American studies isolated a wide range of vitamins in propolis (96), and studies 
into the metallic composition of propolis extract ash were also performed (97). 
Various researchers continued to isolate a range of ﬂavone and ﬂavonoid compounds from 
propolis (98-100); acting on the assumption that propolis, although of complex chemistry, 
was constant between hives and sourced from plants of the Populus genus (101). By the 
1970s, this assumption was generally exploded, with a number of non-standard propolis 
samples from the tropics (where Populus spp. do not grow in quantity) identiﬁed. 
1.4.2 Major propolis types 
A large number of reproducible pure-source propolis types from A. mellifera have since been 
identiﬁed and, in most cases, traced back to the source plant resin (74, 83). It is important to 
note that there is a broad chemical similarity to propolis – bees source resins rich in phenolic 
and terpenoid compounds, with nitrogenous plant-defence compounds (such as alkaloids, 
glucosinolates and cyanides) to date not isolated from propolis (83). Only one exception, a 
report of pyrrolizidine alkaloids in geopropolis from Scaptotrigona postica, exists in the 
literature (57). Some reports of glycosides in propolis also exist (102-104). 
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Propolis type produced by individual hives very broadly corresponds to which suitable 
resinous plants are available within the geographical area where the hive is located (83). 
Furthermore, as much as possible, bees will continue to mostly collect whatever resin is 
already present within the hive, even if closely-related resinous plants are nearby (72-74). As 
such, classiﬁcation of representative propolis types by geographical areas has legitimacy at a 
basic level and has been extensively practiced in the literature in the past (83). The tendency 
of researchers to work with bulk propolis sourced from multiple hives also smooths out inter-
hive differences. Where several resinous plants of equivalent desirability exist, or availability 
of the preferred plant resin is seasonal, typing of propolis by this method is less reliable and 
more complex mixed-source propolis is observed (105, 106). As an increasing amount of 
propolis research tracks individual samples and mixtures to source plant resins, the utility and 
predictability of the following categories are most likely to decrease (106). 
1.4.2.1 Temperate propolis 
 
Figure 3: Compounds commonly isolated from temperate propolis. A: R1 = H, pinocembrin; R1 = 
OH, pinobanksin. B: R2 = R3 = H, chrysin; R2 = R3 = OH, quercetin; R2 = OH, R3 =H, galangin. C: 
caffeic acid phenethyl ester (CAPE).  
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Bees in temperate areas are mostly observed to produce this type of propolis; be they in the 
northern or southern hemispheres, or in the New or Old World (83). The source resins of 
temperate propolis are from exudates from the buds and shoots of trees of genus Populus, 
most especially P. nigra, the black poplar (93). Propolis of this type is observed to be rich in 
ﬂavonoids such as pinocembrin, pinobanksin, galangin and chrysin (ﬁgure 3, A and B), as 
well as phenylpropanoid acids and esters thereof (93). Caffeic acid phenethyl ester (CAPE) is 
the most notable of this latter group (ﬁgure 3, C), and is a compound of intense 
pharmaceutical interest (93). 
Variations of temperate propolis have been noted. Colder climates, such as northern Russia 
and Switzerland, produce slightly different temperate propolis arising from the birch trees 
(especially Betula pubescens) and common aspen (Populus tremula) (74, 107). Other 
resinous plants, historically postulated as temperate propolis sources (horse-chestnut, black 
alder and Scots pine), have been refuted in a recent study by Isidorov et al. (74). A continuum 
of mixtures, with increasingly colder climate, from pure-poplar to pure-birch has been noted 
by at least one study (106). Some samples of Portuguese propolis have been shown to have 
an unusual temperate propolis proﬁle, including (amongst other compounds) quercetin (ﬁgure 
3, B) and kaempferol glycosides, possibly coming from conifers (103). 
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1.4.2.2 Mediterranean propolis 
 
Figure 4: Compounds commonly isolated from Mediterranean propolis. A: totarol, B: isoagatholal, 
C: agathadiol, D:chrysophanol. 
Some propolis samples from the dryer Mediterranean lands, including mainland Greece 
(108), Crete (108), Cyprus (109) and Turkey (110), have been reported with a notably 
different chemical proﬁle to other temperate propolis. These samples contain minimal 
ﬂavonoids and are mostly diterpenoid or anthraquinonal, containing compounds such as 
totarol, isoagatholal, agathadiol and chrysophanol (ﬁgure 4) (83). It has been suggested that 
various cypresses (family Cupressaceae) are the source of these propolis, or at least the 
diterpenoid constituents (83, 108). 
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1.4.2.3 Tropical propolis 
 
Figure 5: Examples of compound classes often isolated from tropical propolis. A: prenylated 
phenylpropanoids (artepillin C), B: prenylated benzophenones (nemorosone), C: caffeoyl quinic acids 
(chlorogenic acid). 
Several types of tropical propolis exist; mostly produced in Central and South America. 
Brazilian green propolis, of great commercial importance, contains mostly prenylated 
phenylpropanoids and caffeoyl quinic acids (ﬁgure 5, A and C) (83). The source plant for this 
propolis is the alecrim-do-campo, Baccharis dracunculifolia (83), a ﬂower of the ﬂavonoid-
rich Asteraceae family (which includes daisies and sunﬂowers) (111). 
A number of red propolis types arising from shrubs of genus Clusia have been reported from 
Venezuela (112), Cuba (113) and Brazil (114). These red propolis types are notable for 
prenylated benzophenones (ﬁgure 5, B) (83, 113); some types contain small quantities of 
ﬂavone C-glycosides (104). Chemically similar red propolis, rich in iso- and neoﬂavonoids, 
are found in Brazil (82), and Nepal (115). These propolis are postulated to arise from various 
plants of the Leguminosae family, such as Dalbergia ecastaphyllum in Brazil (82); 
complicating the matter, several of the American red propolis types are postulated to have 
both Clusia spp. and a legume as resin source (83). 
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1.4.2.4 Paciﬁc propolis 
 
Figure 6: Two representative geranylated ﬂavanones from Paciﬁc propolis. A: nymphaeol A, B: 
nymphaeol C. 
Propolis rich in prenylated and geranylated ﬂavanones has been reported from Okinawa (81) 
and Taiwan (116), amongst other Paciﬁc locations (ﬁgure 6). That from Okinawa has been 
traced to an exudate of the fruit of Macaranga tanarius, of family Euphorbiaceae (81). 
Propolis of similar composition has also been collected in Egypt (117) and Kenya (118): as 
plants of genus Macaranga have a wide distribution, including to Africa, and many of these 
species are resinous (119), it would appear reasonable to classify, confusingly, these as 
‘Paciﬁc’ type propolis also. 
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1.4.3 Australian propolis 
 
Figure 7: Non-ﬂavanone compounds isolated from Western Australian propolis. A: pterostilbene, B: 
xanthorrhoeol, C: 3,5-dimethoxybenzyl alcohol. 
Surprisingly, considering the size of Australia and its beekeeping industry, relatively few 
studies into Australian propolis types exist. An early study by Ghisalberti et al. in 1978 of 
propolis from Mandurah, Western Australia, isolated four ﬂavanones, with evidence of other 
ﬂavanone content, as well as pterostilbene, xanthorrhoeol and 3,5-dimethoxybenzyl alcohol 
(ﬁgure 7) (120). This chemical proﬁle suggested a resin source from grass-trees of 
Xanthorrhoea spp. with Eucalyptus spp. as secondary resin source (120). Unfortunately, there 
appears to be no published work on Western Australian propolis following from this study, 
but studies conﬁrming the ﬂavonoid chemistry of grass-tree resin exist (121). 
A recent study by Massaro et al. into propolis from two sites in South East Queensland and 
North Coast NSW found triterpenoid and ﬂavonoid content, notably C-prenyl and C-geranyl 
ﬂavonoids (122). Two compounds isolated, nymphaeol A and C, have been previously 
isolated from Paciﬁc-type propolis (ﬁgure 6); notably, M. tanarius, a resin source for Paciﬁc 
propolis, grows where these Australian propolis samples were collected (122). The authors 
also adduced for investigation several noted resinous plants common to both sites, including 
Syncarpia glomulifera, Lophostemon suaveolens and several Eucalyptus spp., to account for 
chemical differences from Paciﬁc type propolis (122). This was possibly informed by other 
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studies by the same group into the chemistry of deposit-resins8 (chieﬂy phloroglucinols, 
ﬂavonoids and isoprenoids (123)) and propolis (gallic and diterpenic acids (60); 
methylﬂavanones (124)) of the stingless bee Tetragonula carbonaria, sourced from the same 
area with botanic origin from a variety of plants of the Myrtaceae family, notably the 
eucalypt Corymbia torelliana (60). 
Two studies into ﬂavonoid-content determination of Australian honeys as botanical-origin 
markers suggest that the propolis produced by many hives in Australia is markedly different 
from the temperate type noted in Europe. Both studies noted that all honeys from Europe 
tested, including eucalyptus honeys, contained appreciable amounts (> 1.6 mg per 100 g 
honey) of ﬂavonoids found in temperate propolis (pinobanksin, pinocembrin, and chrysin), 
whereas Australian honey samples contained these compounds in very low concentrations, or 
not at all (125, 126). It would appear that investigations into propolis types in Australia are 
currently scratching the surface of what could prove a rich and rewarding ﬁeld of therapeutic 
study. 
1.4.4 Kangaroo Island propolis 
Kangaroo Island, off the Fleurieu Peninsula of South Australia, is Australia’s third largest 
island; approximately 150 km long and 60 km at its widest (ﬁgure 8). The island, generally 
known as Karta9 to the Kaurna and Ramindjeri nations of the Fleurieu Peninsula (127, 128), 
was taboo – a spirit land of the dead. Although just 13.5 km from the mainland at the closest 
point, the island had been uninhabited for approximately 2,000 years prior to European 
settlement, and was reported by Nicolas Baudin, at the time of Western discovery, as 
                                                 
8 Certain species of stingless bees initially deposit gathered plant resins to a central pile in the hive prior to 
admixture with wax, soil etc. for use as propolis/cerumen. 
9 This name, often glossed as ‘Isle of the Dead’ in Kangaroo Island literature, additionally means ‘lap/female 
genitalia’ in the language of the Kaurna people of the Adelaide Plains. 
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overgrown with vegetation, in contrast to the ﬁre-stick farmed mainland (129). Settlement 
was slow, despite some inhabitation by sealers and whalers from the early 19th century, with 
extensive clearing for farming not undertaken until soldier-settlement after World War II 
(129). As of 1989 (the most recent ﬁgures), 50% of the island remained uncleared, especially 
in the south and west of the island where soil quality is poorer (129). The island is overall 
arid (ﬁgure 9), despite consistent winter rains, as much of the soil is laterite, sandstone and 
sand (129). The island is rich in marsupial life (as reﬂected by its name) with little predation 
(129). 
 
Figure 8: General map of Kangaroo Island, SA. Location of Hanson Bay Sanctuary is marked by the 
red star. The Fleurieu Peninsula is in the top right corner, the Dudley Peninsula is to the right of the 
island. Map credit: Nature Connect Pty Ltd 
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Figure 9: A typical Kangaroo Island apiary site. Note the extreme aridity and over-grazing of the 
location, and the dominant mallee vegetation. 
Kangaroo Island has a large range of native resinous plants, due to this combination of recent 
European settlement, dry conditions, poor soil and high grazing pressure (129). In addition, 
as Kangaroo Island has an exclusive population of Ligurian bees (A. mellifera ligustica) 
(ﬁgure 2), a subspecies especially noted for resin collection (130), the island produces large 
quantities of chemically distinctive propolis (131, 132). 
Previous work by this group has investigated a number of unique Kangaroo Island propolis 
types, with plant resin source identiﬁed in most cases. Propolis rich in ﬂavonoids and 
methoxychalcones, particularly pinobanksin 3-acetate and a novel derivative thereof, has 
been observed arising from the kangaroo thorn wattle, Acacia paradoxa (132). Several 
propolis types from chemotypes of the sword sedge complex Lepidosperma viscidum (ﬁgures 
10 and 11), and related L. spp., have also been identiﬁed, notably propolis types rich in C- 
and O-prenylated polyhydroxystilbenes (primarily 3,5,4ʹ,5ʹ-tetrahydroxystilbenes), 
methoxystilbenes and cinnamic acid derivates (131, 133). A second chemotype exclusively 
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C-prenylated and lacking O-prenylated compounds has also been noted (133). It is important 
to note that the discovery of these very distinct chemotypes is contributing to reappraisal of 
the taxonomy of the Lepidosperma genus, and of Lepidosperma viscidum s.l. in particular 
(134-138). Recently completed work has identiﬁed diterpenes (most notably serrulatane 
diterpenes), sesquiterpenes, and ﬂavonoids in propolis sourced from leaves of Myoporum 
insulare, a coastal shrub of the Scrophulariaceae family (139).
 
Figure 10: A thicket of sticky sword sedge, L. viscidum s.l., at another Kangaroo Island apiary site. 
Such ‘circles’ of sedge, having grown from single remnant plants along seasonal watercourses, are 
common in the pastures of the south coast of Kangaroo Island. 
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Figure 11: A Ligurian honey bee, A. mellifera ligustica, collecting resin from the base of a sticky 
sword sedge, L. viscidum s.l., on Kangaroo Island for use in propolis. 
Two more propolis types recently found on Kangaroo Island will be described in this thesis: a 
propolis rich in C-prenylated ﬂavanones, notably 6,8-diprenyleriodictyol, resin source 
unknown but most probably within the Fabaceae; and another ﬂavanone-rich propolis with 
resin source L. viscidum s.s. There exists evidence for additional propolis types from 
Kangaroo Island; formal description of these requires further research. 
1.5 Biological activity and medicinal use of propolis 
1.5.1 Antimicrobial and antiparasitic activity 
Unsurprisingly, given the noted anti-infective role of propolis in the hive, propolis extracts 
consistently demonstrate a wide range of antibiotic activity (140); use of propolis extract for 
mouth infections is one of the oldest known medical uses of propolis in Europe, dating back 
to the Middle Ages (5). This activity, however, is not consistent between various propolis 
types. Most antibacterial activity of propolis extract can be attributed to phenolic and 
ﬂavonoid content; possibly through complexing with the metallic constituents of cellular ion 
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channel proteins (141). Generally, propolis extracts are observed to be most effective against 
Gram-positive bacteria, most probably due to poor permeability of Gram-negative 
membranes by molecules in propolis alongside active removal by cellular pumps (140). Other 
antibiotic pathways have been observed, however. Inhibition of RNA polymerase was noted 
in one study (142). Several studies have observed disruption of cell division (143), 
differentiation, cytoplasm organisation, even up to cell lysis (144). 
Flavonoid-rich extracts of various propolis samples have been observed to have antibacterial 
action on most common human pathogens including Bacillus cereus (143, 145), 
Vancomycin-resistant Enterococcus spp. (146), Escherichia coli (147-149), Pseudomonas 
aeruginosa (147), Salmonella enterica (147), Staphylococcus aureus (143, 145, 150), S. 
mutans (144), S. pyogenes (151), and S. sanguis (144), amongst many others. In addition, 
water-soluble elements of propolis have demonstrated activity against Gram-negative 
pathogens (such as Klebsiella pneumoniae, Proteus vulgaris, E. coli, P. aeruginosa) in at 
least one study (152). 
One interesting limitation was observed in a study of Portuguese propolis samples extracted 
in three solvent systems (80% ethanol, 80% methanol, and water), all rich in phenolics, 
especially the 80% ethanol extract. Despite demonstrated activity against E. coli, P. 
aeruginosa and particularly S. aureus throughout all microorganisms the reference strains 
were more sensitive than those isolated from biological ﬂuids (153), which raises some 
concerns about the numerous propolis extract studies above conducted on reference microbe 
lineages. 
Investigation of the antibiotic activity of more volatile components of propolis, generally 
mono- or sesquiterpene alcohols, has also revealed a range of activity extending to Gram-
negative bacteria (49). β-Eudesmol, δ-cadinene and another unidentiﬁed sesquiterpene 
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alcohol from Bulgarian propolis were observed to have notable action against S. aureus, as 
did sesquiterpene-rich volatiles from Canary Islands propolis (154, 155). Various samples of 
volatiles from both Greek and Brazilian propolis, with very high α- and β-pinene content (up 
to 63% and 31% respectively), had effect against E. cloaceae and E. coli, various fungi, and 
(with higher α-pinene content) S. aureus, Staphylococcus epidermidis, P. aeruginosa and K. 
pneumoniae (156, 157). Anatolian propolis volatiles, including phenethyl and benzyl 
alcohols, cedrol and α-bisabolol, demonstrated activity against several food pathogens, 
particularly Bacillus cereus and methicillin-resistant S. aureus (158). 
Growth of numerous pathogenic fungal and parasitic genera have been observed to be 
inhibited by some propolis extracts to some extent, including Candida (159, 160), Fasciola 
(161), Giardia (162, 163), Leishmania (164), Trichomonas (165), Trichosporon (160) and 
Trypanosoma (166). Notably, the last study also showed efﬁcacy in rats in vivo (166). This 
broad antifungal and antiprotozoal activity is likely also attributable to ﬂavonoid content, 
with various ﬂavanones and chalcones commonly extracted from propolis (pinocembrin, 
pinostrobin, 2,4-dihydroxychalcone, 2,4-dihydroxy-3-methoxychalcone) observed to be 
antifungal and antiparasitic in their own right (167). 
Propolis extracts and isolated compounds have wide activity against viruses as well. 
Adenoviruses (168), bromoviruses (169), coronaviruses (168), herpesviruses (170), 
myxoviruses, polioviruses (168), potato viruses (171) and rotaviruses have all shown some 
sensitivity (168). Several pathways have been identiﬁed, including virus replication (172), 
induction of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) (173), 
antineuraminidase action in inﬂuenza viruses (174, 175), and haemagglutinin production 
(176). 
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Flavonoid-rich extracts of Serbian propolis have been observed to potentiate the action of 
some antibiotics against otherwise-resistant strains of S. aureus, K. pneumoniae and Candida 
albicans; notably ceftriaxone, doxycycline and nystatin. Other studies have shown 
potentiation of penicillins and cephalosporins against Gram-negative pathogens by Bulgarian 
and Brazilian propolis, postulated to be by direct inhibition of penicillin-binding proteins 
(147). A potentiation between Brazilian propolis extract and essential oils of ginger and mint 
against S. aureus and E. coli has also been noted (177). It has been suggested a similar 
synergism between phenolics/ﬂavonoids and volatiles probably exists in raw propolis (49, 
178). 
1.5.2 Antioxidant activity 
Propolis extract, as established above, is very rich in phenols, such as cinnamates and 
phenolic acids, and polyphenols such as chalcones and ﬂavonoids; phenols and polyphenols 
account for up to 58% of biologically-active compounds, on average, in temperate-type 
propolis samples (179). Phenols and polyphenols are noted antioxidant compounds. They are 
readily able to neutralise radical products of biological and other processes; the hydrogen-
oxygen bond of their hydroxy groups is weaker than that of aliphatic compounds due to 
electron delocalisation over the neighbouring phenyl ring (180). As such, reactive radical 
species neutralise with this proton and the phenoxyl radical produced is able to stabilise 
through the same electron delocalisation (180). Phenoxyl radicals can then, in turn, neutralise 
each other by production of a phenol and a quinone or by dimerisation (181, 182). In 
addition, phenoxyl radicals can neutralise by direct capture of a radical species (182). The 
antioxidant strength will vary with the number and positioning of hydroxyl and other 
substituents; for examples ortho- and para- monohydroxybenzoic acids display poor 
antioxidant activity compared to meta- forms due to the resonance patterns via the carbonyl, 
and cinnamates are more active and stable than phenolic acids due to the unsaturated carbon 
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linkage (180, 183). Apart from substituents altering activity by electrochemical means, 
substituents may alter the lipophilicity or hydrophilicity of compounds, inﬂuencing their 
activity in vivo (180). Prenyl and geranyl groups are two examples of lipophilic groups of 
current interest in propolis research (131). Additional antioxidant activity of phenolic 
compounds can be provided through chelation of metal ions (usually copper and iron), 
especially by catecholic structures, or by direct inhibition of oxidases in the cell (180). 
Flavonoids and closely related structures are particularly noted within the polyphenols for 
their antioxidant potential. Several common features of their molecular structure mediate this: 
catecholic B-rings readily scavenge radicals and form stable radicals in turn, in addition they 
chelate metal ions; the ketonic C-ring, with unsaturated bond at C2, provides additional 
delocalisation and stabilisation from the B-ring; hydroxyl groups in the A-ring add more 
opportunities for interaction with radicals (181, 184-186). The most potent antioxidant forms 
observed within the ﬂavonoids are ﬂavon-3-ols (e.g. quercetin, myrycetin, morin) and ﬂavan-
3-ols (e.g. epicatechin gallate, epigallocatechin gallate, epigallocatechin, catechin) – all of 
which are often isolated from propolis samples (181, 184). Experimental studies into 
ﬂavonoids from propolis (including ﬁsetin, kaempferol, morin, myricetin, and quercetin) 
conﬁrm their antioxidant capacity against free radical species (187, 188). 
Much of the observed in vitro activity of propolis extracts against various cell line disease 
models is inﬂuenced by the above antioxidant activity (180). 
1.5.3 Anti-inﬂammatory and immunomodulatory activity 
Active research, mostly commencing from the 1990s, has demonstrated wide-ranging 
immunomodulatory activity by propolis extracts at several stages of the innate immune 
system, with pronounced anti-inﬂammatory results, in some cases equal to standard anti-
inﬂammatories (189-191). Studies have shown activity, or inferred activity, by propolis 
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extracts in reducing prostaglandin and leukotriene expression (60, 192, 193). Some studies 
have speciﬁcally shown inhibition of cyclooxygenases and lipoxygenases, or cell membrane 
stabilisation, as probable pathways (60, 194). This effect is not universal, with increased 
expression of inﬂammatory cytokines by stimulus of peritoneal macrophages observed (194). 
This stimulant effect on macrophages would appear to be dose-dependent; lower doses 
inducing hydrogen peroxide release and higher doses inhibiting nitric oxide (NO) production 
(195), with a range of activity against inducible nitric oxide synthase noted (196-198). 
Nevertheless, inhibition of the activation and differentiation of macrophages, generally 
through decrease in cytokine expression, would appear to be one of the main anti-
inﬂammatory pathways of propolis extracts (199-201). The anti-inﬂammatory effect of some 
propolis extracts has been demonstrated in a number of animal models, such as 
formaldehyde-induced arthritis, prostaglandin E2 (PGE2) induced paw oedema, carrageenan-
induced paw oedema (192, 202, 203) and zymosan-induced acute inﬂammation (204). 
Studies looking at compounds isolated from propolis have also demonstrated anti-
inﬂammatory activity. Major ﬂavonoids (chrysin, galangin and quercetin) have been shown 
to reduce PGE2 levels through reduction of cyclooxygenase and lipoxygenase expression, 
particularly COX-2 (205-207). In addition, quercetin, along with genistein, kaempferol, and 
daidzein, inhibits activation of STAT-1 (signal transducer and activator of transcription 1) 
and NF-κΒ (nuclear factor kappa-light-chain-enhancer of activated B cells), important 
transcription factors for inducible NO synthase (187). Caffeic acid has demonstrated 
inhibition of arachidonic acid production as well as COX-1 and -2 activity (208, 209) and 
various oxidases, including myeloperoxidase (210), ornithine decarboxylase, lipoxygenase, 
and tyrosine kinase (211). Through ion channel inhibition, caffeic acid also has known action 
against cytokine release by T cells (212, 213). Caffeic acid phenethyl ester (CAPE) from 
temperate propolis has wide activity: inhibiting cytokine release, reducing T cell proliferation 
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(214), reducing COX-2 expression (215), inhibiting NO release (216) and inhibiting NF-κΒ 
activation (217-220). Artepillin C from Brazilian green propolis has been shown to inhibit the 
production or release of PGE2 (214), NO, and tissue necrosis factor (TNF) (221); prenylated 
analogues were noted to have increased antioxidant activity (222, 223). 
1.5.4 Antineoplastic activity 
Extracts of propolis from a number of locations and a variety of solvents have shown broad 
antineoplastic activity, both in vitro and in vivo (224). Much of this effect is commonly 
attributed to various immunomodulatory activities as described above; particularly 
augmentation of non-speciﬁc immunity by macrophage activation with resultant release of 
immunogenic compounds, as per the anti-inﬂammatory action (225). Other observed or 
proposed pathways include: regulation of kinases (226-228); estrogen-like activity (229, 
230); TRAIL mediated apoptosis (231, 232); caspase regulation (227, 230, 233, 234); and, in 
the case of CAPE, induced oxidative stress via glutathione depletion (235). 
Water extract of Croatian and Brazilian propolis have been shown to inhibit growth of human 
cervical carcinoma and Chinese hamster lung ﬁbroblast lines, and also to decrease number of 
lung tumour nodules in mice (236-238). Water extract of Japanese propolis inhibits murine 
S-180 sarcoma cells, as well as the growth of transplanted tumours in mice (239). Ethanolic 
extract of Brazilian propolis has broad noted effect; preventing colon cancer development in 
rats induced by 1,2-dimethylhydrazine (DMH) (240), increasing NK (natural killer) cell 
activity in murine lymphoma (241), increasing interleukin expression in murine melanoma 
(242, 243), reducing human prostate cell proliferation (226), as well as reducing growth rate 
of four colon cancer lines (CaCo2, HCT116, HT-29 and SW480) (244). This latter anti-colon 
cancer activity was also demonstrated by Chinese propolis ethanolic extract (244). More 
specialised activities have been demonstrated in some studies: antimitotic activity was noted 
for at least one study into Turkish propolis (245). Portuguese propolis extract has been shown 
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at very low concentration to lower lipid peroxidation and hemolysis from peroxyl radicals, 
with resultant antiproliferative effect on cancerous cells speciﬁcally (246). 
Despite these ﬁndings, use of whole propolis extracts is problematic, non-speciﬁc and 
probably unnecessary (224). Much propolis extract is poorly bioavailable due to poor 
aqueous solubility, despite attempts to remedy this through micellar delivery methods (247) 
or use of water extracts (236). An illustrative study by Awale et al. demonstrated the value of 
extraction and testing of individual compounds. Methanolic extract of Brazilian red propolis, 
with 100% cytotoxicity at 10 µg/mL against human pancreatic cancer line PANC-1, was 
investigated for component compounds; activity was mostly due to one isoﬂavonoid 
compound, (6aR,11aR)-3,8-dihydroxy-9-methoxypterocarpan, which maintained 100% 
cytotoxicity against PANC-1 at 12.5 µM, and, in addition, had markedly better speciﬁcity to 
cancerous cells (248). 
As such, studies into the antineoplastic activity of many compounds isolated from propolis 
exist. Chrysin, a noted ﬂavonoid constituent of temperate propolis, has been shown to disturb 
cell cycle progression and hence cancerous cell division (249); observed decrease in 
expression of human telomerase reverse transcriptase has been postulated as a mechanism of 
action (250). In addition chrysin, alongside two other notable compounds from temperate 
propolis, caffeic acid and quercetin, has shown strong cytotoxic effect on ﬁve leukaemia cell 
lines (MOLT, JURKAT, HL-60, RAJI and U937) (251). Chrysin has also been shown to 
reduce size and number of preneoplasmic hepatic nodules, induced by diethylnitrosamine, in 
rats, with associated reduced expression of COX-2, NF-κB and others (233). Many other 
ﬂavonoids have showed antineoplastic activity; in one particularly notable case, a ﬂavanol 
from Mexican propolis, (2R,3S)-8-[3-phenylprop-2-en-1-one]-4′,7-dihydroxy- 
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3′,5-dimethoxyﬂavan-3-ol10, had action against A549 lung cancer and HT-1080 ﬁbrosarcoma 
cell lines stronger than 5-ﬂuorouracil, a current anticancer drug (252). 
In addition to ﬂavonoids, a number of terpenes from propolis have demonstrated anticancer 
potential. Two cycloartanes from Burmese propolis, 27-dihydroxycycloart-24E-en-26-oic 
acid and (22Z,24E)-3-oxocycloart-22,24-dien-26-oic acid, have shown strong cytotoxicity, 
the former against A549, HeLa cervical cancer and HT-1080 (253), the latter against 
PANC-1 (254). Manool, a diterpene from Greek propolis, has shown speciﬁc antiproliferative 
activity against a human colon cancer line, HT-29 (255). 
Perhaps the most commonly studied of propolis compounds against cancer is CAPE. Several 
studies have demonstrated that CAPE has cytostatic and cytotoxic action against various 
cancer cell lines, both animal and human, whilst proving markedly less active against 
analogous non-cancerous cell lines (256, 257). A number of active pathways have been 
elucidated. Broadly, CAPE has demonstrated antioxidant activity; as such, it prevents 
carcinogenesis by oxidative stress and has been suggested as a template for anticancer drug 
design in this area (258). Additional antineoplastic pathways include inhibition of NF-κB, 
arachidonic acid metabolism via lipoxygenases (259), and the nucleotide turnover salvage 
pathway via xanthine oxidase (260, 261). More speciﬁcally, CAPE has demonstrated an 
antihepatocarcinogenic action by inducing a number of cytochrome P450 isoforms that 
metabolise diethylnitrosamine, a noted liver toxin (262). Antioxidant-mediated inhibition of 
tert-butyl-hydroperoxide-induced hepatotoxicity in both HepG2 hepatic cell line and rat liver 
has also been noted (235). Antimetastatic activity has been observed with CAPE: on 
hepatocellular carcinoma via matrix metalloproteinase inhibition (235) as well as A549 lung 
                                                 
10 Li et al. (2010) has this compound named as [4-phenylprop-2-ene-1-one] throughout; inspection of the 
structure given in table 1 of that paper shows this is clearly a nomenclature error for [3-phenylprop-2-ene- 
1-one]. 
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adenocarcinoma cells via the phosphatidyl inositol 3-kinase/Akt pathway (263). CAPE is also 
known to induce mitochondria-mediated apoptosis in human myeloid leukaemia U937 cells 
(230), as well as PANC-1 (264) and prostatic cancer-3 cells (265, 266). This latter action has 
led one study to recommend CAPE as an adjuvant to radiation therapy in prostate cancer 
(266). 
Some prenylated cinnamic acid derivatives investigated for anticancer activity are artepillin 
C, baccharin and drupanin, all derived from Brazilian green propolis (267). All three 
compounds have known cytostatic effect on human gastric, colon cancer and leukemia cell 
lines at low concentration (15 µM) (267). Additionally, artepillin C has demonstrated broad 
apoptotic antineoplastic activity in a number of studies on human cancer cell lines and in vivo 
(268-271), with safety of dosage shown in animal studies (271, 272). 
1.5.5 Other notable activities 
Several studies have suggested beneﬁcial results in diabetes with propolis. Administration of 
encapsulated propolis in type-2 diabetes mellitus has been reported to both decrease fasting 
blood glucose levels and to increase the activity of endogenous insulin (273). CAPE has also 
been proposed as an anti-diabetic agent, as it is observed to stimulate glucose uptake in 
cultured skeletal muscle cells (274). 
Brazilian green propolis has a demonstrated anti-ulcer action, both in stomach and diabetic 
ulcers, by increasing epithelialisation rates and reducing the ingress of pro-inﬂammatory 
neutrophils and macrophages (275-278). 
Propolis collected from Sydney, NSW has been proposed to have protective activity against 
sunburn and skin cancers, reducing cutaneous inﬂammation, immunosuppression and lipid 
peroxidation induced by UV exposure (279). Other skin protective activity has been 
demonstrated by CAPE in several melanoma cell lines (B16-F0, B16F10, SK-MEL-28, 
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SK-MEL-5) (280) and tumour growth inhibition in one model (B16-F0 melanoma in 
C57BL/6 mice) (281). 
1.5.6 Safety of administration 
Propolis extracts appear to be generally non-toxic, despite large variation in absolute toxicity 
(30); studies in mice have returned a LD50 range from 700-7340 mg/kg as a single dose (6, 
282, 283), and chronic ethanolic extract dosing of up to 5000 mg/kg/day demonstrated no 
change in mortality rates of mice in at least one study (284). Reﬂecting this, a large number 
of propolis products are listed on the Australian Register of Therapeutic Goods (421 as of 
October, 2016) as safe for human use (285). 
One caveat is the possibility of allergy to some propolis types. Several studies have reported 
contact dermatitis and other allergic response to propolis (286-289), particularly in 
beekeepers or instrument makers who have had prolonged exposure (32, 290-292). It has 
been suggested that allergenic potential is limited to temperate-type propolis (293), and 
speciﬁcally to two esters present in poplar-type propolis alone: benzyl salicylate and benzyl 
cinnamate (294). Cross reactivity to certain plant fragrances and colophony11 has been noted 
for those sensitive to propolis (295). A study by Orsi et al. gives a possible mechanism for 
propolis allergy showing that despite broad antihistamine action at low dose, in high 
concentrations (300 µg/mL) propolis directly activated mast cells promoting inﬂammatory 
cascade (296). 
                                                 
11 Another name for rosin, especially when manufactured from conifer resins. 
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1.6 Preparation and analysis of propolis samples 
1.6.1 Harvesting and extraction of propolis 
Propolis, being dispersed throughout the hive and containing quantities of beeswax, pollen 
and hive detritus in the raw state, requires harvesting and extraction to produce samples for 
analysis and clinical use. A variety of different methods have been developed. 
Initial harvesting of propolis from the hive can alter the proportion of various chemical 
constituents in resulting propolis samples. A study by Papotti et al. into harvesting of Italian 
propolis from the Emilia Romagna region, of constant poplar source, compared the chemistry 
of samples harvested by three methods: scraping of the inner surfaces of hives, scraping of a 
3-5 mm wide space created by resting the cover above the super of a hive on wooden wedges, 
and scraping of plastic propolis mats12 placed between the super of a hive and the cover. The 
results showed statistically signiﬁcant variation, with the wooden wedges method showing 
lower wax and higher total phenolic content, as well as generally higher ﬂavone and 
ﬂavanone content (297). A later study by the same group showed large variation in a battery 
of antioxidant tests by propolis gathered in these three methods and extracted in multiple 
solvents, with directly scraped samples again testing poorly (298). Another study by Sales et 
al. using Argentinian propolis demonstrated the wooden wedges method produced propolis 
with much higher lead content (3-4 times greater) than that produced by use of two different 
types of propolis mat. This was attributed to use of lead-containing paints and varnishes in 
hive construction (299). 
Propolis is generally ground to a powder, often with help of freezing, prior to extraction with 
a solvent to reduce heterogeneity (24). Many different solvents can be utilised in propolis 
extraction. Studies have been performed using water (36, 204, 238, 239), chloroform and 
                                                 
12 For an example of a propolis mat in use, see ﬁgure 1. 
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acetone (298), ethyl acetate (300, 301), hexane (301), even benzene, ether and others in one 
older patent (302). However, propolis is usually extracted with alcohols, especially ethanol, 
often in combination with water (24). 70% ethanol in water is very commonly used in 
studies; despite this approximating the folk use of distilled spirits to produce propolis tincture 
(5), studies demonstrating the strong hydrogen bonding of ethanol and water to a variety for 
ﬂavonoids commonly found in propolis have been performed, giving a theoretical 
justiﬁcation for the continued use of this system (303, 304). 
Several techniques for increasing the efﬁciency of propolis extraction in ethanol/water 
systems exist. One study into Croatian propolis tested extraction under a range of 50%-96% 
ethanol, room temperature up to boiling under reﬂux, and duration of 30 minutes to 8 hours. 
Optimal extraction was noted at 80% ethanol at room temperature for 1 hour; increased 
temperature, duration and alcoholic concentration was not noted to improve extraction (305). 
Progressive stepwise extraction has shown good results: using 10 g Polish propolis in 100 mL 
of 35% ethanol initially, then 55% on the residue, then ﬁnally 75%, yielded much higher 
polyphenol content (449 mg/g to 178 mg/g) than single extraction with 75% ethanol, with 
better performance across a number of antioxidant assays. This study utilised cold maceration 
over 2 weeks with no agitation (306). Another study extracted 1 part of a Brazilian propolis 
arising from Baccharis uncinella13, in 25 parts 70% ethanol by three methods: cold 
maceration under 24 h continuous stirring, Soxhlet extraction for 6 h at 65°C, and sonication 
in an ultrasonic bath for 1 h at 70°C. In the latter two cases, samples were left to cool for 8 
hours and precipitated wax ﬁltered out. Soxhlet extraction demonstrated the highest 
                                                 
13 This propolis extracted by de Lima et al. (2016) is unusual: Brazilian propolis more usually has the plant 
source Baccharis dracunculifolia. 
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extractive power by UV spectroscopy, but sonication produced extracts with better 
antimicrobial action when loaded into hydrogel patches (307). 
The utility and time-saving capacity of ultrasonic extraction compared to cold maceration in 
70% ethanol systems has also been conﬁrmed in a small study by Trusheva et al. on poplar 
propolis. This study also reported a statistically-signiﬁcant lack of difference between 
propolis to solvent ratios of 1:10 and 1:20. Microwave-assisted extraction was shown to be 
problematic compared to cold-maceration, demonstrating less extractive power than 
ultrasonic methods and showing active destruction of phenolic compounds with repeated 
application (308). Recent work suggest that careful control of temperature during microwave 
methods can prevent this (309). By comparison, ultrasonic extraction, certainly under usual 
schedules, would appear to not appreciably degrade many common ﬂavonoids, as compared 
with extraction of the same ﬂavonoids from honey where glycosylation of some ﬂavonoids 
by ultrasound is noted (310). At least one study has suggested ultrasonic extraction is more 
effective at lower ethanol content (35%) and higher pH, noting higher extractive power and 
bactericidal activity against gram-positive bacteria in resulting extracts than standard 
maceration, with the caveat that antioxidant power is lower (311). 
Another technique shown to be statistically equally-effective as extraction by cold maceration 
is high hydrostatic pressure extraction. This study extracted 10 g of Chinese propolis with 
resin source Styphnolobium japonicum, the Japanese pagoda tree, in 350 mL 75% ethanol in a 
sealed polyethylene bag subjected to 500 MPa pressure for 1 min (312). High pressure 
extraction techniques have also been demonstrated with water extract of green Brazilian 
propolis (313). 
High pressure extraction using supercritical CO2 has been developed in recent years. This 
technique, although less efﬁcient than maceration and other low-pressure techniques, is of 
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interest due to the ability to avoid or reduce use of organic solvents, for both sensitivity and 
food-grade concerns. Initial extraction at 100-150 bar with the second extraction at 250-300 
bar was found to separate waxes from ﬂavonoids and other phenolics (301). Extraction rates 
of Brazilian green propolis were observed to improve with addition of ethanol as a co-
solvent: 5-7% ethanol improved extraction to approximately half that observed with ethanolic 
maceration (301); 10-15% ethanol equalled or bettered maceration extraction (314). Work to 
reﬁne the parameters for extraction of various Brazilian propolis types continues, with a 
particular focus on artepillin C and p-coumaric acid concentrations in resulting extracts (315, 
316). 
Vapour distillation of Brazilian propolis, using ether as solvent (100 g/50 mL for 2 h), to 
produce an essential oil rich in acetophenone and beta-linalool was performed in a study by 
Atungulu et al. The essential oil was observed to prevent oxidation of rice lipids (317). 
1.6.2 Thin layer chromatography 
As a relatively simple technique, TLC has seen extensive use in propolis analysis for many 
years. An early study by Ackermann sets out the approach at its very simplest: samples of 
propolis extract and raw propolis, extracted by the author, were redissolved in ethanol and 
spotted onto the TLC plate, eluted under two solvent systems (toluene:chloroform:acetone 
40:25:35 and hexane:ethyl acetate:acetic acid 60:40:3), developed with dilute sulfuric acid 
solution and heated, observed under UV and inspected visually. Ackemann noted that easily 
distinguished and consistent patterns were formed by both the raw propolis and its associated 
extract (47). With variations in the solvent systems and developing conditions used, and often 
with comparison to individual ﬂavonoid controls, this quick and simple diagnostic system is 
still utilised in more current studies (132, 318). 
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A number of sophistications to increase the analytical power of TLC have been implemented. 
Use of scanning densitometry of TLC chromatograms, with reference to the UV absorption of 
pinocembrin standard, was able to produce absolute percentages of ﬂavonoid content in 
poplar-type propolis samples (319). Attempts at improving the data available from 
densitometry by 2D TLC (where an eluted chromatogram is rotated 90° and eluted under 
another solvent system) with comparison to ﬂavonoid standards were also attempted, but 
limited by the lack of commercial systems at the time (320). Some studies looking at the 
antibiotic potential of compounds in propolis samples have performed bioautographic TLC, 
wherein sterilised developed chromatograms are covered with a thin layer of microbe-
containing growth medium and incubated. Bands with evident antibiotic potential were then 
extracted and analysed by other means (321, 322). 
Increased resolution and precision of chromatograms can be obtained by automation of plate 
loading, elution, development and photography processes, a technique called high precision 
TLC (HPTLC). Most studies currently using TLC for propolis analysis utilise some form of 
HPTLC; resulting chromatograms are visually inspected alone in some studies (323, 324). 
However, more detailed analytical means are common, primarily computer-aided statistical 
analysis of ﬂuorescence under UV of samples. A typical example is a study by Sârbu and 
Moţ, where intensity of light emitted (AU) by a chromatogram under UV (366 nm) was 
calculated for three channels (Red, Green, Blue) over Rf to produce a ‘ﬁngerprint’ for each 
sample. Fuzzy hierarchical clustering of the ﬁngerprints produced subgroups of samples that 
matched collection season and geographical location (325). Similar HPTLC methods have 
been used, with various statistical analyses, most notably principal component analysis 
(PCA), for assessment of poplar-type propolis subtypes and adulteration in the Balkans (326, 
327). PCA of densitometry data of greyscale-converted HPTLC chromatogram images has 
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also been used to successfully differentiate Chinese poplar propolis from poplar bud resin, a 
common adulterant (328). 
Several of the techniques detailed above are being combined in recent studies to extract the 
maximum analytical data from HPTLC. These include: bioautographic HPTLC studies with 
associated statistical analysis of resultant growth medium images (329); automated real-time 
mass spectrometry (MS) analysis of bands eluted by TLC or HPTLC (330), with multivariate 
data analysis (331, 332); and, as a logical conclusion, HPTLC plus bioautography plus real-
time MS (333). 
1.6.3 Ultraviolet-visible and infrared spectroscopy 
Unsurprising, as a long-used and easily-implementable method of analysis, spectroscopy 
across the entire spectrum has been extensively utilised in propolis research. Commonly, 
visual inspection of spectroscopic data has been used to determine levels of various 
constituents in propolis samples or extracts. Ultraviolet-visible light (UV-vis) 
spectrophotometry has been utilised in studies determining levels of lead in Argentinean 
propolis from various harvest methods (299), as well as polyphenol content of Algerian 
propolis via the Folin-Ciocalteu method (334). Near-infrared spectroscopy (NIS) has seen 
more extensive use as a tool for analysis of wax levels in propolis samples (335) and, with 
Fourier transform of spectral data (FTIR), analysis of propolis extract incorporation to 
cyclodextran gel matrices (39) and chitosan ﬁlms (38). FTIR has also seen extensive use in 
evaluation of propolis and nanoparticles, where propolis is source material (336), catalyst for 
other materials (337) and adhered layer on nanoparticles (338). Ukrainian propolis has been 
observed by IR spectroscopy, when forming ﬁlms on various semiconductor materials 
(indium, gallium and bismuth selenides), to have photosensitivity in the IR range (hν < 1.2 
eV), forming a workable IR photodetector in circuits (40, 41). 
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Use of 2D-IR methods is reported in one study into Chinese propolis adulteration by Wu et 
al. This study, having separated propolis extracts from poplar bud resins by PCA of 1D-FTIR 
spectra, formed 2D-data by taking FTIR spectra over a temperature range of 50°C to 120°C. 
This 2D data was used to identify long-chain alkanes, long-chain alkyl esters and long chain 
alkyl alcohols as marker compounds present in poplar bud resin at much higher levels than in 
propolis (78). This is not the only study investigating PCA of FTIR data for identiﬁcation of 
adulteration of Chinese propolis by polar bud resin, a seemingly everlasting problem (339). 
Other studies performing PCA analysis of spectroscopic data have successfully identiﬁed and 
separated propolis by general geography/botany of harvest area (340) and region of harvest 
(341, 342) as well as conﬁrmed pre-determined antioxidant activity of propolis samples (343) 
and ﬂavonoid levels (342). 
Other statistical methods applied to spectroscopic data include partial-least squares regression 
on NIR spectra to predict levels of eight heavy metals in propolis from several countries 
(344), and on UV-vis spectra to predict chemical constituents in commercial Brazilian 
propolis extracts, this latter study ﬁnding manufacturers invariably misstated the contents and 
strength of their products (345). A sophistication of this statistical tool by Nie et al. applied 
several evolutionary machine-learning algorithms to test and strengthen partial-least squares 
regression models for the successful estimation of chrysin and galangin levels in Chinese 
propolis samples (346). 
1.6.4 Gas chromatography 
Gas chromatography-mass spectrometry (GC-MS) techniques have been used to analyse 
propolis components and to group propolis samples since early analyical studies. Several 
early papers on Polish propolis by Maciejewicz et al. set out the general method: propolis 
extracts are vaporised, compounds eluted by GC and simultaneously analysed by MS, with 
identiﬁcation of compounds by reference to GC-UV spectroscopy and tables of MS ion 
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fragments (347-349). As propolis ethanolic extracts are not always suitably volatile various 
mean to increase volatility are often utilised: in these papers by taking the steam-volatile 
fraction of propolis (349) or by hydrolysis of extract in 5% KOH methanolic solution (348). 
Much GC-MS work on propolis, especially those concerned with isolation of compounds 
from propolis samples or extracts, continue with these techniques. Prior rough separation of 
compounds by column chromatography is surprising rare (350), with dry propolis extract the 
main starting material. Although there exist some studies where chemical derivatisation of 
extract to increase volatility apparently was not required (351, 352), these are unusual. Steam 
distillation of volatiles is still occasionally utilised (353), along with more unusual techniques 
such as pyrolysis of propolis samples with GC-MS of the resultant vapour (354). Silylation of 
hydroxyl moieties by either bis(trimethylsilyl)acetamide (BSA) or 
N,O-bis(trimethylsilyl)triﬂuoroacetamide (BSTFA) prior to GC is a common derivatisation 
method (122, 355-357). Use of diazomethane to methylate propolis samples is reported in at 
least one paper (358). 
Many studies have grouped and characterised propolis samples into geographical types by 
visual inspection of data from GC-MS, with studies performed in Europe (106, 107), Greece 
(108), Malta (359), Java (360), Brazil (361), Oman (362), Africa (363) and the USA (364). 
Botanical sources have been identiﬁed by some of these studies (106, 359, 362). 
Differentiation and grouping of propolis produced in one geographical area by various 
species of stingless bees in Brazil (365), several races of Apis mellifera in Turkey (110), and 
between Apis mellifera and Tetragonisca angustula in South East Brazil (366) have also been 
performed by this method. 
An interesting study by Aliboni et al. developed a GC-MS procedure for analysis of levels of 
two common propolis allergens, benzyl salicylate and benzyl cinnamate, added as internal 
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standards. Known quantities of both esters were added to propolis extracts prior to GC, as 
absolute levels in samples would otherwise be below the limit of detection. Any amount of 
both compounds detected above the initial amounts added as standards arises from the 
propolis samples. This study detected the named allergens in poplar-type propolis only (294). 
Curiously few studies performing statistical analysis of GC-MS data exist, compared to TLC 
methods. A study into Brazilian green and brown propolis by Bittencourt et al. produced 
multiple ethanol, hexane and dichloromethane extracts of both propolis types. PCA and 
hierarchical clustering of GC-MS data of these extracts produced consistent clustering by 
extract type and, more broadly, by propolis type. Correlation of 29 compounds isolated with 
each type of extract were performed by Pearson’s correlation method, to produce insight into 
the biologically active compounds for each extract (367). Three studies performing 
multivariate PCA of GC-MS data from standard means and dynamic headspace sampling 
(DHS), a means of isolating volatile components, exist, showing good clustering of Brazilian 
propolis by season of harvest (368), and of Chinese propolis by known botanic type and 
region (369, 370). The latter two studies also included data from olfactometric methods in 
their statistical analysis, one using a standard human olfactory assessment at a GC snifﬁng 
port as compounds were eluted (369), the other utilising this technique and, in addition, an 
‘electronic nose’ odour-proﬁling device (370). 
1.6.5 High performance liquid chromatography 
High performance liquid chromatography (HPLC) is the most commonly utilised tool for 
analysis in propolis research. Perhaps the simplest HPLC technique is visual inspection in 
HPLC-UV chromatograms for previously-obtained standards at known retention times. An 
early paper by Bankova et al. is illustrative; solutions of various ﬂavonoids commonly found 
in propolis (quercetin, pinocembrin, chrysin etc.) at various concentrations and ratios were 
produced and HPLC-UV chromatograms obtained. Samples of south Bulgarian propolis were 
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then analysed; visual comparison with the standards allowed determination of both ﬂavonoids 
present and their comparative composition ratios (371). Amazingly, variations of this basic 
technique for analysing ﬂavonoid composition are still current (372), even as of 2014 (373). 
Other uses of broadly similar HPLC-UV techniques include: quality control of marketable 
propolis and extracts (374, 375), comparison of extraction methods (376), seasonal variation 
analysis (377, 378), counterfeit propolis detection (79, 379), comparison of fresh and aged 
propolis samples (380), and, of course, typing of propolis from single geographical locations 
(361, 381, 382), occasionally with identiﬁcation of plant sources (81, 112, 383). 
A commonly used reﬁnement of HPLC is real-time MS of eluted compounds, as with GC. 
Analytical information from HPLC-MS is commonly used in identiﬁcation of ﬂavonoid and 
general chemical composition of propolis samples and fractions thereof (122, 384-386), or for 
typing and botanical source analysis (74, 387, 388), but other analyses have used this 
technique. Biological investigations into the absorption and excretion rates of commercial 
poplar propolis extract in humans and also into dry Uruguayan poplar propolis extract 
metabolism in rats have analysed blood samples (389), and plasma and urine samples (390) 
taken at various time points after ingestion. A previously mentioned study by Papoti et al. 
into variation in propolis chemistry with harvesting method also utilised HPLC-MS (298). 
More sophisticated uses of HPLC-UV and HPLC-MS data beyond visual inspection exist. A 
paper by Zhou et al. developed a means of similarity scoring of HPLC-UV ﬁngerprints. 19 
distinctive chromatogram peaks arising from ﬂavonoids (not all identiﬁed) in Chinese 
propolis were taken as the parameters for the ﬁngerprint: peak height and retention time were 
marked relative to the peak for chrysin, an easily identiﬁable and dominant peak. Roughly 
120 samples of propolis from 10 provinces of China were ﬁngerprinted and average, 
representative ﬁngerprints calculated for each province. Average similarity score for 
individual samples to their respective province’s average ranged from 0.793 ± 0.042 to 0.962 
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± 0.023 (range 0.000-1.000), with the authors noting that the accuracy of the calculated 
province representative ﬁngerprint declined with both increased geographic spread and lower 
number of samples within a province (391). An automated look-up program utilising a library 
of UV and MS data from HPLC of 39 phenolic compounds commonly found in propolis was 
created by Gómez-Romero et al. This program was able to successfully identify, with high 
certainty, polyphenolic compounds in a commercial dietary supplement of known chemistry 
containing mostly propolis, lemon, borage, brassicas, garlic and onion (392). 
As with GC, a surprisingly limited number of studies on statistical analysis of HPLC data 
have been performed. PCA performed on HPLC-UV data of 40 samples of SE Brazilian 
propolis identiﬁed three groups, distinguished by variant levels of kaempferol derivatives, 
p-coumarates and benzopyran derivatives, some prenylated. Plant sources were not identiﬁed 
(393). PCA of HPLC-UV data on a limited subset of 12 peaks corresponding to common 
polyphenolic compounds in propolis was able to separate 44 Bulgarian propolis samples into 
identiﬁable lowland and highland varieties, again without identifying botanic source (394). A 
method utilising HPLC-UV ﬁngerprints, obtained in line with green analytical chemistry 
principles, was shown to reliably separate Brazilian green propolis from propolis samples 
from other countries, both by PCA and by partial least squares-discriminant analysis (395). 
PCA of MS data alone, obtained via HPLC methods, clearly separated 14 samples of 
Brazilian red propolis into three distinct groups, only one of which identiﬁably matched a 
known D. ecastaphyllum resin source (82), highlighting the current ﬂuid identity of ‘red 
propolis’ and the value of statistical analysis (396). 
1.6.6 Nuclear magnetic resonance 
Nuclear magnetic resonance (NMR) has generally seen use in propolis research as a means of 
determining structure for compounds puriﬁed from propolis, often alongside MS and various 
spectroscopic methods. Such use dates back to the 1980s, such as in a study by Bankova et al. 
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identifying pinocembrin, chrysin, galangin, quercetin, isorhamnetin, and tectochrysin in 
Bulgarian poplar-type propolis (397). 1D 1H- and 13C-NMR are still current as identiﬁcation 
methods, with use of methanol-d4 or chloroform-d as solvent standard (352, 398-400). 
Common 2D-NMR experiments, such as correlation spectroscopy (COSY), heteronuclear 
single-quantum correlation spectroscopy (HSQC) and heteronuclear multiple-bond 
correlation spectroscopy (HMBC) are occasionally reported (401, 402), including one study 
investigating the stability and breakdown products of nemorosone, the main constituent of 
Clusia rosea ﬂoral resin and brown Cuban propolis (403). 
Some studies utilising NMR data, generally 1H-NMR spectra, for typing by visual similarity 
have been performed (387, 404). One interesting Argentinian toxicology study analysed 
samples of a commercial propolis cold-remedy that had been prepared using improper 
solvents, proving fatal in 15 out of 29 cases studied. 13C-NMR was utilised to conﬁrm HPLC 
ﬁndings that the extract was 65% w/v diethylene glycol and 32% propylene glycol, and 
contained very little actual propolis (405). Visual inspection of 1H-NMR has been used by 
our group to compare plant resins, resin samples from bee corbiculae and propolis samples, 
demonstrating A. paradoxa and Lepidosperma sp. ‘Montebello’, among others, as botanical 
sources of Kangaroo Island propolis (132, 406). This later study also utilised hierarchical 
clustering of 1H-NMR data to a small degree (406). 
Computerised analysis of NMR data is increasingly utilised. Bertelli et al. took the 1H-NMR 
spectra of 12 common phenolics in propolis. 1H-NMR spectra of 65 propolis samples were 
then taken, and processed to correct misalignment of peaks due to factors such as pH, ionic 
strength, solvent, ﬁeld inhomogeneity and temperature. The standardised ﬁngerprints were 
then analysed using proprietary software to assess presence and relative amounts of the 12 
phenolics; results were conﬁrmed by HPLC-MS analysis (407). PCA of 1H-NMR ﬁngerprints 
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has also been performed, successfully grouping propolis by broad geographical location 
(408), harvesting method (297) and botanic source in one collection area (409). 
Work by Maraschin et al. on propolis from Santa Catarina state, Brazil, has utilised machine 
learning techniques to identify variables for grouping of propolis as PCA on 1H-NMR spectra 
of these samples produced insufﬁcient clustering, with samples spread widely over axes of 
two principal components identiﬁed. Several techniques were found to be useful when 
applied to processed and binned 1H-NMR data, where each binned shift range represented 
one variable: PLS-DA, a multivariate regression method for identifying and testing key 
variables; random forest, a random evolutionary algorithm method producing hierarchical 
results; and two wrapper method evolutionary algorithms J48/EA and JRip/EA, utilising 
evolutionary ‘ﬁtness’ as a measure of solutions. The authors noted that, in addition, these 
processes not only produced accurate grouping metrics, both by broad type and season of 
harvest, but also highlighted shift ranges representative of marker compounds in propolis 
types encountered (410, 411). 
1.7 Standardisation of analytical data 
1.7.1 Limitations of propolis studies 
Despite the obvious wide range of biological activity of propolis extracts, progress into 
standard medical application and processing of these extracts has been slow and extreme 
caution must be exercised in extrapolating from individual studies to propolis generally. 
Many studies persist in poor identiﬁcation of the propolis samples used. Despite large 
amounts of evidence and resulting consensus for at least 40 years that propolis is not 
chemically consistent, a number of studies are still performed on ‘propolis extract’, deﬁned 
no further (293). As Araujo et al. note, many studies into stingless bee propolis even fail to 
report the genus, let alone species, of the producing bee (214). There is a continuum of 
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attempts at identiﬁcation of propolis in biological studies: by broad location, such as a 
number of studies unhelpfully listing ‘Australia’ as source of propolis samples (384, 412, 
413) down to by location and likely plant resin source, stating local plants (122). 
The gold standard of propolis identiﬁcation is analytical comparison of plant resin source to 
propolis from individual hives, combined with direct observation of collection by bees (133, 
293). This is rarely demonstrated in studies, as resin collection by bees is not a particularly 
common activity (63). Chemical comparison alone is often illustrative, but not always 
accurate – several misidentiﬁcations of plant source by use of chemical markers alone are 
noted in the literature (81). Complicating matters is the tendency of studies to investigate 
bulk propolis from a number of hives in an area; a serious issue for source identiﬁcation due 
to the known variance in collection habits even in neighbouring hives (76, 83). 
There is an unhelpful vitalist approach by some researchers in propolis towards a ‘magical 
thinking’ that anything that is ‘natural’ (i.e. propolis and bee products) must inherently be 
better than standard ‘chemical’ pharmaceuticals or products14 (414, 415). This unstated (or 
even explicit) belief colours some research: sadly, a number of very poor quality studies on 
the use of propolis as part of ‘apitherapy’ (often in regimes alongside royal jelly, bee venom, 
‘herbs’ and other oddities) for all sorts of maladies are still presented at conferences (416). 
This belief, in a lesser and perhaps unconscious form, can be seen in the far larger number of 
studies that investigate biological activities of propolis extract as opposed to individual 
compounds isolated from propolis (83). Even allowing for known synergistic effects within 
propolis samples, the science of biological activity of propolis would be more robust – and 
                                                 
14 The rejoinder to this viewpoint is expressed succinctly and thoroughly in Goldberg and Chemjobber (2014).  
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more immediately translatable to use as standard therapy – through looking at compounds 
individually or in known combinations (224). 
Propolis is a complex, non-standard, mixture; reﬁnement and standardisation of extractive 
and analytic techniques, alongside thorough statistical analysis of analytical data, is both 
paramount and generally lacking from the literature (293). What few studies do perform 
statistical analysis of their propolis samples are often host to other deﬁciencies: for instance, 
those studies outlined above utilising PCA, or other statistical analysis, on NMR ﬁngerprints 
had a sample size no larger than 80 (410), with one performing PCA on a mere 6 samples 
(409). None of these studies included resinous plants from the area, even in cases where 
novel propolis was identiﬁed and speciﬁed to a geographic area (408), although use of marker 
compounds was widespread. 
1.7.2 Utility and necessity of NMR metabolomics 
A sounder metabolomic approach, considering these limitations in propolis research, is 
clearly warranted. Metabolomic analysis, broadly deﬁned15, is one of a number of ‘omic’ 
analyses, such as genomics or proteomics, that aim to look at the totality of expression of 
certain substances within an organism (417). In the case of metabolomics, the compounds 
investigated are not genes or proteins but small molecules: secondary metabolites arising 
from cellular processes, such as sugars, organic acids, terpenes, amino acids etc. (418). 
Metabolomics, initially developed for the investigation of human cells or biological liquids 
for medical purposes (417, 419) has seen much use over the last decade for analysis of 
natural products; allowing characterisation and separation of closely related plants, as well as 
quantitative evaluation of metabolite content by comparison to standards (‘chemometrics’) 
                                                 
15 With the caveat that one pioneer of NMR metabolomics, Jeremy Nicholson, is quoted in Hunter (2009) as 
stating: ‘‘Metabolomics has about 20 published deﬁnitions, conﬂicting but all analytical, all about measuring 
some stuff in some other stuff’’. 
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(418, 419). Due to the complexity of identifying and evaluating every possible molecule in 
plant samples (which can run to the thousands for even one part of a plant) use of NMR 
ﬁngerprinting, produced through standardised means, is typical (418, 419). This produces a 
snapshot of chemical identity that, although not the ‘platonic ideal’ of total chemical identity 
of a sample, is more information-rich than chromatographic data and ideal for further 
statistical analysis, often by PCA (418-420). NMR methods are, in addition, quicker and 
require less plant sample to produce useable data (420). 
1.7.3 NMR metabolomics in honey 
An illustration of the improvements needful in propolis research can be made by reference to 
metabolomics and chemometrics studies performed on another beehive product of varying 
botanical source: honey. 
Honey is produced by honeybees from a very large number of plant nectars, plant secretions 
and bug excretions (honeydews) (421). As per propolis, there is both a broad chemical 
similarity amongst honeys (> 95% supersaturated saccharide solution, mostly glucose and 
fructose (422)) but wide-ranging individual chemical differences depending on the botanic 
source. Such minor components include proteins, amino acids, organic acids, ﬂavonoids, 
vitamins, minerals, and volatiles (421). Qualiﬁcation of these differences is necessary: not 
only to reliably identify single-source honeys for marketing, organoleptic or medicinal 
purposes but, unfortunately, to identify adulteration with various sugar syrups or fraudulent 
labelling (421). The standard means of identiﬁcation of honey source is by 
melissopalynology: microscopic identiﬁcation of pollen grains within the honey (423), 
generally with the aid of physiochemical properties, such as colour, ﬂavour, pH, electrical 
conductivity, optical activity, and enzymatic activity (424, 425). Melissopalynology, 
however, is an imperfect tool: it is slow and requires specially-trained staff to implement, 
and, due to environmental presence of pollen, is not totally speciﬁc to one plant source but 
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instead more suited for differentiation by geographic area (421, 426). Fraudulent ﬁltering of 
honey to remove pollen, sometimes with misleading addition of other pollen, can also 
invalidate the analysis (421). Even with addition of physiochemical measures a minor 
component of honey, with marked properties such as strong ﬂavour or colour, can dominate 
in a blend (427). 
As such, a number of metabolomic investigations of honey have been performed, utilising a 
variety of analytical tools. However, NMR analysis is certainly the most promising: with a 
capacity to identify structure of marker compounds; ease, speed, speciﬁcity and 
reproducibility of process; and non-destructive to samples (421). PCA on 1H-NMR spectra of 
Polish honey water extract separated heather, buckwheat, lime, rape, acacia and multiﬂoral 
honeys, identifying speciﬁc marker compounds for several, such as 4-(1-hydroxy- 
1-methylethyl)-1,3-cyclohexadiene-1-carboxylic acid for lime honey (428). Similar work on 
Brazilian honey separated eucalyptus, citrus and wildﬂower honey as well as adulterated 
honeys, the latter showing higher levels of citric acid, ethanol and 5-hydroxymethylfurfural 
as markers (429). Other honey source markers identiﬁed by various NMR studies include: 
kynurenic acid for sweet chestnut, α-isophorone and 2,5-dihydroxyphenyl acetic acid for 
strawberry-tree (430), and quercitol for oak honeydew (identiﬁed by 2D total correlation 
spectroscopy (TOCSY)) (431). A recent work by Popescu et al. integrated physiochemical 
investigations with NMR to characterise various Romanian honeys (432). Various NMR 
means of identifying adulterated honey have been performed, with 1D 1H-NMR PCA proving 
equally as discriminative as more complex investigations (429, 433, 434). 
Recent developments are demonstrating the predictive power of large-scale metabolomic 
methods. One impressive study by Schievano et al. investigated 1H-NMR spectra of 
chloroform extracts of a large representative sample range of Italian honeys, identiﬁed by 
traditional melissopalynologic methods, forming a training set (n = 983, 174 citrus, 130 
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acacia, 111 chestnut, 96 linden, 85 eucalyptus, 78 wildﬂower, 65 honeydew, 54 sulla, 40 
rhododendron, 37 thistle, 30 sunﬂower, 31 asphodel, 24 ailanthus, 12 cherry, 11 apple, and 5 
alfalfa). PCA was used to cluster NMR spectra; from these clusters, one-versus-all orthogonal 
partial least squares-discriminant analysis (OPLS-DA) created models where one class of 
honey was compared to all other honeys considered as a single class, with marker compounds 
identiﬁed and used to reﬁne the models. These models were used to produce a predictive 
score for new honey samples, ranging from 0 if the sample did not belong to that class to 1 if 
it did belong to that class. Intermediate scores indicated signiﬁcant contribution of that class 
to the total makeup of the new sample. Using these means, 120 new honey samples were able 
to have primary, secondary and tertiary nectar source identiﬁed, with > 90% agreement with 
traditional means (427). Similar studies, though at much smaller scales, have also been 
performed to identify Finnish honeys (435), and to predict manuka content of New Zealand 
and Oceania honey (436). 
Propolis research is heading, slowly, towards sound metabolomics although, as previously 
mentioned, identiﬁcation of marker compounds with biological origin is lacking. One notable 
exception, however, is a paper by Anđelković et al. investigating botanic source of poplar-
type propolis. This study investigated propolis samples (n = 59) from Serbia, Bosnia and 
Herzegovina and Bulgaria, alongside buds of the aspen (Populus tremula), black poplar (P. 
nigra) and American aspen (P. x euramericana), grown in Serbia. Reference to in-house 
NMR databases of phenolics, along with 2D NMR methods, were used to identify 23 
metabolites in propolis samples. Orthogonal partial least squares to latent structures (OPLS) 
analysis was used to correlate altitude of collection site with NMR spectra, successfully 
separating higher-altitude propolis from lower-altitude samples. To identify the botanical 
source, two-way orthogonal partial least squares (O2PLS) analysis was performed on both 
the propolis and P. spp. buds datasets to identify covariance; resultant models identitiﬁed P. 
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tremula as resin source above 500 m and P. nigra and P. x euramericana as resin source 
below 400 m. The OPLS and O2PLS models produced were used to identify metabolites 
most important for separation; scoring was done by VIP scores of the predictive components 
(VIPpred) method, with score > 1 as cutoff for importance. Samples collected above 500 m 
altitude were notable for 1,3-di-p-coumaryl-2-acetyl-glycerol, 1,3-diferulyl-2-acetyl-glycerol, 
benzyl p-coumarate and coniferyl benzoate. Samples collected below 400 m were notable for 
chrysin, galangin, pinocembrin, and pinobanksin 3-O-acetate. Altitudes 400-500 m returned 
mixtures of the above. Although the ﬁndings of this paper are by no means surprising, the 
thoroughness of analysis is certainly novel in the propolis ﬁeld (437). 
1.7.4 Use of similarity scoring in natural products 
It has been clearly demonstrated that PCA, hierarchical clustering, partial-least squares and 
other statistical analyses of analytical data, most especially 1H-NMR data, can cleanly 
differentiate and group natural products by similarity. With the addition of plant material 
databases, plant source may also be identiﬁed by these means as well as distinctive marker 
compounds. However, not all natural product databases are static: performing a full analysis 
of all data every time a new natural product sample is added to a database is tedious and takes 
away from the speed and utility of these processes. 
Similarity scoring is a general term for numerous means of producing a score, generally 
ranging from 0-1, for quickly analysing the likeness of one sample to another sample or 
average of samples. The concept, as a means of quickly interpreting NMR and other 
analytical data, has existed in the literature for some years, due to the relative ease of spectral 
acquisition versus the relative time-intensive manual structural analysis of spectra. Several 
papers by Bodis et al. set out the general method. Various means of mathematical 
comparison, such as correlation coefﬁcient, dot product, Euclidean distance, and match 
probability may be utilised, but only work well for broad or very close in shift NMR spectral 
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peaks (438). Compression and standardisation of data points to counteract this are performed 
by normalising integral intensities between 0 and 1 and ‘binning’ total integral value over 
shift ranges (438). This approach may be generalised to 2D and HSQC spectra, complete with 
automated removal of solvent and artefact peaks (439). More recent work by Castillo et al. 
has avoided the need for binning and normalising by converting NMR spectra to 
representative binary ‘trees’, with (ideally) one node per peak, converging to a radix at the 
mass centre of the spectrum. Created trees are then compared for similarity. This method, 
despite being quicker and more data efﬁcient, loses some data as nearby peaks are coalesced 
into one node (440). These methods are already being used in active research of new natural 
products. In one example, automated similarity scoring of fractions from extracts of sponges 
of order Poecilosclerida, looking for unusual and non-repeating signals (i.e. low similarity to 
a library of compound spectra), identiﬁed and isolated a novel compound, iotrochotazine A, a 
potential tool for Parkinson’s disease modelling (441). 
In beehive products, to date, little similarity scoring has been performed, with PCA of total 
analytical datasets the standard separating treatment. The robust study of Schievano et al., as 
mentioned above, demonstrates the value for both honey and propolis of greater use of 
similarity scoring, with the use of OPLS-DA models to produce scores for likeness to known 
honey types (427). With regards to propolis, the less-complete HPLC-similarity paper of 
Zhou et al., utilising correlation coefﬁcients between propolis chromatograms and average 
propolis chromatograms for geographic regions, is perhaps the most complete example (391). 
As such there is a need for calculator tools to produce similarity scores from NMR data of 
propolis samples. NMR spectra utilised should be: obtained by a standardised means to 
reduce spectral variance; robustly identiﬁed and typed by hierarchical clustering, PCA or 
other statistical means; and identiﬁed with plant resinous sources or marker compounds by 
the same. This technique, increasingly used in natural products research and novel to propolis 
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research, would allow quick and reliable identiﬁcation of propolis samples and, with some 
alterations, identiﬁcation of mixtures. 
1.8 Propolis as tool for natural products research 
Greater analytical power is of extreme importance in propolis research as the struggle to 
identify and produce new pharmaceutically-active compounds for biological testing currently 
faces many issues. Fashionable combinatorial chemistry methods, though productive for 
optimising structures, are seemingly poorly productive without natural product lead 
compounds: Newman et al. note only one approved drug, sorafenib, arising de novo from 
combinatorial chemistry in the 30 years from 1981-2010 (442). Understandably, even the 
most thorough of combinatorial databases can scarcely compare to the chemical space of 
innately active compounds produced by millions of years of evolution by millions of species 
(443). In these circumstances, reappraisal of the value of natural products chemistry must be 
stressed. It bears repeating that at least 40% of drugs in the pharmacopeia are ultimately 
traceable to natural products research (442). This percentage is higher with regards to 
antibiotics and anticancer drugs, an area where growing rates of resistance are rapidly 
invalidating many of humanity’s most powerful tools for health and progress (442, 443). The 
capacity to more rapidly and thoroughly identify and assess the full range of secondary 
metabolites and derivatives from natural products is absolutely essential; metabolomic and 
chemometric analysis is the answer (444, 445). 
However, we do not have the resources, manpower or funding to assess every plant in a given 
environment thoroughly. Propolis is a particularly useful solution in this circumstance: the 
bees do the initial chemometric assessment for us. As mentioned above, bees collect 
speciﬁcally resinous plant material of innate biological activity (72-74), immunogenic and 
antibiotic (88, 89), for hive defence and hygiene (90): any plant product with these activities 
is already worthy of further pharmaceutical research. As bees forage up to 11 km from the 
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hive (67, 68), a large area is inspected and only materials worthy of further investigation 
brought back to a central location, and all within days of a hive being placed in situ16. Far too 
many propolis researchers are happy to stop at this point, but identiﬁcation of plant source 
and separation of active compounds allows pharmaceutical research proper to commence. 
Application of metabolomic techniques at this stage furthers the investigative power of 
propolis collection and ease of plant source and lead compound analysis. 
In an Australian context, propolis is an even more useful tool. Much of the country lacks the 
resinous plants honeybees prefer to collect from (Populus spp.) forcing honeybees to collect 
from novel plants – approximately 8 on Kangaroo Island alone, so far, for instance (131-133, 
139, 406). Our country has a very large number of native stingless bees, whose cerumen is 
largely unanalysed (123). Australia has a distinctive ﬂora, much of it not fully characterised, 
and the harsh climate and predation conditions to encourage resin production (446). Despite 
numerous promising ethnopharmacological studies, our indigenous population was subject to 
a harsh and, in many ways, ongoing dispossession, disrupting full transmission of indigenous 
knowledge of medicinal plants (446, 447). In rare cases, Kangaroo Island in particular, there 
was no indigenous population at the time of Western settlement (129). Conceivably, the 
number of pharmaceutically interesting compounds from natural products awaiting discovery 
in the Australian bush is very large indeed: propolis research is one promising means to ﬁnd 
them. 
  
                                                 
16 Speaking from experience, this is far more efﬁcient than any doctoral candidate or other researcher can ever 
hope to achieve. 
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1.9 Aims of study 
This study formed part of ongoing investigations into Australian propolis, and Kangaroo 
Island propolis more generally as the most chemically-distinctive Australian propolis types 
identiﬁed to date. Past investigations by this group have been directed towards three 
overarching aims: 
• Chemistry of novel Australian propolis types 
• Botanical sources of these propolis types 
• Pharmaceutical evaluation of these propolis and botanical sources. 
This study inherited those broad aims. Work of the past studies have uncovered an ever 
increasing number of types and subtypes of KI propolis with broad pharmaceutical interest: a 
clear need for a more systemic investigation means for both propolis samples and resinous 
plants on KI, easily expandable to mainland studies, has gradually presented itself. 
Metabolomic assessment means have demonstrated their worth in natural products studies, 
including in another variable and complex beehive product, honey. As an initial means of 
separating and grouping chemically-similar propolis samples, metabolomics, especially NMR 
metabolomics, is the obvious choice. Data from these analyses would enable generation of a 
set of calculator tools allowing quick, accurate and relatively easy identiﬁcation of individual 
samples. 
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With this background, the particular aims of this study were: 
• Formulation of reproducible, standard analysis methods for KI propolis samples and 
resinous plants 
• Metabolomic and statistical analysis of the results of these standard analyses, with 
sub-aims: 
o conﬁrmation or identiﬁcation of KI propolis types and subtypes 
o conﬁrmation or identiﬁcation of plant sources of KI propolis types 
o identiﬁcation of non-pure propolis samples 
• Programming of similarity-scoring calculating tools for the immediate assessment of 
individual Kangaroo Island propolis samples 
• Chemical characterisation of new KI propolis types identiﬁed by metabolomic means 
• Initial biological assessment of compounds isolated from new propolis types. 
Scope was allowed for minor expansion of these particular aims to cover mainland plants 
closely related to KI resinous plants, as well as mainland propolis identiﬁably of novel 
chemistry. Methods and tools generated were required to be easily-implementable and 
immediately expandable to cover propolis research Australia-wide, in order to meet the 
overarching aims of our group’s research. 
  
 
 
 
 
 
Chapter Two 
Materials and methods  
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2.1 Materials 
2.1.1 Propolis 
Over 1400 propolis samples (approximately 1 g to > 1000 g) were individually collected over 
a period from winter 2006 to winter 2016 by beekeepers or researchers, primarily on 
Kangaroo Island, from a large number of geographically and botanically diverse apiary sites. 
Each sample was collected by manual scraping from a plastic propolis mat (such as that 
illustrated in ﬁgure 1) at the top of one hive or hives at one apiary site, on one collection date. 
Samples were not collated or mixed between collection dates or hives/apiary sites. Duplicate 
samples were not collected. Scraped propolis was transferred to ziplock freezer bags for 
storage. 
2.1.2 Plant and plant resin samples 
Over 200 plant samples, primarily of genus Lepidosperma, were collected over a period from 
summer 2010 to winter 2016 by researchers, primarily from Kangaroo Island and within 
foraging distance of apiary sites. Lack of permits precluded collection from nature reserves 
on Kangaroo Island. Where size permitted, whole plants were collected; for larger plants, 
foliage appearing resinous or shiny was collected. Where quantity permitted, duplicate 
samples were collected. 
For some Lepidosperma spp., resin (20 to 100 mg) for analysis was removed by gently 
running a fresh pointed bamboo stick (3 mm diameter satay stick) along the inner surfaces of 
the leaf and transferred to a 4 mL glass vial with a Teﬂon disc seal. 
2.1.3 Solvents and reagents 
Solvents used in this study, including acetic acid, acetone, chloroform, dichloromethane, 
ethanol (food-grade), ethyl acetate, hexane, isopropanol, methanol and methanol (HPLC-
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grade), were of analytical grade unless otherwise noted and purchased from Chem-Supply 
Pty Ltd (Gillman, South Australia, Australia). 
Deuterated chloroform and methanol were sourced from Cambridge Isotope Laboratories, 
Inc., Andover, MA, USA. Deuterated DMSO was sourced from Sigma-Aldrich Chemie 
GmbH, Steinheim, Westphalia, Germany. 
Iron (II) chloride tetrahydrate was sourced from Sigma-Aldrich Chemie GmbH, Steinheim, 
Westphalia, Germany. Iron (III) chloride hexahydrate and silica gel 60 H (particle size 5 – 40 
µm) were sourced from Merck Group, Darmstadt, Hesse, Germany. 
2.2 General instruments and equipment 
2.2.1 Data processing 
All data processing, unless otherwise mentioned, was performed using Microsoft Excel 2013 
(Microsoft Corp., Redmond, WA, USA). 
2.2.2 Mass spectrometry 
All MS was performed by the Mass Spectrometry Facility of the School of Chemistry, 
University of Sydney in electrospray ionisation mode using MeOH as solvent. Low-
resolution MS was performed using an amaZon SL quadrupole ion trap mass spectrometer 
and high-resolution electrospray ionisation mass spectrometry (HRESIMS) was performed 
using a 7T solariX XR Fourier transform ion cyclotron resonance mass spectrometer (both 
Bruker Corp., Billerica, MA, USA). 
2.2.3 Nuclear magnetic resonance 
All NMR experiments were performed using a Gemini 2000 400MR System, with SMS 
autosampler and software interface VnmrJ v.4.2 revision A (all Varian, Inc., Palo Alto, CA, 
USA) on an 8-core HP Z420 Workstation (Hewlett-Packard Co., Palo Alto, CA, USA). 1H 
spectra were measured at 400 MHz and 13C spectra at 100 MHz; both at temperature 23°C. 
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2.2.4 Rotary evaporator 
Initial drying of samples was performed using either: R-114 Rotavapor with V-700 vacuum 
pump, V-850 vacuum controller and B-490 water bath, or; R-210 Rotavapor with MZ 2C 
NT+AK+EK vacuum pump (Vacuubrand GmbH & Co. KG, Wertheim am Main, Baden-
Württemberg, Germany), V-850 vacuum controller and B-490 water bath (all BÜCHI 
Labortechnik AG, Flawil, St. Gallen, Switzerland unless noted). An FE 500 recirculating 
cooler (JULABO GmbH, Seelbach, Baden-Württemberg, Germany) was used to circulate 
cold water (5°C) for condensation. Water baths were maintained at 40°C and vacuum < 50 
mBa used with multiple ﬂushing of rotary evaporator during drying process. 
2.2.5 Scales 
For weights ≥ 320 g, a Basic BA610 laboratory scales was used (Sartorius AG, Göttingen, 
Lower Saxony, Germany). For weights < 320 g an AB304-5 laboratory scales was used 
(Mettler-Toledo, Greiensee, Zürich, Switzerland). 
2.2.6 Sonication bath 
An FXP10 M ultrasonic cleaner (Unisonics Australia Pty Ltd, Brookvale, NSW, Australia) 
was used in extracting propolis samples. Samples were sonicated three times for 15 minutes 
with 15 or 30 minutes cooling between treatments (maximum bath temperature approx. 
50°C). 
2.2.7 Ultraviolet lamp 
Inspection of TLC plates was performed using a Spectroline ENF-260C/FE UV lamp and 
CM-10 ﬂuorescence analysis cabinet (Spectrosonics Corp., Westbury, NY, USA). 
2.2.8 Vacuum oven 
A 5831 vacuum oven (National Appliance Co., Salt Lake City, UT, USA) using a DirectTorr 
vacuum pump (Sargent-Welch, Buffalo, NY, USA) was used for ﬁnal drying of samples for 
NMR analyses. Samples were dried for 16 hours at < 20 mBa, and temperature < 40°C. 
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2.2.9 Vacuum pump 
Vacuum for short-column chromatography was provided by a V-700 vacuum pump with 
V-850 vacuum controller (BÜCHI Labortechnik AG, Flawil, St. Gallen, Switzerland). 
2.3 General methods 
2.3.1 Storage of samples 
Propolis samples underwent initial storage by individual beekeepers in domestic freezers17. 
All samples after collection by the research group were transferred to Sydney by domestic 
cooler box. Long term storage of propolis was in a Kelvinator No Frost 360 Freezer (AB 
Electrolux, Stockholm, Sweden). Long term storage of resinous plants was in the freezer 
compartment of a Silhouette Series II refrigerator (Westinghouse Electric Corporation, 
Cranberry Township, PA, USA). Samples undergoing active laboratory investigation were 
temporarily stored in a PLFSD-400 Laboratory Freezer (Labec Laboratory Equipment Pty 
Ltd, Marrickville, NSW, Australia). All samples undergoing refrigeration were stored at 
approx. -18°C. 
2.3.2 Propolis preparation 
2.3.2.1 Crushing of propolis 
Propolis samples were cooled to a low temperate (-20°C to -80°C) and crushed to a powder, 
with the powder thoroughly mixed to reduce heterogeneity. 
2.3.2.2 Extraction of propolis 
1. Prepared propolis samples from 2.3.2.1 (500-5000 mg for ﬁngerprint generation; 30 
or 60 g for CP-propolis fractionation) were mixed with EtOH or MeOH (10-100 mL; 
600 or 1200 mL) in a conical ﬂask or scintillation vial, as appropriate for the volume 
of solvent, then treated in a sonication bath as per 2.2.6. 
                                                 
17 Two samples, P109 and P112, went through a washing-machine by accident prior to freezing. 
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2. The mixture was allowed to cool to room temperature (approx. 22°C) and left for up 
to 72 hours away from light. 
3. The mixture was ﬁltered using a glass funnel and a ﬂuted ﬁlter (qualitative no. 1, 125 
mm). 
4. The mixture was evaporated in a round bottomed ﬂask with a rotary evaporator and 
the residue weighed. 
2.3.3 Taxonomic identiﬁcation of plant samples 
2.3.3.1 Lepidosperma spp. samples 
Identiﬁcation of Lepidosperma spp. and other Cyperaceae plant samples was performed by 
the National Herbarium of New South Wales, Royal Botanic Gardens, Sydney, NSW, 
Australia. Identiﬁcation was by comparison to morphological and anatomical characters, 
primarily those identiﬁed by Hodgon et al. (2006) (448) augmented by Barrett (2007) (449, 
450) and Plunkett et al. (2013, 2014) (136-138). Further characters were added based on 
differences among specimens observed by this study and Plunkett et al. (unpublished paper) 
(451). Morphological characters were scored from herbarium specimens with the aid of a M8 
stereomicroscope (Leica Camera AG, Wetzlar, Hesse, Germany). Morphological dimensions 
were measured once per tentative new species to form a voucher specimen using a steel rule, 
electronic callipers or microscope eyepiece graticule for each dimension. Fruit and perianth 
characters were also assessed by stereomicroscope. Diagnostic characters were photographed 
and stored, along with the voucher specimen, at the National Herbarium. 
2.3.3.2 Other plant samples 
Non-Cyperaceae plant samples were provisionally identiﬁed in-house using Kangaroo Island 
botany resources (452-454). 
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2.3.3.3 Labelling of plant samples 
Plant samples collected were assigned an individual code of form YYMMDD-AB, where ‘A’ 
was the collection site order and ‘B’ the sample collection order. For example, 160720-21 
represents the ﬁrst plant collected at the second site of plant collection on the 20th July, 2016. 
2.3.4 Sedge resin extraction 
1. Harvested whole sedges were trimmed of roots, cut to approx. 10-15 cm long from the 
base, washed of dirt, and dried. 
2. These sedge bases were cut to 1 cm lengths by scissors into an Erlenmeyer ﬂask, to a 
weight of 1-10 g sedge. 
3. 50 mL MeOH, EtOH, or a mixture of these two solvents was added to the ﬂask and 
the contents gently agitated for approx. 5 minutes. 
4. The resulting extract was ﬁltered using a glass funnel and a ﬂuted ﬁlter (qualitative 
no. 1, 320 mm). 
5. The extract was evaporated in a round bottomed ﬂask with a rotary evaporator and the 
residue weighed. 
2.3.5 Thin layer chromatography 
2.3.5.1 Small-scale extraction of propolis 
1. Prepared propolis from 2.3.2.2 (1 g) was weighed into a 20 mL glass scintillation vial 
and EtOH or MeOH (15 mL) added. 
2. The sample vials were sonicated as per 2.2.6. 
3. Time was allowed for the vials to cool to room temperature (approx. 22°C) and for the 
un-dissolved content to settle before TLC analysis. 
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2.3.5.2 Small-scale preparation of plant sample extracts 
1. Individual plant samples, collected in the ﬁeld, were stored in ziplock plastic bags. 
2. A 20 mL glass scintillation vial was ﬁlled with collected plant material and 1-2 mL 
EtOH or MeOH added. The sealed vial was shaken, and left for approx. 1 min. 
2.3.5.3 TLC procedure 
1. F254 Silica gel 60 H coated 200 mm × 200 mm sheets (Merck Group, Darmstadt, 
Hesse, Germany) were each cut to four 100 mm × 100 mm sheets (‘plates’). 
2. A ﬁne pencil line was drawn 10 mm from the lower edge of the plate. Points to apply 
samples were marked on the line by pencil 10 mm from the edge, then at 8 mm 
intervals using a ruler, producing 11 marked points to apply samples per plate. The 
codes for each of the samples were written in pencil against each mark.  
3. Fine glass capillaries were prepared by drawing soda glass, melted in a natural light 
petroleum gas ﬂame, and cutting the capillaries to length (approx. 80 mm) with a 
small silicon carbide stone.  
4. A selected glass capillary was placed in a vial with EtOH as cleaning solvent. The 
capillary after removal was touched onto a clean sheet of tissue paper to empty the 
capillary. The clean capillary was dipped into the ﬁrst sample solution to draw up the 
liquid by capillary action. To spot the plate the capillary was touched onto the coded 
mark on the plate to allow liquid to ﬂow out of the capillary to give a spot 2-3 mm in 
diameter.  
5. To clean the capillary the remaining liquid was drawn out by touching the end of the 
capillary onto tissue paper then drawing cleaning solvent into the capillary. 
6. Steps 4 and 5 were repeated until all the samples were spotted onto the plate, and the 
plate was left standing (approx. 5 min) before development to allow any remaining 
spotting solvent to evaporate.  
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7. A TLC development tank was prepared by adding development solvent 
(hexane:isopropanol 4:1, 25 mL) to the tank, which was ﬁtted with an upright 
rectangular sheet of ﬁlter paper to assist with rapid solvent vapour saturation of the 
tank. After time was allowed for the tank to approach solvent vapour saturation the 
TLC plate was placed in the chamber. The plate was allowed to develop until the 
solvent front reached the top of the plate. The developed plate was removed from the 
tank and the solvent allowed to evaporate. 
8. Where sample quantity allowed, steps 1-7 were performed in duplicate. 
9. Plates were photographed in visible light, short wavelength UV light (254 nm) and 
long wavelength UV light (365 nm). 
10. To further visualise constituents plates were treated by a pre-prepared solution of 
FeCl2 or FeCl3 chemical reagent, as per 2.3.5.4, and photographed.  
2.3.5.4 Production and utilisation of iron chloride reagents 
FeCl2 tetrahydrate (1 g) or FeCl3 hexahydrate (1 g) was dissolved in EtOH (100 mL) and 
ﬁltered (glass funnel and folded ﬁlter paper) to remove any particles. The reagent solution 
(100 mL) was poured into a large Petri dish. The TLC plate held by the top right-hand corner 
was quickly immersed and removed from the reagent solution, allowed to drain and then 
placed on absorbent paper sheets to allow the EtOH to evaporate. Colour development 
occurred immediately on contact with the reagent.  
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2.3.5.5 Visual assessment of extracts 
Samples were visually classiﬁed based on retention and detection characteristics of the 
chromatograms produced by the above methods. Four means of visual assessment, with 
comparison to standards, were made: 
1. Visible image 
2. UV short wavelength ﬂuorescent background image (254 nm) 
3. UV long wavelength image of ﬂuorescent emission (365 nm) 
4. Visual image after development with FeCl2 or FeCl3 reagent. 
2.3.6 High performance liquid chromatography 
2.3.6.1 Preparation of propolis samples 
1. Prepared propolis samples from 2.3.2.2 (10 mg) were mixed with methanol (5 mL) in 
a scintillation vial then treated in a sonication bath two times for 5 minutes with 15 
minutes cooling between treatments (maximum bath temperature approx. 50°C). 
2. The mixture was allowed to cool to room temperature (approx. 22°C) and left for 12 
hours. 
3. The mixture was ﬁltered using a glass funnel and a ﬂuted ﬁlter (qualitative no. 1, 125 
mm). 
4. Propolis extract (0.1 mL) was taken and transferred to a 2 mL HPLC vial. 
5. Solvent system (MeOH:H2O:AcOH, 65:34.8:0.2, 0.9 mL) was added to the propolis 
extract. 
6. HPLC sample was centrifuged for clarity, if needed, using a Sorvall RC 6 Plus 
Centrifuge (Thermo Fisher Scientiﬁc, Waltham, MA, USA). 
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2.3.6.2 Production of HPLC ﬁngerprint 
Samples were run on a Shimadzu Nexera X2 LC-30 AD liquid chromatograph with 5IL-30A 
autosampler, using Kinetex 5µm EVO C18 100A 150 mm x 4.6 mm, 4.6 µm column with 
UV detection at 302 nm, using Shimadzu Nexera X2 5PD-M30A diode array detector. 
Solvent system was as follows: solvent A MeOH:H2O:AcOH 40:59.8:0.2; solvent B MeOH. 
A:B 70:30 for 2 min, then gradient to B 100% over 10 min, then B for 5 min. Chromatograms 
were obtained and processed using LabSolutions v.5.54 SP1 (all Shimadzu Corporation, 
Kyoto, Japan). Tables of AUC to raw retention time were produced for each sample and 
exported to Microsoft Excel 2013. The average retention time of a control peak, present in all 
sample at retention time approx. 8.3 min, over three runs of a reference propolis sample 
(P1166) was calculated, and adjustments made to rentention times for all samples such that 
the control peak in all samples was at constant relative retention time (8.339 min). An 
example of the ﬁngerprint generation process may be found at Appendix I (ﬁgure 65 and 
table 57). 
2.3.7 1H-NMR ﬁngerprint generation 
2.3.7.1 Preparation of propolis samples 
1. A portion of the ﬁltrate from 2.3.2.2, step 3, (600 µL) was evaporated in a round 
bottomed ﬂask with a rotary evaporator, and dried in a vacuum oven. 
2. This residue, assuming weight range 10-20 mg, was dissolved in either chloroform-d 
(with addition of up to 50 µL DMSO-d6 as co-solvent) or methanol-d4, transferred to 
a 5 mm diameter borosilicate NMR tube and brought up to 650 µL volume 
(equivalent liquid height of 4.8 cm) with either chloroform-d or methanol-d4. 
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2.3.7.2 Preparation of plant resin samples 
1. Resin samples were dissolved in EtOH (2 mL) and left for up to 8 hours, with 
occasional agitation, until fully dissolved. 
2. For plant samples not readily yielding resin, sticky plant material was taken and cut to 
1 cm lengths by scissors into an Erlenmeyer ﬂask, to a weight of 1-2 g sedge. 
3. EtOH (20 mL) was added and the ﬂask left for 8 hours, with occasional gentle 
swirling. As a later reﬁnement of this method, MeOH (1-2 mL) was added, gently 
swirled over the plant material, and decanted after 1-2 minutes. 
4. Solutions from either step 1 or 3 were ﬁltered through ﬂuted ﬁlter paper (qualitative 
no. 1, 125 mm) into a round bottom ﬂask and evaporated to dryness by rotary 
evaporator. 
5. The weighed samples were redissolved in a known volume of DCM, proving freely 
soluable, and a portion containing approximately 10 mg of resin was evaporated to 
dryness. 
6. Further drying was achieved by vacuum oven. 
2.3.7.3 Production of 1H-NMR ﬁngerprint 
1. Dry samples from 2.3.7.1 or 2.3.7.2, assuming weight range 10-20 mg, was dissolved 
in either chloroform-d (with addition of up to 50 µL DMSO-d6 as co-solvent) or 
methanol-d4, transferred to a 5 mm diameter borosilicate NMR tube and brought up to 
650 µL volume (equivalent liquid height of 4.8 cm) with either chloroform-d or 
methanol-d4. 
2. Dissolved samples underwent 1D 1H-NMR experiments (256 scans). 
3. Fid ﬁles produced were imported to ACD/ NMR Processor Academic Edition v. 
12.01. 
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4. Fourier transformation was performed on obtained spectra using the software’s 
default algorithm. 
5. Spectra were adjusted to reference of TMS = 0.00 ppm or CD3OD = 3.31 ppm 
6. Spectra were normalised by removal of solvent signals, if their relative height = 1, 
using the software’s default algorithm. In chloroform-d samples, potential solvent 
signals were CDCl3 [7.24-7.33 ppm], DMSO [2.55-2.65 ppm], EtOH [3.68-3.74 
ppm], H2O [1.56-2.31 ppm, broad peak]. In methanol-d4 samples, potential solvent 
peaks were CD3OD [3.31 ppm], MeOH [3.34 ppm], H2O [4.87 ppm, broad peak]  
7. Further normalisation was performed by removing signals for waxy substances not of 
interest (< 1.5 ppm) if their relative height was = 1. 
8. Phasing of spectra was performed by the software’s algorithm. 
9. Baseline was adjusted for spectra: ﬁrst automatically by the software’s algorithm, then 
by hand if needed. 
10. All shifts for peak heights above 0.05 relative height were automatically marked. 
Those in range < 1.5 ppm and any remaining solvent signals were unmarked. 
11. Any additional signals in ranges 3.2-3.5 ppm (C-prenyl CH2), 4.5-5.8 ppm (O-prenyl 
CH2) and 10-14 ppm (H-bonding) were marked by hand. Care was taken not to 
include artefacts from solvent signal removal. 
12. A table of shift to relative peak height was produced for marked signal, representing 
the ﬁngerprint for the propolis or plant sample, and exported to Microsoft Excel 2013. 
13. Depending on sample availability, both chloroform-d and methanol-d4 ﬁngerprints 
were produced for each sample. 
An example of the ﬁngerprint generation process may be found at Appendix I (ﬁgures 66-67 
and table 58). 
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2.3.8 Hierarchical clustering 
1H-NMR: Tables of recorded relative peak heights at all shifts 1.5-14 ppm (in binned 
increments of 0.01 ppm, this being innate to the processing software) for all propolis and 
plant samples were produced using Microsoft Excel 2013. 
HPLC: Tables of ﬁngerprints of AUC to RRT were calculated using Microsoft Excel 2013 
for each sample over RRT range 1.000 to 14.100 min (in binned increments of 0.001 min, 
this being innate to the processing software). 
Tables produced from the above were transferred to IBM SPSS Statistics vv. 21-24 
(International Business Machines Corp., Armonk, NY, USA). Hierarchical clustering analysis 
by variables, with each sample as a variable, was performed using between-groups linkage 
with squared Euclidean distance as interval measure, and dendrogram presentations of these 
results produced. 
2.3.9 Principal component analysis 
1H-NMR ﬁngerprints produced as per 2.3.7.3 underwent PCA using MATLAB R2016b v. 
9.1.0.441655 (The MathWorks, Inc., Natick, MA, USA), and plug-in PCA Toolbox for 
MATLAB v. 1.2 (Milano Chemometrics and QSAR Research Group, Milan, Italy) (455). 
Fingerprint data, being already normalised, was not scaled at any stage of PCA analysis. 
Optimal number of principal components was estimated using PCA Toolbox’s algorithm, 
with venetian blinds cross-validation. PCA was then performed using this number of 
principal components using PCA Toolbox’s algorithm and the results plotted using 
MATLAB’s plot capacity. 
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2.3.10 Similarity scoring 
2.3.10.1 General method of similarity scoring calculators 
Fingerprints generated by the methods detailed in 2.3.6.2 and 2.3.7.3 are of the form binned 
shift range or relative retention time (RRT) to peak height or area under curve (AUC). 
Comparison was made between two ﬁngerprints: for the purposes of this general method, ‘A’ 
and ‘B’. For each binned point produced from the above calculations, the average peak height 
or AUC of A and B was taken and that of A was subtracted; the absolute value of this 
difference between the average of A + B and A was recorded (‘C’), that is to say that: 
𝐶𝐶 =  �𝐴𝐴 + 𝐵𝐵2 − 𝐴𝐴� 
with the result that as B → A or A → B , C → 0; by comparison as B → 0, C → 𝐴𝐴/2, or (if B 
> A) A → 0, C → 𝐵𝐵/2. 
The total sum of peak height or AUC of A, B and of difference value C at each binned point 
over the total range of shift/RRT was calculated (‘ΣA’, ‘ΣB’, ‘ΣC’). The similarity score 
(‘SS’) was calculated using these summed values by the following formula: 
𝑆𝑆𝑆𝑆 = 1000 �1 − 2 Σ𝐶𝐶
Σ𝐴𝐴 + Σ𝐵𝐵� 
as such, if total differences between ﬁngerprints at binned points were large, SS → 0. This is 
as where A > B, ΣB → 0 and ΣC → Σ𝐴𝐴/2; and where B > A, ΣA → 0 and ΣC → Σ𝐵𝐵/2, thus 
overall ΣC → Σ𝐴𝐴+Σ𝐵𝐵
2
. Conversely, if total differences between the two ﬁngerprints at binned 
points were small (i.e. ΣC → 0) SS → 1000. 
Inspection of the formula used makes it clear that two completely identical ﬁngerprints will 
result in a similarity score, A to B, of 1000. Comparison of one ﬁngerprint A to a null 
ﬁngerprint B will result in a similarity score, A to B, of 0. Comparison of two completely 
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dissimilar ﬁngerprints A and B will also return a similarity score of 0, as at each binned point 
of A, either A or B will have peak height or AUC = 0. 
2.3.10.2 HPLC chromatogram similarity calculator 
A tool for calculating similarity between chromatogram ﬁngerprints was created using 
Microsoft Excel 2013 by the general method 2.3.10.1. The tool compared AUC for one 
ﬁngerprint to another (‘A’ and ‘B’) at each binned point over RRT range 1.000 min to 14.099 
min. To smooth data, increasing utility and accounting for chromatographic variance, 
multiple primary bin ranges of RRT 0.001 min, 0.01 min, 0.05 min, 0.1 min, 0.15 min and 
0.2 min were all automatically calculated. In addition, for each of these bin ranges, secondary 
smoothing of data by addition of primary values with overlapping (‘secondary binning’) was 
performed utilising: the sum of 5 neighbouring primary values with an overlap of 4 
neighbouring primary values utilised per primary value increment and similarly 5 with 3 
overlap, 5 with 2 overlap, 5 with 1 overlap and 2 with 1 overlap.  
2.3.10.3 1H-NMR spectra similarity calculators 
Two tools for calculating similarity between 1H-NMR spectra ﬁngerprints, one for 
chloroform-d and one for methanol-d4 spectra, were created using Microsoft Excel 2013 by 
the general method 2.3.10.1. The tool compared peak heights for one ﬁngerprint to another 
(‘A’ and ‘B’) at each binned point over shift range 1.50 ppm to 14.00 ppm. To smooth data to 
increase utility and account for spectral variance, multiple primary bin ranges of 0.01 ppm, 
0.02 ppm, 0.05 ppm, 0.1 ppm and 0.15 ppm were all automatically calculated. In addition, for 
each of these bin ranges, secondary binning was performed utilising: the sum of 5 
neighbouring primary values with an overlap of 4 neighbouring primary values utilised per 
primary value increment and similarly 5 with 3 overlap, 5 with 2 overlap, 5 with 1 overlap 
and 2 with 1 overlap. 
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2.3.10.4 Content prediction 1H-NMR spectra similarity calculators 
Three tools for calculating similarity between propolis 1H-NMR spectra ﬁngerprints and a 
changeable ﬁngerprint created from average ﬁngerprints of pure propolis types or plant resins 
were created using Microsoft Excel 2013. Two of these tools, one for chloroform-d and one 
for methanol-d4 spectra, calculate a similarity score, by general method 2.3.10.1, of a new 
propolis sample ‘A’, using a standard bin range and overlap, to a ﬁngerprint generated using 
changeable percentage constitution of average pure-source propolis samples identiﬁed by 
metabolomic methods from 3.3 and 3.5 ‘B’. One of these tools, for methanol-d4 spectra only, 
calculates a similarity score, by general method 2.3.10.1, of a new propolis sample ‘A’, using 
a standard bin range and overlap, to a ﬁngerprint generated using changeable percentage 
constitution of average plant resin samples identiﬁed as propolis sources by metabolomic 
methods from 3.3 and 3.4 ‘B’. All tools produce, automatically, similarity scores by general 
method 2.3.10.1 to calculated ﬁngerprints for a range of set mixtures to inform estimation and 
production by the user of the ﬁngerprint with the greatest similarity to sample A. 
2.3.11 Fractionation  
2.3.11.1 Short column vacuum chromatography 
1. Columns were prepared by loading a cylindrical glass funnel with sintered-glass base 
(internal diameter 4.5 cm or 7 cm) with an appropriate volume of Merck silica gel 60 
H. 
2. The funnel was attached to the top port of a bell jar through a rubber bung, and the 
bell jar attached by a rubber line to a vacuum pump. 
3. The silica was compressed by hand under vacuum (50 mbar) to packed silica gel 
height 1-2 cm. 
4. Samples from 2.3.2.2 or 2.3.4, in the round-bottom ﬂask, were fully dissolved in a 
chlorinated solvent (DCM or CHCl3). 
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5. A wide-neck conical ﬂask of appropriate volume (25, 50 or 100 mL) was placed 
inside the bell jar under the funnel. 
6. The dissolved sample was loaded onto the prepared column under low vacuum (800 
mbar). 
7. Additional solvent as per step 4 was added in small quantities until solvent was 
observed to collect in the conical ﬂask, at which stage solvent was allowed to run until 
no solvent was observed above the line of silica in the funnel, this forming the ﬁrst 
fraction. 
8. A series of increasingly polar fractions, using combinations of DCM, CHCl3, hexane, 
EtOAc and EtOH, were ran through the column under low vacuum and collected. 
9. TLC was performed on eluted fractions using solvent system hexane:isopropanol 4:1 
(25 mL), and chromatograms assessed as per 2.3.5.5. 
10. Fractions with no obvious constituents by TLC were discarded. 
11. Fractions were evaporated to near dryness by rotary evaporator, weight of fraction 
recorded, and stored in round bottom ﬂasks (generally 50-150 mL capacity) at room 
temperature (approx. 22°C) away from light. 
12. Fractions with chromatographic features of interest by TLC were assessed by 
1H-NMR as per 2.3.7.3 (steps 1-5); near-identical fractions by 1H-NMR were 
combined. 
13. Impure fractions and combined fractions, of interest, were re-fractionated as per the 
above process. 
2.3.11.2 Labelling of fractions 
Fractions and combined fractions were labelled in form p.x-(y-z), where x represents page of 
lab book where results were recorded (with ranges pp. 75-117 from the first lab book and pp. 
3-57, from the second lab book; the page ranges used in the two lab books did not overlap), 
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and y-z represents the range of fractions identiﬁed as similar and combined. For example, 
p.75-(5-7) represents the ﬁfth, sixth and seventh fractions resulting from the schedule set out 
on p. 75 of the ﬁrst lab book, combined into one dry sample; p.9-15 represents the ﬁfteenth 
fraction from the schedule on p. 9 of the second lab book, dried. 
2.3.11.3 Characterisation by NMR spectroscopy 
1. Weighed fractions of interest were redissolved in a known quantity of DCM, proving 
freely soluble, and an aliquot containing approx. 10-20 mg of sample was taken. 
2. This aliquot was evaporated in a round bottomed ﬂask with a rotary evaporator and 
dried in a vacuum oven. 
3. This residue, assuming weight range 10-20 mg, was dissolved in methanol-d4, 
transferred to a 5 mm diameter borosilicate NMR tube and brought up to 650 µL 
volume (equivalent liquid height of 4.8 cm) with methanol-d4. 
4. Samples underwent 1D 1H-NMR (256 or 1024 scans) and 13C-NMR (5000 scans) 
experiments. 
5. Where necessary, 2D NMR experiments were also performed. 
6. Fid ﬁles produced were imported to ACD/ NMR Processor Academic Edition v. 
12.01. 
7. Fourier transformation was performed on obtained spectra using the software’s 
default algorithm. 
8. Spectra were adjusted to reference of TMS = 0.00 ppm or CD3OD = 3.31 ppm 
(1H-NMR) or CD3OD = 49.15 ppm (13C-NMR). 
9. Phasing of spectra was performed by the software’s algorithm. 
10. Baseline was adjusted for spectra: ﬁrst automatically by the software’s algorithm, then 
by hand if needed. 
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2.3.12 Biological assays 
2.3.12.1 Sample preparation 
Dry samples of DK-1 (p.85-17) were weighed and transferred to 2 mL glass HPLC vials, 
which were then posted to Euroﬁns Panlabs (St. Charles, MO, USA), except where noted, for 
the performance of all assays. 
2.3.12.2 Cell viability assay 
This assay was performed by Euroﬁns Panlabs (Taipei, Taiwan). 43 cancer cell lines and 
HUVEC umbilical vein endothelium as control cell line (table 53) were grown in a suitable 
medium (RPMI 1640, 10% foetal bovine serum, 2 mM L-alanyl-L-glutamine, 1 mM sodium 
pyruvate or a special proprietary medium). Cells were incubated for 16 h, and a control plate 
for each cell line was harvested at this time. DK-1 at 10 µM was added to the seeded plates 
and incubated for 72 h. Seeded plates, both untreated and treated with just the vehicle used to 
dissolve DK-1, were also incubated. All three plate types were then harvested. Mass or cell 
count of both control and treated plates were calculated; from this percentage growth 
inhibition for that cell line was calculated. 
2.3.12.3 Cell proliferation assay 
Cell proliferation experiments were performed by the general methods of Fallahi-Sichani et 
al. (2013) (456) and Barretina et al. (2012) (457). 90 cancer cell lines (Appendix VI, table 
59) were grown in a suitable medium. Cells were seeded into plates and incubated. 25.4 mg 
of DK-1 was used to create a stock 30 µM solution. This solution was diluted by half-log 
steps, and assays performed over 10 concentrations. DK-1 was added the day following cell 
seeding at these 10 concentrations. At the same time, a time zero untreated cell plate was 
generated. At 7 days post-seeding, the growth media were replaced and the plates were re-
dosed with DK-1, to a maximum of the initial concentration of 30 µM. After a 10-day 
incubation period, cells were ﬁxed and stained to allow ﬂuorescence imaging of nuclei. 
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2.3.12.4 Melatonin receptor assay 
Assays to assess the antagonist capacity of DK-1 at MT3 (ML2) melatonin receptors were 
performed as per the methods of Pickering and Niles (1990) (458). MT3 (ML2) receptors 
from hamster brain were treated with a speciﬁc radioactive ligand, [125I]-2-iodomelatonin, at 
0.1 nM. DK-1 was added at 10 µM, and the experiment incubated for 1 h at 4°C. 
Displacement of the ligand by DK-1 was measured by scintillation counting. 
2.3.12.5 Anti-inﬂammatory assays 
DK-1 at 10 µM was subjected to 41 anti-inﬂammatory assays (tables 54 and 55). In the 
interests of brevity, only abbreviated methods for assays returning strong positive results (> 
50% inhibition relative to control) follow. 
COX and LO: Cyclooxygenase-2 assay was performed as per Warner et al. (1999) (459) and 
Riendeau et al. (1997) (460) on human recombinant insect Sf21 cells with 0.30 μM 
arachidonic acid substrate, and incubated for 5 minutes at 37°C. EIA quantitation of PGE2 
was used as assessment method. 5-Lipoxygenase assay was performed as per Pufahl et al. 
(2007) (461) on human recombinant insect Sf9 cells with 25.0 μM arachidonic acid substrate, 
and incubated for 20 minutes at 25°C. Spectroﬂuorimetric quantitation of rhodamine-123 was 
used as assessment method. 12-Lipoxygenase assay was performed as per Romano et al. 
(1993) (462) and Sekiya et al. (1982) (463) on human platelets with 30.0 μM arachidonic 
acid substrate, and incubated for 15 minutes at 25°C. Spectrophotometric quantitation of 
12-HETE was used as assessment method. 
Other oxidases: Monoamine oxidase assay was performed as per Urban et al. (1991) (464) 
and Youdim and Finberg (1991) (465) on human recombinant insect Hi5 cells with 50.0 μM 
kynuramine substrate, and incubated for 60 minutes at 37°C. Spectroﬂuorimetric quantitation 
of 4-hydroxyquinoline was used as assessment method. Myeloperoxidase assay was 
performed as per Svensson et al. (1987) (466) on human PMN leukocytes with 20.0 mM 
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guaiacol substrate, and incubated for 5 minutes at 25°C. Spectrophotometric quantitation of 
tetraguaiacol was used as assessment method. 
Histamine: Histamine H1 assay was performed as per Debacker et al. (1993) (467) on 
human recombinant CHO-K1 cells with 1.20 nM [3H]-pyrilamine as ligand and 1.0 μM 
pyrilamine as non-speciﬁc ligand, and incubated for 3 h at 25°C. Radioligand binding was 
measured as assessment method. Histamine H2 assay was performed as per Ruat et al. (1990) 
(468) on human recombinant CHO-K1 cells with 0.10 nM [125I]-aminopotentidine as ligand 
and 3.0 μM tiotidine as non-speciﬁc ligand, and incubated for 2 h at 25°C. Radioligand 
binding was measured as assessment method. 
Transcription response of NF-κB was performed as per Lenardo and Baltimore (1989) 
(469) on human tissue, incubated for 4 h at 37°C, with assessment by spectroﬂuorimetric 
quantitation of β-galactosidase. This experiment was also performed at concentrations of 
DK-1 of 1 µM, 0.1 µM, 10 nM and 1 nM. 
2.3.12.6 Epigenetic assays 
DK-1 at 10 µM was submitted to 143 assays to assess interaction with enzymes or cellular 
mechanisms behind epigenetic processes (Appendix VI, table 60), including bromodomains, 
chromodomains, MBT domains, PHD domains, Tudor domains, various methyltransferases, 
acetyltransferases, demethylases, deacetylases, kinases and ubiquitin modifying enzymes. In 
the interests of brevity, only abbreviated methods for assays returning stronger positive 
results (> 40% inhibition compared to control) follow. All biological ligands were human 
recombinant E. coli sourced, and incubated at room temperature for 30 minutes unless 
otherwise noted. Assessment was either by AlphaScreen sandwich immunoassay or, where 
tritiated ligands were utilised, by scintillation counting, unless otherwise noted. Lys = lysine 
for all methods. 
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Domain assays: bromodomain assays followed the method of Filippakopoulos et al. (2012) 
(470) with 75 nM biotin-H4 diacetyl Lys 5/8 as ligand. Chromodomain assays followed the 
method of Kaustov et al. (2011) (471) with 5 or 8 nM biotin-H3 trimethylated Lys 27 as 
ligand. MBT domain assays followed the method of Kim et al. (2006) (472) with 50 nM 
biotin-H3 methylated Lys 4 or 60 nM biotin-H4 dimethylated Lys 20 as ligand. PHD domain 
assays followed the method of Xie et al. (2012) (473) with 15 nM biotin-H3 trimethylated 
Lys 9 as ligand, and incubation for 15 min. 
Histone acetyltransferases: CREBBP assay followed the method of Von Wantoch 
Rekowski and Giannis (2010) (474) with 50 nM biotin-H3 acetyl Lys 56 as ligand. MYST4 
assay followed the process of Heery and Fischer (2007) (475) with 20 nM human 
recombinant (Sf9 cell) sourced histone H4 full and 20 nM [3H]-acetyl CoA as ligands, and 
incubation for 10 min. 
Histone methyltransferases: G9a assay followed the method of Yost et al. (2011) (476) 
with 5 nM histone H3 full length and 25 nM [methyl-3H]-(S)-adenosylmethionine 
([3H]-SAM) as ligands, and incubation for 120 min. hSMYD2 assay followed the method of 
Brown et al. (2006) (477) with 25 nM histone H4 full length and 100 nM [3H]-SAM as 
ligands, and incubation for 10 min. PRMT1 assay followed the method of Cheng et al. (2004) 
(478) with 25 nM histone H4 full length and 60 nM [3H]-SAM as ligands, and incubation for 
90 min. PRMT3 assay followed the method of Li et al. (2012) (479) with 250 nM histone H4 
full length and 250 nM [3H]-SAM as ligands, and incubation for 120 min. PRMT4 assay 
followed the method of Selvi et al. (2010) (480) with 25 nM human recombinant (Sf9 cell) 
sourced histone H3 full length and 60 nM [3H]-SAM as ligands, and incubation for 60 min. 
PRMT6 assay followed the method of Iberg et al. (2007) (481) with 25 nM histone H3 full 
length and 120 nM [3H]-SAM as ligands, and incubation for 120 min. WHSC1 (NSD2) assay 
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followed the method of Kang et al. (2009) (482) with 1500 nM core histone and 250 nM 
[3H]-SAM as ligands, and incubation for 15 min. 
Kinase assays followed the method of Baek (2011) (483), with 50 nM human recombinant 
(Sf21 cell) or human recombinant insect cell sourced histone H3 full length as substrate and 
50 nM [33P]-ATP as ligand, and incubation for 10 min. 
  
 
 
 
 
 
Chapter Three 
Metabolomic classiﬁcation of propolis and 
resinous plants from Kangaroo Island   
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3.1 Initial ﬁeld assessment of propolis by thin layer 
chromatography 
 
Figure 12: Representative standard chromatographic images by TLC for the main KI propolis types. 
Samples used were: S1: P28, S2: P912, CP: P493, PS: P1009, KT: P241, TT: P932, F: P266. 
Classiﬁcation of propolis samples on Kangaroo Island was necessary to allow initial 
assessment of chemistry and to provisionally identify reproducible single-plant-source 
propolis types, there being no NMR facility on the island. A TLC protocol (2.3.3), as a 
portable and rapid method, was found to be suitable. This method has been previously 
utilised in other investigations into Kangaroo Island propolis (131-133, 139, 406). Use of 
FeCl2 1% in ethanol was found to produce equally clear development of plates as the FeCl3 
solution method; in addition the use of hydrogen peroxide in various concentrations as an 
additional development agent was investigated and found unnecessary. 
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A number of standards corresponding to single-source propolis have been identiﬁed and used 
for TLC identiﬁcation of new samples, with propolis samples producing clean exemplars of 
these markers used as standards, as per ﬁgure 12. Probable pure-source propolis samples, 
identiﬁed by this method, were returned to Sydney for further analysis by NMR. Clearly 
mixed-origin samples, of minimal research interest, were discarded. 
Ongoing assessment has provisionally typed over 1400 propolis samples, predominantly from 
Kangaroo Island apiaries, with 356 samples being further analysed to produce 1H-NMR 
ﬁngerprints in chloroform-d solvent and 207 samples in methanol-d4 solvent. Notably, unlike 
many propolis studies, each sample analysed was harvested on one collection date from one 
hive or apiary site. 
3.2 Hierarchical clustering of propolis samples 
3.2.1 Hierarchical clustering of chloroform-d 1H-NMR ﬁngerprints 
Initial clustering was performed on 356 ﬁngerprints obtained in CDCl3, with results as per 
Appendix II, ﬁgure 68. Although some promising clustering matching initial TLC 
identiﬁcation was displayed, as labelled on the dendrogram, non-speciﬁcity of these clusters 
was noted with inclusions of mixtures and samples identiﬁed as other propolis types by TLC 
for each cluster of mostly pure-type propolis samples. In addition, splitting of some propolis 
types into clusters at distance was noted; particularly for S1 and CP propolis. 
Several factors possibly contributed to poor clustering of ﬁngerprints produced by this 
method. Many mixed samples, otherwise unidentiﬁed by TLC, were assessed in the hope that 
clustering with their main propolis component would occur: this was not the case, and the 
samples were observed to crowd out the dendrograms produced. Only 31 samples out of the 
356 were extracted speciﬁcally for this experiment; representing most of the CP-type and 
King Island, Tasmania samples. Other spectra were provided from previous work by our 
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research team. Notably, some very early samples were extracted with different solvents, such 
as ethyl acetate, with solvent peaks attributable to this necessitating removal in some spectra 
during the ﬁngerprint production process. In addition, samples collected prior to P356 were 
not initially assessed by TLC but by visual inspection of 1H-NMR spectra, possibly 
producing different assessments of content. 
Perhaps the most important factor introducing variability and, thus, reducing accuracy of the 
dendrogram was the use of chloroform-d as spectrographic solvent, and ethanol as extraction 
solvent. Chloroform-d was found to poorly dissolve propolis ethanolic extracts, necessitating 
use of DMSO-d6 as co-solvent. Amount of DMSO-d6 used varied with the solubility of the 
propolis sample; this variation was observed, despite the small quantity used absolutely 
relative to the chloroform-d, to create differences in shift of peaks visibly arising from 
common structural features. An example of this is shown in ﬁgure 13 for two CP propolis 
samples; the increased consistency in spectral features by using methanol-d4 is manifest. 
Ethanol as extraction solvent was observed to extract large amounts of waxes and other long-
chain carbon compounds from propolis samples, leading to raw 1H-NMR spectra with large 
peaks at low shift of low metabolomic utility. These peaks proved tedious to remove from 
spectra during normalisation, and artefacts of the removal process potentially altered shift in 
some samples. 
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Figure 13: Example of inconsistency in spectral shift of signals arising from common structural 
features in two CP propolis samples, caused by use of the chloroform-d:DMSO-d6 system (shift range 
6.77-6.98 ppm). A uniform difference of shift of approx. 0.025 ppm is clearly observable between 
P474 and P720 in the chloroform-d:DMSO-d6 system . The methanol-d4 spectra of the two samples, 
by comparison, are nearly identical to one another. 
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Attempts to improve the speciﬁcity of clustering were made on a small subset of samples by 
increasing binning ranges from 0.01 ppm to 0.02 ppm, 0.05 ppm, 0.1 ppm and 0.15 ppm 
(ﬁgure 14). This subset was composed of up to four (where possible) recently-collected and 
processed samples of each propolis type identiﬁed on KI along with some mixed samples and 
one mainland sample each from Myponga, SA and Mt Magniﬁcent, SA. One F-type sample 
used, P418, was later identiﬁed as a mixture of F- and KT-type propolis. 
Increase of binning range in this subset was found to produce little improvement in ﬁnal 
clustering, with sample P418 especially noteworthy for clustering with PS-type samples, not 
F- or KT-type. At binning range 0.15 ppm, sample P734 from Myponga, visually much 
different spectrally from KI samples, was observed to cluster with PS-type samples, an 
obvious error. 
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Figure 14: Dendrograms by hierarchical clustering of a subset of chloroform-d 1H-NMR propolis 
ﬁngerprints at increased binning range. 
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3.2.2 Hierarchical clustering of methanol-d4 1H-NMR ﬁngerprints 
To improve clustering results, a stocktake was made of all propolis samples at hand, 
identiﬁed as pure-source by TLC. 207 propolis samples were located and were freshly 
extracted using a standard and consistent methanolic process. Extracts produced 
underwent 1H-NMR using methanol-d4 alone as spectroscopic solvent. Fewer samples were 
processed than in 3.2.1, as many earlier propolis samples were no longer available and 
obvious mixed samples were not processed. Samples from King Island, Tasmania, were also 
excluded as outside the scope of research. 
Methanol as extraction solvent was found to be equally extractive as ethanol for compounds 
of interest, whilst extracting markedly less waxy compounds. However, increased time was 
needed for precipitation of microparticles of waxes prior to ﬁltration by comparison to 
ethanol extracts. Methanol-d4 as spectroscopic solvent was found to fully dissolve all 
propolis extract samples, with variance in shift much reduced, as demonstrated by ﬁgure 13. 
Clustering results of samples, as per Appendix II, ﬁgure 69, were markedly tighter and very 
closely matched TLC identiﬁcation. All samples processed were observed to cluster with 
similar propolis types, or by dominant component in mixed samples. Three exceptions, 
samples P1052, P1246 and P1409, were found on re-examination by TLC to be mixtures with 
no dominant component. Other re-classiﬁcations are detailed in 3.2.3. 
The bias towards S1-type or S1-dominant-mixed samples (112 out of 207) was not observed 
to impair successful clustering of other types, including minor propolis types. This 
dominance by S1-types reﬂects several factors: actual collection habits of bees on KI, past 
and ongoing research interest in this type of propolis, and ﬁnancial imperatives for 
beekeepers on KI to produce this type of propolis, which has been commercialised. 
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3.2.3 Reassessment of propolis samples from methanol-d4 clustering results 
Table 1: Anomalous propolis samples by hierarchical clustering, with predicted type and new TLC 
results. Hex = hexane, iPrOH = isopropanol, DCM = dichloromethane, EtOAc = ethyl acetate. 
 
Predicted type by calculator 
Ratio
Sim
ilarity Score
(M
k 4.1)
(± 5%
)
(1000)
 hex:iPrO
H 9:2
DCM
:EtO
H 3:1
P1241
S1:TT
CP
S1:CP
55:45:00
728
S1:CP
S1:CP
P956
S2
KT
KT:S2
75:25:00
634
KT m
ix
KT:S2 m
ix
P1332
F
KT
KT
100
611
KT
F
P850
KT
S2
S2
100
736
S2
S2
P1061
KT
S2
S2
100
674
S2
S2
P1253
KT
PS
PS:KT
90:10:00
714
KT:PS
KT:PS:CP
P798
CP
PS
PS:KT
80:20:00
651
PS:CP
PS m
ix
P42
sedge 2a
S1
S1:KT
55:45:00
635
?S1 m
ix
?S1 m
ix
P810
PS
S1
S1:TT
80:20:00
702
S1:PS
S1 m
ix
P954
CP
S1
S1:PS
55:45:00
674
S1:KT:PS
S1:KT:PS
P808
CP
S1
S1
100
695
S1:F
S1
P1073
S1:TT
S1
S1:CP
95:05:00
681
S1:TT
S1
P906
S1:R
f  0.7
S1
S1:F
95:05:00
746
S1 m
ix
S1 m
ix
P815
KT
S1
S1:S2
95:05:00
791
S1:S2
S1:S2
P604
KT
?
S1:TT
80:20:00
617
S1:S2
S1:S2
P1421
CP
F
F:CP
75:25:00
645
CP:PS
PS m
ix
P1409
S1
?
S1:TT
60:40:00
612
S1:TT
S1 m
ix
P386
KT
KT variant 2
KT
100
347
KT variant 2
KT variant 2
P513
KT
KT variant 2
KT:F
95:05:00
448
KT variant 2
KT variant 2
P955
KT
KT variant 1
KT:F
90:10:00
456
KT variant 1
KT variant 1
P863
KT
KT variant 1
KT:TT
85:15:00
600
KT variant 1
KT variant 1
P1051
F
KT variant 1
PS:CP
70:30:00
411
KT variant 1
KT variant 1
Type by new
 TLC
Sam
ple
O
riginal type by TLC
Type by clustering
  91 
 
 
Figure 15: Representative TLC chromatogram of standard KT and variants. Differences are 
particularly obvious under long wave UV and with Fe3+ treatment. Samples used were: KT P241, KT 
V1 P955, KT V2 P386. 
Several samples were found to have apparently clustered anomalously by comparison to their 
initial TLC identiﬁcation (table 1). Factors inﬂuencing this inconsistency could include 
heterogeneity of propolis sampled and difﬁculties in ﬁeld visual assessment by TLC. Notably, 
the signatures for S2 and KT, in particular, can prove difﬁcult to separate accurately when 
run under only one solvent system (ﬁgure 12). These identiﬁed samples were re-assessed by 
TLC in two different solvent systems, hexane:isopropanol 9:2 and dichloromethane:ethyl 
acetate 3:1, with visual results generally conﬁrming dominant constituent as per cluster 
position by dendrogram. Results were also shown to have good concordance with predictions 
made by an in-house spectra assessment calculator described in Chapter 4.  
Interestingly, KT-type propolis, already shown to come from A. paradoxa (132, 133), appears 
to have at least three distinct chemotypes, with variant expression of some constituents. TLC 
appearance of the three variant chemotypes can be seen in ﬁgure 15. The low maximal 
similarity scores generated by the calculator (generally < 500) would support identiﬁcation of 
these as true variants and not mixtures of propolis types identiﬁed to-date (table 1). 
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3.2.4 Hierarchical clustering of HPLC ﬁngerprints 
 
Figure 16: Dendrogram by hierarchical clustering of HPLC CP propolis ﬁngerprints 
Some initial work on clustering of propolis by HPLC ﬁngerprints was performed using 32 
CP-type propolis samples (ﬁgure 16). Further work on HPLC hierarchical clustering was 
abandoned due to poor results with HPLC chromatogram similarity scoring calculator tools 
compared to 1H-NMR calculator tools, as described in section 4.2. 
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3.3 Hierarchical clustering of propolis and plant resin 
samples 
 
Figure 17: Dendrogram by hierarchical clustering of methanol-d4 1H-NMR resinous plant 
ﬁngerprints. Samples observed to cluster with related samples are marked and labelled in red. 
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Table 2: Identiﬁed resin sources of Kangaroo Island propolis types 
 
To conﬁrm speciﬁcity of plant resin source of those KI propolis types where plant source has 
been established, ﬁngerprints were formed of 86 KI plant resin samples and related plants of 
genera Lepidosperma, Acacia and Myoporum. Plant resin was taken from harvested whole or 
part plant samples, identiﬁed by traditional means. The dendrogram of these plant resins 
shows very close matching of plant resin samples to previously identiﬁed species and 
chemotype, even amongst the numerous similar Lepidosperma spp. (ﬁgure 17). A possible 
exception is the L. sp. ‘Montebello’ complex, currently undergoing taxonomic 
reclassiﬁcation, where variant chemotypes tentatively identiﬁed by visual inspection of 
1H-NMR were not observed to cluster cleanly. 
Addition of these 86 samples to the 207 propolis samples from 3.2.2 allowed hierarchical 
clustering of propolis with plant sources (Appendix II, ﬁgure 70). Results were as per table 2, 
and matched results previously published in several studies (131, 132, 406). PS-type propolis 
was observed to cluster with leaf resin samples of Myoporum insulare, family 
Scrophulariaceae, a ﬂowering shrub widespread through coastal areas of Australia, 
conﬁrming the identiﬁcation of this plant as resin source in a recent thesis (139). Results 
further conﬁrm and inform the current taxonomic re-evaluation of the L. viscidum complex 
into several species, as the chemically-distinct resin sources of S1 and S2 propolis fell 
previously within the bounds of L. viscidum s.l. Notably, F-type propolis was observed to 
cluster with L. viscidum s.s. resin, and S2-type propolis was observed to cluster with L. sp. 
‘Flinders Chase’ resin; as-yet unpublished ﬁndings previously observed by our group. 
Propolis Type Resin source species Family Common Name
S1 Lepidosperma  sp. 'Montebello' Cyperaceae Sticky Sword Sedge
S2 Lepidosperma  sp. 'Flinders Chase' Cyperaceae Sticky Sword Sedge
KT Acacia paradoxa DC. Fabaceae Kangaroo Thorn
PS Myoporum insulare R.Br. Scrophulariaceae Common Boobialla
F Lepidosperma viscidum R.Br. s.s Cyperaceae Sticky Sword Sedge
  95 
 
3.4 Principal component analysis to identify mixed 
propolis samples 
Table 3: Samples used for the generation of average plant resin ﬁngerprints. Plant sample codes are 
as per 2.3.3.3 
 
Several mixed samples being identiﬁed as clustering with their main propolis component 
(3.2.3), investigation of the ﬁngerprint datasets from 3.2.2 by another statistical means, 
principal component analysis, to conﬁrm and identify additional mixed samples was 
performed. Subsets consisting of all ﬁngerprints for each propolis type were taken and 
compared to the average ﬁngerprints of each known resin source for KI propolis types. To 
avoid errors of classiﬁcation, only ﬁngerprints from samples of L. viscidum observed to 
cluster with F-type propolis, and also no ﬁngerprints of identiﬁed variants of L. sp. 
‘Montebello’, were used when calculating the averages. This was required as older dated 
samples identiﬁed as L. viscidum were so identiﬁed prior to the taxonomic separation of other 
related clades within genus Lepidosperma; similarly, L. sp. ‘Montebello’ is currently under 
taxonomic investigation. Table 3 lists all plant resins used for calculation of averages. 
It is important to note that the principal components (PC) identiﬁed by PCA are a somewhat 
artiﬁcial means of reducing the complexity/dimensionality of the dataset. As such, the 
identiﬁed PCs and eigenvalues bear no easily interpretable meaning, beyond being able to be 
Acacia paradoxa
Lepidosperma  sp. 
'Flinders Chase'
Lepidosperma  sp. 
'Montebello'
Lepidosperma 
viscidum s.s.
Myoporum insulare Ficinia nodosa
160720-21 150314-02 160723-11 141021-01 160723-51 131202-01
160720-23 160218-01 160723-12 160219-01 160723-52 131202-02
160720-31 150721-22 160723-21 160722-01 160723-61 131202-03
150929-04 160723-31 160803-11 160721-31
150929-16 160723-32
150929-18 160723-41
150102-11 160723-71
150102-21 160520-01p
160520-01r
100717-52
110426-53
120412-22
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applied to the matrix of the Cartesian space of the dataset in such a way to create a new 
dataset, at lower dimensionality, that covers a portion of the observed variance in the original 
dataset. Generally, identiﬁcation of enough PCs to cumulatively explain approx. 80% of 
observed variance in the dataset is considered sufﬁcient, starting with those PCs that are most 
predictive. Plotting of the transformation of the dataset by one PC alone is possible, but 
plotting of 2 PC-transformed datasets together (forming a ‘biplot’) is often more illustrative. 
3D plotting is also possible but, although cosmetically appealing, has been rejected for this 
study as it adds little additional capacity to interpret the resulting plots, especially where 
more than 3 PCs have been required to explain variance. Non-notable generated biplots from 
small datasets may be found in Appendix III. 
3.4.1 Sedge type 1 propolis 
Table 4: Identiﬁed principal components for the S1 propolis dataset 
 
PCA on the large S1 propolis dataset (n = 123) yielded 3 principal components, explaining 
81.5% of variance as per table 4. Figures 18 and 20 cluster S1 samples into two groupings; 
comparison of average spectra for both groups showed the most marked difference was major 
peaks at 1.75, 1.78 and 3.78 ppm for the minor grouping, whereas major grouping samples 
had their major peaks at 1.76, 1.79 and 3.79 ppm. 
component eigenvalue explained variance % cumulative variance %
PC1 5.1106 70.9393 70.9393
PC2 0.49118 6.818 77.7574
PC3 0.27108 3.7628 81.5202
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Figure 18: Biplot of PC1 to PC2 for the S1 propolis dataset 
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Figure 19: Biplot of PC1 to PC3 for the S1 propolis dataset. S1 samples in red. 
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Figure 20: Biplot of PC2 to PC3 for the S1 propolis dataset. S1 samples in red. 
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This consistent small difference of 0.01 ppm between these shifts suggests separation could 
be an artefact caused by these peaks sitting on the boundaries of binning ranges. Figure 19 
supports this, with both groups not observed to separate. Previously identiﬁed S1 + TT mixed 
samples, P1246 and P1052, are clustered together and at distance from both S1 chemotypes 
in all biplots, conﬁrming previous identiﬁcation. Other mixed samples are not generally 
observed to lay separately in ﬁgure 18, but are observed to be apart from pure S1 samples in 
other biplots. Samples P112, P246, P305, P1385, P1393, P1412 and P1416 appear to be 
newly identiﬁed mixed samples, being at distance from S1 chemotypes. P808 and P1073 
would appear, curiously, to have been possibly mis-identiﬁed as mixed samples, being 
observed to cluster cleanly with other S1 in all biplots. This ﬁnding could be a result of 
possible heterogeneity in these propolis samples. 
3.4.2 Sedge type 2 propolis 
Table 5: Identiﬁed principal components for the S2 propolis dataset 
 
PCA on the S2 propolis dataset (n = 13) yielded 3 principal components together explaining 
75.8% of observed variance, as per table 5. The small size of the dataset in this experiment 
reduces accuracy of results. Nevertheless, identiﬁed mixed samples P604, P815 (S1 + S2) and 
P956 (KT + S2) were seen to cluster near the appropriate plant resin for their contaminant in 
at least one 2D biplot of principal components. P1090 appears to be an unusual chemotype of 
S2, or a mix with an as-yet unidentiﬁed propolis, clustering closely with other pure S2 
samples in only one biplot (Appendix III, ﬁgure 73).  
component eigenvalue explained variance % cumulative variance %
PC1 3.1213 51.8654 51.8654
PC2 0.91873 15.2663 67.1318
PC3 0.52138 8.6637 75.7955
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3.4.3 C-prenyl-type propolis 
Table 6: Identiﬁed principal components for the CP propolis dataset 
 
PCA on the CP propolis dataset (n = 45) yielded 3 principal components together explaining 
81.4% of observed variance, as per table 6. Two mainland SA samples with chemical 
similarities to CP propolis by visual inspection of 1H-NMR spectra, P1431 and P1432, were 
observed to not cluster closely with CP, although P1432 clustered more closely with CP and 
at large distance from P1431 when PC2 and PC3, together accounting for 15.4% of variance, 
were plotted (ﬁgure 23). A previously identiﬁed CP + S1 mixed sample, P1241, was observed 
to cluster apart from pure CP samples in ﬁgures 21 and 22. 
P1179 and P476 are possible newly identiﬁed mixed samples, being observed to be at some 
distance from the body of CP samples in 2 out of 3 biplots each. Observation of closest 
average resins in these biplots would suggest P476 is a mix with either F, S1 or S2, and 
P1179 is either a S1 or F mix. 
component eigenvalue explained variance % cumulative variance %
PC1 4.231 65.9789 65.9789
PC2 0.53513 8.3449 74.3238
PC3 0.456 7.1109 81.4347
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Figure 21: Biplot of PC1 to PC2 for the CP propolis dataset. CP samples in red. 
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Figure 22: Biplot of PC1 to PC3 for the CP propolis dataset. CP samples in red. 
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Figure 23: Biplot of PC2 to PC3 for the CP propolis dataset. 
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3.4.4 Flavanone-type propolis 
Table 7: Identiﬁed principal components for the F propolis dataset 
 
PCA on the F propolis dataset (n = 11) yielded 3 principal components together explaining 
79.2% of observed variance, as per table 7. P1421, a previously identiﬁed complex mixture, 
was observed to cluster at distance from F in ﬁgures 75 and 76 (Appendix III). There seems 
to be large chemical range in F-type propolis, with P99 and P266 clustering apart from L. 
viscidum s.s. in all biplots. Although deﬁnitive interpretation is hampered by the low number 
of samples, it is possible these samples represent an F-type propolis sourced from another 
chemotype of L. viscidum or even another species in genus Lepidosperma. This position is 
also supported by Appendix II, ﬁgure 70, where these two samples cluster together at 
distance from other F samples and L. viscidum s.s. 
3.4.5 Kangaroo thorn propolis 
Table 8: Identiﬁed principal components for the KT propolis dataset 
 
component eigenvalue explained variance % cumulative variance %
PC1 4.2531 56.9846 56.9846
PC2 1.2071 16.1733 73.1579
PC3 0.45449 6.0895 79.2473
component eigenvalue explained variance % cumulative variance %
PC1 2.6743 50.9628 50.9628
PC2 0.54029 10.2959 61.2587
PC3 0.44704 8.519 69.7776
PC4 0.24934 4.7514 74.5291
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Figure 24: Biplot of PC1 to PC2 for the KT propolis dataset. KT samples in red. 
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Figure 25: Biplot of PC1 to PC3 for the KT propolis dataset. KT samples in red. 
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Figure 26: Biplot of PC1 to PC4 for the KT propolis dataset. KT samples in red. 
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Figure 27: Biplot of PC2 to PC3 for the KT propolis dataset 
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Figure 28: Biplot of PC2 to PC4 for the KT propolis dataset 
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Figure 29: Biplot of PC3 to PC4 for the KT propolis dataset 
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PCA on the KT propolis dataset (n = 29) showed greater variance between samples, with 4 
principal components required to explain 74.5% of observed variance, as per table 8. Figures 
24-26 appear to conﬁrm the separate identity of the two variants of KT propolis noted in 
3.2.3. These biplots additionally show already noted mixed samples at distance from pure 
KT. Inspection of ﬁgures 27-29 would seem to indicate there is some form of continuum 
between these variants, perhaps due to bees collecting resins of multiple chemotypes of A. 
paradoxa; in addition, the positioning of average A. paradoxa (generally not centred within 
KT samples) would seem to indicate at least one of the plant resin samples for these species 
is chemically similar to a variant KT. 
Certain samples appear in many biplots to be unusual members of the KT class, without 
being identiﬁably mixtures with other types; P32, P96, P244, P1227 are notable in this 
regard. Observed positioning suggest these may form a third broad chemotype of KT 
propolis. P1007 is markedly different than other KT samples in its clustering. There is some 
evidence from the biplots that it is a member of the broad F class: Appendix II, ﬁgure 70 also 
supports this, as P1007 is observed to cluster within the F-class there. 
3.4.6 Purple spot propolis 
Table 9: Identiﬁed principal components for the PS propolis dataset 
 
component eigenvalue explained variance % cumulative variance %
PC1 2.9833 56.7785 56.7785
PC2 0.73808 14.0472 70.8257
PC3 0.43467 8.2728 79.0985
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Figure 30: Biplot of PC1 to PC2 for the PS propolis dataset. PS samples in red. 
  114 
 
 
Figure 31: Biplot of PC1 to PC3 for the PS propolis dataset. PS samples in red. 
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Figure 32: Biplot of PC2 to PC3 for the PS propolis dataset. PS samples in red. 
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PCA on the PS propolis dataset (n = 25) yielded 3 principal components together explaining 
79.1% of observed variance, as per table 9. All PS samples were found to closely cluster in 
all biplots, showing low chemical variance in PS samples. Recent work into the chemistry of 
M. insulare would seem to support this, with a low range of compounds found in the resin 
compared to other KI resinous plants (139). Figures 31 and 32 show previously identiﬁed 
mixes clustered with appropriate plant resins. 
P1048 appears to be a newly identiﬁed mixed sample, of similar composition to P1253. 
P1253 has previously been identiﬁed by TLC as a PS + KT mix, but its position in these 
biplots would appear to support reclassiﬁcation as a PS + S2 mix. KT and S2 have proven 
difﬁcult to successfully differentiate visually, especially in mixtures (ﬁgure 12).  
3.4.7 Ficinia nodosa and triterpene-type propolis 
Some samples of Ficinia nodosa, the knobby club rush, produce a resin with apparent 
steroid-like triterpenoid chemistry. 1H-NMR spectra of these resins appear visually similar to 
those of TT-type propolis from KI. It is important to note that neither Ficinia nodosa resin 
nor TT-type propolis have, as yet, had chemical characterisation performed due to scarcity of 
materials. As such, the identiﬁcation of triterpene chemistry is tentative, but suggested by 
TLC chromatograms and 1H-NMR spectra of these samples: particularly peaks in range 0.5-
0.7 ppm, suggestive of shielded methyl groups, and lack of clearly observable TLC features 
under visible light and UV, suggestive of saturated structures (ﬁgure 12). 
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Figure 33: Biplot of PC1 to PC2 for the F. nodosa and TT propolis dataset. F. nodosa resin samples 
are observed to cluster closely in the bottom right of the biplot. 
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Table 10: Identiﬁed principal components for the F. nodosa and TT propolis dataset 
 
Hierarchical clustering (Appendix II, ﬁgure 69) seems to indicate a broad similarity between 
TT-propolis and another propolis type identiﬁed in two samples, notable for a TLC spot at Rf 
0.7 (silica gel F254, hexane:isopropanol, 9:2). In an attempt to make clearer these 
relationships, a dataset of all F. nodosa resin samples, and all propolis samples containing 
either TT or Rf 0.7 as visible components by TLC, was produced (n = 10) and PCA 
performed. Two principal components, explaining 75.5% of observed variance, were 
identiﬁed as per table 10. 
Results, despite the small dataset, suggests strongly that F. nodosa is not the source of TT or 
Rf 0.7 (ﬁgure 33). Notably, TT and Rf 0.7 samples were observed to cluster as one group; 
mixed samples with S1 clustered to another group including both types. This would suggest 
that TT and Rf 0.7 can tentatively be identiﬁed as members of a broad family: more samples 
for analysis would allow conﬁrmation of this possible classiﬁcation, as well as 
characterisation of the chemistry of these propolis types. 
  
component eigenvalue explained variance % cumulative variance %
PC1 6.0385 59.7567 59.7567
PC2 1.5883 15.7178 75.4745
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3.4.8 Reassessment of propolis samples from principal component analysis 
results 
Table 11: Anomalous propolis samples by PCA, with predicted type and new TLC results. Hex = 
hexane, iPrOH = isopropanol, DCM = dichloromethane, EtOAc = ethyl acetate. 
 
Predicted type by calculator 
Ratio 
Sim
ilarity score
(M
k 4.31)
(± 5%
)
(1000)
hex:iPrO
H 9:2
DCM
:EtO
Ac 3:1
P112
S1
S1 m
ix
S1
100
771
S1 m
ix
S1
P246
S1
S1 m
ix
S1
100
712
S1:trace S2
S1:S2
P305
S1
S1 m
ix
S1
100
766
S1
S1
P1385
S1
S1 m
ix
S1:CP
85:15:00
730
S1
S1
P1393
S1
S1 m
ix
S1:CP
70:30:00
701
S1:CP
S1:CP
P1412
S1
S1 m
ix
S1:TT
90:10:00
670
S1:KT
S1:KT
P1416
S1
S1 m
ix
S1:TT
85:15:00
692
S1:F
S1:S2
P808
S1 m
ix
S1
S1
100
694
S1:KT
S1:KT
P1073
S1 m
ix
S1
S1:CP
95:05:00
680
S1:CP
CP:S1
P1090
S2
S2 m
ix?
S2
100
556
S2:CP
S2
P476
CP
CP m
ix
CP:F
65:35:00
435
CP:PS
PS:CP
P1179
CP
CP m
ix
CP:F
50:50:00
701
CP:F
CP
P1007
KT
F
KT:F
65:35:00
627
KT:F
KT:F
P1253
PS
PS:S2 or PS:KT
PS:KT
90:10:00
718
PS:KT:CP
PS:KT
Type by new
 TLC
Sam
ple
O
riginal type by TLC
Type by PCA
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Samples identiﬁed as possible mixtures or misclassiﬁcations by PCA on datasets, as detailed 
above, were reanalysed as per 3.2.3, using a newer version of the calculator tool (table 11). 
Results were found to match reasonably well between PCA, calculator and TLC for samples 
not containing S1. S1 results were found to have a poorer match between PCA and TLC, and 
especially between PCA and the calculator tool; this is in line with the interpretation of the 
observed splitting of the S1 dataset as artefactual. PCA appears to identify more false 
positives than hierarchical clustering, although this conclusion must be qualiﬁed as this was 
the secondary method of identiﬁcation used and the most obvious errors of initial TLC 
identiﬁcation were already removed. In addition, false positives due to heterogeneity of 
propolis samples cannot be entirely discounted. 
3.5 Principal component analysis to identify chemotypes of 
plant resins 
Informed by the results in 3.5, principal component analyses of Lepidosperma spp. plant resin 
ﬁngerprint databases were performed to identify potential chemotypes within traditionally 
taxonomically-delineated species. Insufﬁcient A. paradoxa resin samples precluded PCA 
analysis of these resins, despite evidence from 3.4.5 that different chemotypes of A. paradoxa 
exist on KI. Small absolute numbers of other plant resin samples limit absolute interpretation 
of PCA results, but some suggestive ﬁndings are listed below. Non-notable generated biplots 
from may be found in Appendix III. 
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3.5.1 Lepidosperma sp. ‘Flinders Chase’ 
Table 12: Identiﬁed principal components for the L. sp. ‘Flinders Chase’ dataset 
 
A ﬁngerprint dataset of all identiﬁed L. sp. ‘Flinders Chase’ and L. sp. ‘Flinders Chase’ 
variant samples, alongside P1090 as an unusual S2 sample, was produced (n = 10). PCA 
produced 2 principal components explaining 78% of observed variance (table 12). The small 
size of the dataset reduces the certainty of observed results; however, samples are observed to 
split to two groups, with resin sample 160218-01 appearing to also be L. sp. ‘Flinders Chase’ 
variant. P1090 does not cluster closely with either standard or variant L. sp. ‘Flinders Chase’, 
adding to evidence it is either not a pure S2 sample or a very unusual chemotype. 
3.5.2 Lepidosperma sp. ‘Montebello’ 
Table 13: Identiﬁed principal components for the L. sp. ‘Montebello’ dataset 
 
A ﬁngerprint dataset of all identiﬁed L. sp. ‘Montebello’ and L. sp. ‘Montebello’ variant 
samples, along with other samples observed to cluster with them in ﬁgure 17, was produced 
(n = 23). Three principal components were identiﬁed, explaining 80.6% of observed variance 
(table 13). 
component eigenvalue explained variance % cumulative variance %
PC1 3.7762 63.0543 63.0543
PC2 0.89425 14.932 77.9863
component eigenvalue explained variance % cumulative variance %
PC1 4.2837 65.592 65.592
PC2 0.61856 9.4715 75.0634
PC3 0.36064 5.5222 80.5857
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Figure 34: Biplot of PC1 to PC2 for the L. sp. ‘Montebello’ dataset 
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Figure 35: Biplot of PC1 to PC3 for the L. sp. ‘Montebello’ dataset 
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Figure 36: Biplot of PC2 to PC3 for the L. sp. ‘Montebello’ dataset 
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Chemistry of the L. sp. ‘Montebello’ complex appears to be highly variable between samples, 
with much looser clustering observed. Variant type 1 samples appear to cluster apart from 
standard and variant type 2 in ﬁgures 34 and 36. The variant type 2 sample, with unidentiﬁed 
L. sp. 160810-01, appear to cluster apart from standard and variant type 1 in ﬁgures 34 and 
35. L. viscidum samples cluster apart from all L. sp. ‘Montebello’ types in ﬁgures 34 and 36. 
Some reassessment of samples is indicated by the results. Sample 151224-01, identiﬁed as L. 
congestum, appears to consistently cluster with L. sp. ‘Montebello’. L. sp. 160810-01 appears 
to be L. sp. ‘Montebello’ variant 2. Inspection of clustering patterns across biplots suggests 
160723-71 and 160723-91 are not variant 1, but instead standard L. sp. ‘Montebello’. 
Similarly, 160520-01r, 110426-53, and 120412-22 appear to be variant 1, not standard L. sp. 
‘Montebello’. 100717-52 is at distance from all L. sp. ‘Montebello’ in all biplots; it is perhaps 
an entirely different chemotype. 
These results can only be considered tentative until more L. sp. ‘Montebello’ resin samples 
are available for investigation; however, these ﬁndings match exactly with the observed 
results of hierarchical clustering as per ﬁgure 17. 
3.5.3 Lepidosperma viscidum 
Table 14: Identiﬁed principal components for the L. viscidum dataset 
 
A ﬁngerprint dataset of all identiﬁed L. viscidum, plus average for L. viscidum and L. sp. 
‘Montebello’, was produced (n = 7). Two principal components, explaining 83.4% of 
observed variance were identiﬁed (table 14). The extremely small dataset would suggest L. 
viscidum has very variant chemistry, with the potential for at least 3 chemotypes within the 5 
component eigenvalue explained variance % cumulative variance %
PC1 4.6545 51.0638 51.0638
PC2 2.9477 32.3386 83.4024
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samples; although certainly reﬂecting the observed chemical range of F-type propolis, 
absolute interpretation requires more samples of L. viscidum resin.  
3.5.4 Lepidosperma spp. 
Table 15: Identiﬁed principal components for the L. spp. dataset 
 
Some preparatory PCA work on a dataset of all Lepidosperma spp. resin ﬁngerprints was 
performed (n = 73); high numbers of principal components (> 5) were require to explain 
>70% observed variance, precluding clear visualisation compared to hierarchical clustering. 
Results at lower dimensions (as per table 15) showed clear separation of L. congestum and L. 
sp. ‘Montebello’ complex (ﬁgures 37-39), but poorer resolution of other L. spp to individual 
clusters.  
component eigenvalue explained variance % cumulative variance %
PC1 2.1368 37.241 37.241
PC2 0.66745 11.6324 48.8734
PC3 0.45851 7.991 56.8644
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Figure 37: Biplot of PC1 to PC2 for the L. spp. dataset 
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Figure 38: Biplot of PC1 to PC3 for the L. spp. dataset 
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Figure 39: Biplot of PC2 to PC3 for the L. spp. dataset 
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3.6 Discussion 
Bees on KI, in the absence of Populus spp., show resourcefulness and capriciousness in their 
collecting habits: certain propolis types (notably CP) have a strong seasonal component, and 
neighbouring hives in apiary sites can produce markedly different propolis. This is especially 
true when the favoured plant source for S1-type propolis, L. sp. ‘Montebello’, is unavailable. 
Despite TLC methods having proved useful for identiﬁcation of some propolis types in past 
studies on KI (131-133), the need for standardised methods of analysis was clear. Given the 
wide range of resin sources, known, suspected and unknown, on Kangaroo Island, a 1H-NMR 
metabolomics approach to classifying propolis samples has shown great utility. A stepped 
schedule of initial TLC ﬁeld assessment, followed by hierarchical clustering and then PCA 
of 1H-NMR ﬁngerprint datasets, has shown good capacity to identify pure-plant-source 
samples and separate out mixed samples. 
Initial TLC typing of propolis samples has been, and remains, a useful tool for our research 
group. Sophistications of TLC, such as automation as in HPTLC, have shown utility as a sole 
analysis method in many propolis studies (1.6.2), and as a source of data for statistical 
analysis. However use of such methods in this study was precluded by lack of equipment, and 
by early availability of good results through NMR methods. Field use of simple TLC with 
comparison to standards is a less-than-perfect system. Notably, in our studies, despite some 
very clear variant types initially identiﬁed by TLC, mis-identiﬁcation of samples has 
occurred, as demonstrated by table 1. This was especially noted in mixed samples where the 
chromatographic trace of the dominant element overlaps other signals, and where standard 
chromatographic traces are similar in appearance (such as in F, S2 and KT). Nevertheless, as 
a means of performing a ‘quick and dirty’ assessment of samples as harvested, TLC by the 
schedule in 2.3.3 has demonstrated an acceptable balance between portable application, in a 
remote location without full laboratory facilities, and accuracy. As a means of gaining some 
  131 
 
insight, via pre-labelling of samples, for the interpretation of statistical analyses of 1H-NMR 
ﬁngerprints, our method has proven useful. 
1D 1H-NMR metabolomics has proven much more useful than HPLC with single UV 
wavelength detection in this study. More sophisticated HPLC methods, such as HPLC-MS, 
automated library look-up of chromatograms, and addition of statistical analyses are very 
common in other propolis analysis studies, with good results (1.6.5), but these techniques are 
generally slower, require higher processing of samples and work best with large chemical 
differences between propolis types. Initial work performed on hierarchical clustering of 
HPLC data was soon abandoned (3.2.4) due to very poor results with HPLC calculator tools 
(4.1). This is perhaps not entirely unexpected; most other propolis analysis studies using 
statistical analysis of HPLC have separated only two or three chemically-diverse propolis 
types (82, 393-396). By comparison, this study has identiﬁed a large number of propolis 
types and subtypes through 1D 1H-NMR alone, a result not seen in any propolis HPLC 
metabolomic studies by any method. NMR offers, at some level, immediate chemical 
analysis of samples tested, whereas HPLC generally requires a database of known peaks to 
produce any chemical data. In resin sources of known chemistry (such as in temperate-type 
propolis and variants) continued use of HPLC metabolomics is more arguable. However, the 
capacity of NMR to provide data-rich ﬁngerprints with good resolution, demonstrated 
repeatedly in other ﬁelds of study, is becoming more established in propolis science (407-
411). This study supports this trend towards 1H-NMR metabolomics in propolis; however, the 
absolute necessity for a standardised method of ﬁngerprint production should be stressed. 
Several studies have shown that collection method alone can be identiﬁed by NMR 
metabolomics (297, 298); this study found the use of small quantities of DMSO-d6 as 
spectroscopic co-solvent, and also different extraction solvents in some samples, created 
appreciable peak shift changes with corresponding imperfect clustering results. It is worth 
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noting that the prior ‘vetting’ by TLC in the ﬁeld allowed easy identiﬁcation of this outcome. 
Speciﬁc use of 1H-NMR ﬁngerprints was observed to be sufﬁcient to be used alone, without 
need for obtaining time-intensive 13C-NMR or 2D ﬁngerprints. This ﬁnding is in line with 
other NMR metabolomics studies (407-411). 
Hierarchical clustering was not observed to separate mixed propolis samples as desired. 
Ideally, mixtures of similar makeup would have been observed to cluster into their own 
groups, as part of a sub cluster of a larger cluster including the major constituents. Instead, 
mixed samples were generally observed to group within the cluster of their major propolis 
constituent, especially with S1 mixes, with the noted exception of some very complex mixes 
(such as P1409) and very distinct mixed types (such as S1 + TT). However, the capacity to 
reassign correctly misidentiﬁed mixed samples by TLC and those with similar and, thus, 
poorly-discernible TLC standards (S2, KT, F) was noted as per table 1. Clariﬁcation of 
previously-observed chemotypes and identiﬁcation of new chemotypes within KT propolis 
was also possible. As such 1H-NMR hierarchical clustering performed a useful error-
detection method.  
PCA, despite very common use in propolis metabolomics and generally (82, 297, 393-396, 
408, 409), was used only for the secondary purpose of identiﬁcation and conﬁrmation of 
mixed samples. Hierarchical clustering allowed a clearer immediate identiﬁcation of 
groupings and subgroupings, with an easy reading of constituent member samples of these 
groupings; clearly shown by demonstrating ﬁgure 17 with ﬁgures 37-39. It is noteworthy that 
results of PCA on subsets of 1H-NMR ﬁngerprints generally matched interpretations from 
hierarchical clustering; notably with mixed samples, variants and misidentiﬁcations by TLC. 
A small number of additional misclassiﬁcations were identiﬁed by PCA (table 11); several of 
these ﬂagged samples do not match the new TLC results. Addition of average plant resins 
was found to be of limited utility as mixed samples were not reliably observed to identiﬁably 
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cluster with their secondary source. Exceptions were with the CP, S2 and PS datasets. This 
study’s PCA method, not dissimilar to others utilised in the literature (297, 408, 409), 
required lengthy data-preparation and biplot interpretation. The method proved useful for 
additional identiﬁcation of mixed samples, albeit with a greater number of potential false 
positives than hierarchical clustering and without accurate characterisation of these mixed 
samples. 
PCA methods may have proved more useful as an initial and sole analysis method with 
greater sample numbers (484), most especially in the case of the minor propolis types. 
However, given the nature of bees and resin collection, there is no way to quickly promote 
the production of particular KI propolis types (76, 77). Even hive placement is not 
guaranteed; hives within human sight of L. sp. ‘Montebello’, the seemingly preferred resin 
source for KI bees, have been found to produce pure CP propolis. In cases where plant resin 
source is not known, such as CP, one can only hope that sites previously known for CP 
production will hold for directed collection. This study’s methods produced good results even 
with the preponderance of S1 propolis samples; results should improve further over the years 
with increased propolis samples. A possible reﬁnement to further reduce the small degree of 
uncertainty in assignment of some samples, potentially due to the heterogeneity of propolis, 
would be to extract all samples in at least duplicate and average out the resulting ﬁngerprints 
or, as a ‘sanity check’, assess both samples individually. 
In this study samples were collected on the one collection day either from individual hives or 
from one apiary site, and were not pooled samples from multiple apiaries. This is an 
important reﬁnement given the potential difference in propolis source observed in 
neighbouring hives or apiaries (72-74). Notably, virtually all other propolis metabolomics 
studies have neglected to use this reﬁnement, which most likely explains the small number of 
propolis types and lack of variants identiﬁed by these studies. This blending of samples 
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smooths variance between samples within propolis types and would additionally tend to 
reduce identiﬁable propolis types to those corresponding to the major resin sources, as 
demonstrated in this study by the sorting of KI mixed source propolis samples by statistical 
means to their major component. This process of physical data averaging, almost always 
unacknowledged, likely explains the cleaner results by PCA in many studies. Propolis 
characterisation studies isolating compounds that are not found in the supposed resin source 
are illustrative (407-411). One can only suspect, given the biodiversity of Brazil, for instance, 
that there must be more than two or three plants bees utilise as resin sources. Extrapolation of 
our study’s method to other geographical areas would most likely identify a host of minor 
propolis types in these cases and, potentially, associated plant sources. 
1D 1H-NMR metabolomics have been shown to accurately and reliably identify pure-source 
KI propolis samples, but less reliably identify mixed samples. For this, use of calculator 
similarity tools, informed by the results from hierarchical clustering and PCA of 1H-NMR 
ﬁngerprints, was found to be necessary. Development of these tools is discussed in Chapter 4. 
  
 
 
 
 
 
Chapter Four 
Generation of similarity-scoring calculator 
tools  
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4.1 HPLC chromatogram similarity calculator 
 
Figure 40: Form of the HPLC chromatogram similarity calculator. Fingerprints of chromatograms 
‘A’ and ‘B’, in the forms of tables of AUC at RRT are copied and pasted to the appropriate locations. 
Sample names can be entered, and are automatically ﬁlled across all data smoothing options (ﬁgure 
41). Buttons for clearing data entered are shown. Similarity score out of 1000 is displayed for the 
preferred binning arrangement. 
Preliminary work on similarity scoring of HPLC chromatograms enabled creation of a 
calculator to compare HPLC ﬁngerprints as per ﬁgure 40. Pre-generated data ﬁngerprints of 
RRT to AUC, of the form demonstrated by Appendix I, table 57, for sample P410 were 
copied and pasted to the appropriate locations, clearly indicated in the ﬁgure. Automatic 
calculation of similarity after application of data smoothing techniques was performed (ﬁgure 
41). Macros were recorded to allow automatic clearing of ﬁngerprints entered, as per the 
labelled buttons in ﬁgure 40. 
A= RRT AUC B= RRT AUC
Doug King's HPLC Chromatogram Similarity 
Calculator, Dec 2014
#DIV/0!
Similarity score A to B (out of 1000):
(5 values, 2 overlap, 0.15 min bucketed)
[name here] [name here]
Clear All
Clear A Clear B
Clear AUC B
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Figure 41: Examples of the data smoothing calculations; primary binning by 0.05, 0.1, 0.15 and 0.2 
min not shown. In addition to these primary binning calculations, secondary data smoothing by 
adding up to 4 neighbouring primary bin values at each point (with various overlap of neighboring 
primary values per primary increment) was performed as per 2.3.10.2 (not shown). 
To determine the optimal data smoothing to use as a standard for the calculator, testing was 
performed on a subset of propolis samples. Comparison was made to P1166a, a CP propolis 
sample of good purity. Fingerprints from duplicate HPLC runs of P1166 (designated P1166b 
and P1166c) as well as more distantly-related CP propolis samples as assessed by 
hierarchical clustering (Chapter 3, ﬁgure 16) were used, with results as per table 16. The best 
overall binning arrangement was determined to be by primary bins of 0.15 min RRT, with 
additional smoothing by using a secondary moving bin by summing of 5 x 0.15 min 
neighbouring binned ranges at each point, with an overlap of 2 neighbouring values per 
primary increment. Figure 42 shows an example of the general process of the secondary data 
smoothing calculation mechanism. 
RRT (0.001 
min)
similarity 
score A to B 
(out of 1000)
#DIV/0! RRT (0.01 min)
similarity 
score A to B 
(out of 1000)
#DIV/0!
sum AUC A sum AUC B sum |(A+B)/2 - A| sum AUC A sum AUC B sum |(A+B)/2 - A|
0 0 0 0 0 0
AUC A AUC B |(A+B)/2 - A| AUC A AUC B |(A+B)/2 - A|
[name here] [name here] [name here] [name here]
1.000 0 0 0
1.001 0 0 0
1.002 0 0 0
1.003 0 0 0
1.004 0 0 0
1.005 0 0 0
1.006 0 0 0
1.007 0 0 0
1.008 0 0 0
1.009 0 0 0 0 0 0
1.010 0 0 0
1.011 0 0 0
1.012 0 0 0
1.013 0 0 0
1.014 0 0 0
1.015 0 0 0
1.016 0 0 0
1.017 0 0 0
1.018 0 0 0
1.019 0 0 0 0 0 0
1.020 0 0 0
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Table 16: Similarity scores of P1166a to other propolis samples by the HPLC similarity calculator 
(out of 1000). Column headings are primary binning increments of RRT (min), row headings 
secondary data smoothing (number of primary binning values added, number of overlapping primary 
values used per primary increment). Blue: highest score per primary binning, yellow: highest score 
per secondary binning, red: highest similarity score overall, green: lowest similarity score overall.  
 
P473
0.0001
0.01
0.05
0.1
0.15
0.2
P798
0.0001
0.01
0.05
0.1
0.15
0.2
1, 0
69
71
129
143
170
928
1, 0
25
28
38
53
118
867
5, 4
70
138
175
207
224
928
5, 4
28
45
142
174
191
868
5, 3
59
133
175
208
235
925
5, 3
24
42
150
180
207
861
5, 2
84
159
146
206
223
925
5, 2
34
49
151
179
175
856
5, 1
59
135
159
182
247
908
5, 1
24
42
139
170
212
836
2, 1
69
99
152
168
183
928
2, 1
25
33
76
132
151
868
P475
0.0001
0.01
0.05
0.1
0.15
0.2
P410
0.0001
0.01
0.05
0.1
0.15
0.2
1, 0
102
194
238
261
298
843
1, 0
77
135
195
227
253
729
5, 4
139
258
298
328
360
844
5, 4
98
201
273
307
316
731
5, 3
127
236
289
336
378
830
5, 3
86
188
283
327
326
721
5, 2
146
285
261
339
348
842
5, 2
101
206
270
304
303
717
5, 1
122
212
282
334
405
803
5, 1
86
204
290
312
334
683
2, 1
119
230
267
289
312
843
2, 1
88
162
230
263
282
729
P842
0.0001
0.01
0.05
0.1
0.15
0.2
P471
0.0001
0.01
0.05
0.1
0.15
0.2
1, 0
379
409
681
744
817
696
1, 0
372
510
612
680
692
572
5, 4
382
666
858
878
894
696
5, 4
448
638
684
718
738
569
5, 3
326
643
842
876
896
695
5, 3
421
629
693
716
743
567
5, 2
425
737
859
889
908
706
5, 2
473
638
687
712
736
579
5, 1
344
664
790
873
888
704
5, 1
414
619
681
711
758
569
2, 1
381
521
764
853
870
696
2, 1
400
581
651
692
710
570
P1166b
0.0001
0.01
0.05
0.1
0.15
0.2
P1166c
0.0001
0.01
0.05
0.1
0.15
0.2
1, 0
406
406
678
760
886
667
1, 0
417
418
626
712
859
654
5, 4
406
707
918
948
974
667
5, 4
417
663
889
924
953
656
5, 3
361
683
909
946
976
669
5, 3
377
635
880
916
957
660
5, 2
467
789
912
968
983
670
5, 2
447
738
882
945
962
660
5, 1
373
702
842
940
969
677
5, 1
393
663
800
901
950
666
2, 1
406
541
803
915
938
667
2, 1
417
519
763
880
913
655
prim
ary binning increm
ents (m
in)
prim
ary binning increm
ents (m
in)
secondary data smoothing method (primary values added, overlap in primary values)
  139 
 
 
Figure 42: Method of data smoothing by primary binning and secondary addition of primary values 
demonstrated for one sample, P44 (methanol d-4 1H-NMR spectrum), for shift range 1.66 to 1.81 
ppm. Primary binning by 0.01 ppm (as produced by ACD Labs 1D-NMR Processor) and 0.02 ppm is 
shown, and secondary smoothing by summing ﬁve neighbouring primary values with an overlap of 4 
primary values per primary increment is demonstrated. Additional data smoothing methods were 
utilised by the calculators; binning of HPLC chromatograms followed the same general method. 
Raw
 shift binned at 0.01 ppm
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Data smoothing was found to be necessary, due to the variation inherent in HPLC: note that 
similarity scores of P1166a to its duplicate runs P1166b and P1166c prior to binning were 
poor (406/1000 and 417/1000, respectively) and to more-distantly related CP samples 
extremely poor (< 100). Nevertheless, the best data preparation for HPLC ﬁngerprints arrived 
at by the above calibration is still non-ideal. Although returning good similarity scores for 
closely-related and duplicate samples, the binning arrangement returned poor, albeit 
improved, similarity scores for the more distantly-related samples (< 350/1000). Inspection of 
the calibration results for these more distantly-related CP samples would suggest primary 
binning by 0.2 min RRT, utilising secondary summing of 5 primary values with 4 overlap per 
primary increment, could be a better system; however, this system results in poorer similarity 
scores for those samples more closely-related to P1166a. This is presumably due to the loss 
of precision of HPLC ﬁngerprints by such major smoothing arrangements. 
HPLC ﬁngerprint similarity scoring, as such, was found generally unsatisfactory for KI 
propolis analysis; with the caveat that analysis was not made of non-CP type propolis 
samples. Further work on HPLC ﬁngerprint similarity scoring, including obtaining non-CP 
ﬁngerprints, was abandoned, as superior results were already obtained via 1H-NMR methods 
described below. 1H-NMR ﬁngerprints, in addition, were easier to obtain, requiring less lab 
preparation of raw propolis samples and proving quicker to obtain experimentally. 
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4.2 1H-NMR spectra similarity calculators 
4.2.1 Chloroform-d 1H-NMR spectrum similarity calculator 
 
Figure 43: Form of the chloroform-d 1H-NMR spectrum similarity calculator. Fingerprints of samples 
‘A’ and ‘B’, in the forms of tables of spectral data from ACD Labs 1D-NMR are copied and pasted to 
the appropriate locations. Sample names can be entered, and are automatically ﬁlled across all 
binning options (not shown). Buttons for clearing data entered are shown. Similarity score out of 
1000 is displayed for the preferred binning arrangement. 
A calculator to compare 1H-NMR ﬁngerprints from the chloroform-d method was produced 
(ﬁgure 43). Tables of signal data from ACD Labs 1D-NMR Processor for each ﬁngerprint 
giving peak number, shift (in ppm and Hz) and peak height, of the form demonstrated by 
Appendix I, table 58, for sample P410 were copied and pasted to the appropriate locations 
(marked A and B in the ﬁgure). Data for peak number and shift in Hz were ignored by the 
calculator. Automatic calculation of similarity over primary binned ranges and secondary 
moving bin overlaps was performed, similar to the process for the HPLC calculator, with 
initial binning by 0.01 ppm, 0.02 ppm, 0.05 ppm, 0.1 ppm, and 0.15 ppm. Macros were 
recorded to allow automatic clearing of ﬁngerprints entered, as per the labelled buttons in 
ﬁgure 43. 
  
A= B=
[name here] [name here]
Doug King's NMR Spectrum Similarity Calculator, Dec 2014
paste table of peak heights for A below paste table of peak heights for B below
Similarity score A to B (out of 1000)
(5 values, 3 overlap)
#DIV/0!Clear All Data
Clear B
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Table 17: Similarity scores of P159 to other propolis samples by the chloroform-d 1H-NMR 
calculator (out of 1000). Column headings are primary binning increments (ppm), row headings 
secondary data smoothing (number of primary binning values added, number of overlapping primary 
values used per primary increment). 
 
P159 calc
0.01
0.02
0.05
0.1
0.15
110427-73
0.01
0.02
0.05
0.1
0.15
1, 0
368
506
557
653
637
1, 0
489
566
588
607
620
5, 4
570
645
711
732
740
5, 4
604
616
636
653
657
5, 3
577
635
718
734
752
5, 3
612
623
631
654
650
5, 2
564
629
685
735
718
5, 2
612
617
614
645
651
5, 1
556
599
717
733
764
5, 1
614
619
633
651
640
2, 1
484
549
648
696
732
2, 1
566
596
615
625
638
P788 (S1)
0.01
0.02
0.05
0.1
0.15
P494 (CP)
0.01
0.02
0.05
0.1
0.15
1, 0
452
575
612
647
667
1, 0
197
321
384
399
474
5, 4
614
645
678
691
697
5, 4
371
406
459
473
500
5, 3
618
637
676
677
696
5, 3
380
400
469
484
514
5, 2
630
653
670
684
690
5, 2
387
409
504
494
507
5, 1
596
625
649
694
693
5, 1
363
403
469
516
568
2, 1
555
610
646
683
689
2, 1
298
355
414
459
483
P734 (M
yponga)
0.01
0.02
0.05
0.1
0.15
P735 (M
t M
agnificent)
0.01
0.02
0.05
0.1
0.15
1, 0
206
285
351
439
492
1, 0
183
241
284
329
387
5, 4
363
412
529
603
581
5, 4
279
325
452
501
490
5, 3
356
402
547
623
604
5, 3
281
322
473
513
509
5, 2
369
439
556
654
605
5, 2
265
330
446
544
500
5, 1
360
402
547
605
666
5, 1
285
313
451
513
540
2, 1
274
342
420
496
590
2, 1
240
275
326
434
484
DK-131202-01
0.01
0.02
0.05
0.1
0.15
1, 0
121
183
240
273
327
5, 4
247
277
347
371
354
5, 3
245
277
369
376
387
5, 2
233
292
407
426
405
5, 1
256
283
349
429
387
2, 1
188
238
283
333
373
secondary data smoothing method (primary values added, overlap in primary values)
prim
ary binning increm
ents (ppm
)
prim
ary binning increm
ents (ppm
)
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To determine the optimal binning range and overlap to use as a standard for the calculator, 
testing was performed on a subset of propolis samples and source plant resins (table 17). 
Comparison was made to P159, an S1-type propolis sample. A subset of increasingly more 
distantly-related ﬁngerprints, as determined by the dendrogram Appendix II, ﬁgure 68, were 
assessed over all binning and overlap ranges. Two ﬁngerprints of plant resins were also 
utilised: 110427-73, an example of L. sp. ‘Montebello’, the resin source for S1 propolis; and 
131202-01, a sample of F. nodosa, as an example of a highly dissimilar ﬁngerprint. In 
addition, similarity to an incomplete calculated ﬁngerprint for P159 (‘P159 calc’), calculated 
using Excel from spectra from pure compounds isolated from S1 propolis and HPLC data of 
relative proportions of those compounds in P159 from previous work (131, 133), was 
assessed. 
From this, a binning system of 0.01 ppm-wide primary bins with additional secondary 
binning by summing of 5 x 0.01 ppm neighbouring binned ranges at each point, with an 
overlap of 3 neighbouring values per primary increment was selected. This method was found 
to produce reasonable similarity (> 575/1000) to other S1 and plant-source ﬁngerprints 
(P159calc, P788, 110427-73) with increasingly lower similarity to more dissimilar 
ﬁngerprints by hierarchical clustering. In addition, no loss of data precision from increasing 
the width of the primary bin was required, raw shift ranges from ACD Labs 1D-NMR 
Processor already being rounded to 0.01 ppm. 
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4.2.2 Methanol-d4 1H-NMR spectrum similarity calculator 
 
Figure 44: Form of the methanol-d4 1H-NMR spectrum similarity calculator. Fingerprints of samples 
‘A’ and ‘B’, in the forms of tables of spectral data from ACD Labs 1D-NMR are copied and pasted to 
the appropriate locations. Sample names can be entered, and are automatically ﬁlled across all 
binning options (not shown). Buttons for clearing data entered are shown. Similarity score out of 
1000 is displayed for the preferred binning arrangement. 
In line with the increased accuracy and speciﬁcity observed by hierarchical clustering of 
methanol-d4 1H-NMR ﬁngerprints, a calculator to compare these ﬁngerprints was produced 
(ﬁgure 44). This calculator operated as per that described in 4.2.1. 
Several of the samples used for calibration of the chloroform-d calculator being unavailable 
for production of methanol-d4 ﬁngerprints, a new subset of propolis ﬁngerprints and average 
propolis ﬁngerprints were utilised for calibration (table 18). Comparison was made to P129, 
an S1-type propolis sample. Fingerprints compared were P130, P788 and P40 (progressively 
less closely clustered S1 samples by hierarchical clustering) and P932 (TT-type) as a very 
dissimilar sample. For additional comparisons, an average ﬁngerprint was produced for S1, 
KT, PS and F propolis, utilising all of those samples where a methanol-d4 ﬁngerprint was 
available and informed by hierarchical clustering (Appendix II, ﬁgure 69). 
  
A= B=
[name here] [name here]
Doug King's NMR Spectrum Similarity Calculator, July 2016
paste table of peak heights for A below paste table of peak heights for B below
Similarity score A to B (out of 1000)
(2 values, 1 overlap)
#DIV/0!Clear All Data
Clear B
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Table 18: Similarity scores of P129 to other propolis samples by the methanol-d4 1H-NMR calculator 
(out of 1000). Column headings are primary binning increments (ppm), row headings secondary data 
smoothing method (number of primary binning values added, overlap in primary values used per 
primary increment). Colour coding is as per table 16. 
 
P130 (close S1)
0.01
0.02
0.05
0.1
0.15
P788 (less close S1)
0.01
0.02
0.05
0.1
0.15
no o/lap
776
842
857
896
938
no o/lap
579
656
719
742
742
5, 4
890
916
943
951
962
5, 4
710
743
758
748
747
5, 3
888
914
934
947
956
5, 3
708
743
751
765
744
5, 2
868
916
939
942
966
5, 2
708
744
785
765
762
5, 1
884
914
930
942
960
5, 1
692
750
746
765
792
2, 1
851
876
905
937
946
2, 1
661
698
748
753
758
P40 (distant S1)
0.01
0.02
0.05
0.1
0.15
Average S1
0.01
0.02
0.05
0.1
0.15
no o/lap
490
613
694
717
743
no o/lap
767
822
876
895
903
5, 4
680
721
739
732
732
5, 4
872
894
902
897
898
5, 3
684
720
745
748
721
5, 3
875
890
898
905
896
5, 2
666
706
741
726
759
5, 2
855
893
913
902
900
5, 1
673
732
736
727
768
5, 1
872
887
900
901
910
2, 1
608
672
709
737
750
2, 1
831
859
893
902
905
Average KT
0.01
0.02
0.05
0.1
0.15
Average PS
0.01
0.02
0.05
0.1
0.15
no o/lap
151
193
221
329
321
no o/lap
98
174
219
269
298
5, 4
253
309
400
502
584
5, 4
237
294
414
474
474
5, 3
252
313
379
514
576
5, 3
240
293
404
477
455
5, 2
253
306
410
494
639
5, 2
233
294
384
488
462
5, 1
254
303
394
509
705
5, 1
233
285
386
537
520
2, 1
186
225
297
383
390
2, 1
151
223
282
395
438
Average F
0.01
0.02
0.05
0.1
0.15
P932 (pure TT)
0.01
0.02
0.05
0.1
0.15
no o/lap
161
216
236
352
390
no o/lap
192
265
308
341
351
5, 4
287
373
467
577
620
5, 4
315
342
361
362
392
5, 3
301
371
455
592
597
5, 3
317
343
340
374
375
5, 2
316
342
497
585
624
5, 2
312
329
373
364
388
5, 1
307
359
460
627
674
5, 1
309
331
341
355
398
2, 1
207
252
360
443
470
2, 1
266
310
340
359
375
prim
ary binning increm
ents (ppm
)
prim
ary binning increm
ents (ppm
)
secondary data snoothing method (primary values added, overlap in primary values)
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Table 19: Similarity scores of P129 to other propolis samples by the methanol-d4 1H-NMR calculator 
(out of 1000) after rejection of above-average similarity scores (blacked out). Grey: similarity scores 
above average of the remaining values, dark tawny: highest similarity score, light tawny: lowest 
similarity score. 
 
P130 (close S1)
0.01
0.02
0.05
0.1
0.15
P788 (less close S1)
0.01
0.02
0.05
0.1
0.15
no o/lap
776
842
857
896
938
no o/lap
579
656
719
742
742
5, 4
890
916
943
951
962
5, 4
710
743
758
748
747
5, 3
888
914
934
947
956
5, 3
708
743
751
765
744
5, 2
868
916
939
942
966
5, 2
708
744
785
765
762
5, 1
884
914
930
942
960
5, 1
692
750
746
765
792
2, 1
851
876
905
937
946
2, 1
661
698
748
753
758
P40 (distant S1)
0.01
0.02
0.05
0.1
0.15
Average S1
0.01
0.02
0.05
0.1
0.15
no o/lap
490
613
694
717
743
no o/lap
767
822
876
895
903
5, 4
680
721
739
732
732
5, 4
872
894
902
897
898
5, 3
684
720
745
748
721
5, 3
875
890
898
905
896
5, 2
666
706
741
726
759
5, 2
855
893
913
902
900
5, 1
673
732
736
727
768
5, 1
872
887
900
901
910
2, 1
608
672
709
737
750
2, 1
831
859
893
902
905
Average KT
0.01
0.02
0.05
0.1
0.15
Average PS
0.01
0.02
0.05
0.1
0.15
no o/lap
151
193
221
329
321
no o/lap
98
174
219
269
298
5, 4
253
309
400
502
584
5, 4
237
294
414
474
474
5, 3
252
313
379
514
576
5, 3
240
293
404
477
455
5, 2
253
306
410
494
639
5, 2
233
294
384
488
462
5, 1
254
303
394
509
705
5, 1
233
285
386
537
520
2, 1
186
225
297
383
390
2, 1
151
223
282
395
438
Average F
0.01
0.02
0.05
0.1
0.15
P932 (pure TT)
0.01
0.02
0.05
0.1
0.15
no o/lap
161
216
236
352
390
no o/lap
192
265
308
341
351
5, 4
287
373
467
577
620
5, 4
315
342
361
362
392
5, 3
301
371
455
592
597
5, 3
317
343
340
374
375
5, 2
316
342
497
585
624
5, 2
312
329
373
364
388
5, 1
307
359
460
627
674
5, 1
309
331
341
355
398
2, 1
207
252
360
443
470
2, 1
266
310
340
359
375
prim
ary binning increm
ents (ppm
)
prim
ary binning increm
ents (ppm
)
secondary data snoothing method (primary values added, overlap in primary values)
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To obtain a binning system that improved the spread of similarity scores across samples, for 
each sample the average similarity score across all binning systems was taken and those that 
returned above-average similarity were discarded (table 19). Of the systems left, increasing 
the primary binning range was found to unnecessarily inﬂate the similarity scores, as was 
using secondary smoothing by summing of ﬁve neighbouring primary values at any overlap. 
By comparison, utilising no secondary binning (i.e. using the raw primary values at 0.01 ppm 
binning) produced unnecessarily low similarity scores. As such, a binning system using raw 
primary binning of 0.01 ppm with secondary summing of two neighbouring values with one 
overlap per primary increment was chosen as producing high similarity scores to S1 
ﬁngerprints (> 600/1000, > 800/1000 to average S1) with low similarity scores to non-S1 
ﬁngerprints (< 300/1000 in all cases). As with the chloroform-d calculator, no loss of data 
precision by increasing the width of the primary bin was required with this primary bin range. 
These results were markedly better than those observed for the chloroform-d ﬁngerprint 
similarity calculator; once again, the beneﬁt and necessity of absolutely consistent ﬁngerprint 
generation methods is thus demonstrated. 
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4.3 Constituent propolis calculators 
4.3.1 Chloroform-d 1H-NMR propolis calculator 
 
Figure 45: Form of the chloroform-d 1H-NMR propolis calculator. Use of calculator is as per labels. 
Note shift range continues in the original to 13.99 ppm (not shown). Calculation of average propolis 
ﬁngerprints, performed automatically by the calculator, is not shown. 
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Figure 46: An example of a newly-generated mixed ﬁngerprint (S1:CP, 33:67). Desired percentages 
are entered at top of the ﬁgure. These percentages are applied to the calculated average ﬁngerprints 
for each pure type, and the resulting calculated spectrum is displayed at right. Note shift range 
continues in the original to 13.99 ppm (not shown). 
Utilising all typed chloroform-d ﬁngerprints produced and identiﬁed as from pure-source 
propolis samples, a similarity scoring calculator for estimation of composition of a new 
propolis sample was produced (ﬁgure 45). Average ﬁngerprints were calculated for each 
pure-source propolis type, and an automatic means of creating a new mixed ﬁngerprint of 
various percentage proportions of these average ﬁngerprints was programed, as shown in 
ﬁgure 46. A macro was recorded to allow automatic clearing of ﬁngerprints entered, as per 
the labelled button in ﬁgure 45. 
S1 S2 KT CP PS F TOTAL
33% 0% 0% 67% 0% 0% 100%
shift S1 S2 KT CP PS F
CALCULATED 
SPECTRUM
1.50 0 0 0 0.015773 0 0 0.015773211
1.51 0 0 0 0 0 0 0
1.52 0 0 0 0.002081 0 0 0.002080526
1.53 0 0 0 0.001784 0 0 0.001784316
1.54 0.000137 0 0 0.003618 0 0 0.003755464
1.55 0.000969 0 0 0.003332 0 0 0.004301607
1.56 0.000422 0 0 0.011235 0 0 0.011657067
1.57 0.002481 0 0 0.004775 0 0 0.007255751
1.58 0.002577 0 0 0.005829 0 0 0.008405623
1.59 0.010943 0 0 0.031684 0 0 0.042627053
1.60 0.010537 0 0 0.013153 0 0 0.023690211
1.61 0.010876 0 0 0.009242 0 0 0.020118268
1.62 0.003914 0 0 0.108864 0 0 0.112778308
AVERAGE SPECTRA pure source propolises
2. ↓ adjust proportions of propolises in CALCULATED SPECTRUM here ↓
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Figure 47: The ‘ready reckoner’ panel of the chloroform-d 1H-NMR propolis calculator 
Fingerprints of new propolis samples, in the form of a table from ACD Labs 1D-NMR 
Processor as per 4.2.1, could be copied and pasted to labelled location in ﬁgure 45. These 
new ﬁngerprints were then compared, using the binning schedule developed in 4.2.1, to the 
newly-generated mixed ﬁngerprint and a similarity score out of 1000 returned. 
In addition, similarity scores to set mixtures of average ﬁngerprints were automatically 
calculated and displayed in a ‘ready reckoner’ panel to inform users as to the likely 
composition of a new sample (ﬁgure 47). 
To test the accuracy of the calculator, a representative propolis sample from each identiﬁed 
type was taken (table 20). Fingerprints of 50:50 mixtures of each of these propolis samples 
were produced using Excel by addition of half-spectra, and these ﬁngerprints assessed by the 
calculator. The estimated proportions that produced the highest similarity score for these 
50:50 mixed ﬁngerprints were recorded, as well as the similarity score, and the absolute 
percentage error from true calculated (table 21). 
Pure
Similarity 
Score
S1 
Dominant
Ratio
Similarity 
Score
KT 
Dominant
Ratio
Similarity 
Score
CP 
Dominant
Ratio
Similarity 
Score
Other Ratio
Similarity 
Score
S1 0 S1:S2 50:50 0 KT:S1 50:50 0 CP:S1 50:50 0 S1:KT:CP 33:33:33 0
S2 0 75:25 0 75:25 0 75:25 0 S1:KT:PS 33:33:33 0
KT 0 90:10 0 90:10 0 90:10 0 S1:CP:PS 33:33:33 0
CP 0 95:5 0 95:5 0 95:5 0 KT:CP:PS 33:33:33 0
PS 0 S1:KT 50:50 0 KT:S2 50:50 0 CP:S2 50:50 0 S1:KT:CP:PS 25:25:25:25 0
F 0 75:25 0 75:25 0 75:25 0
90:10 0 90:10 0 90:10 0
95:5 0 95:5 0 95:5 0
S1:CP 50:50 0 KT:CP 50:50 0 CP:KT 50:50 0
75:25 0 75:25 0 75:25 0
90:10 0 90:10 0 90:10 0
95:5 0 95:5 0 95:5 0
S1:PS 50:50 0 KT:PS 50:50 0 CP:PS 50:50 0
75:25 0 75:25 0 75:25 0
90:10 0 90:10 0 90:10 0
95:5 0 95:5 0 95:5 0
S1:KT:CP 50:25:25 0 KT:S1:CP 50:25:25 0 CP:S1:KT 50:25:25 0 PS:S1:KT 50:25:25 0
S1:KT:PS 50:25:25 0 KT:S1:PS 50:25:25 0 CP:S1:PS 50:25:25 0 PS:S1:CP 50:25:25 0
S1:CP:PS 50:25:25 0 KT:CP:PS 50:25:25 0 CP:KT:PS 50:25:25 0 PS:KT:CP 50:25:25 0
Max 0 S1:KT:CP:PS 55:15:15:15 0 KT:S1:CP:PS 55:15:15:15 0 CP:S1:KT:PS 55:15:15:15 0 PS:S1:KT:CP 55:15:15:15 0
3. ↓ using the READY RECKONER results below, refine proportions of propolises in CALCULATED SPECTRUM ↓
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Table 20: Propolis samples used to calculate 50:50 mixed ﬁngerprints for assessment of the accuracy 
of the chloroform-d 1H-NMR propolis calculator 
 
Table 21: Estimated proportions by the chloroform-d 1H-NMR propolis calculator of produced 50:50 
spectra, with similarity score and error from true in percentage points 
 
The calculator was able to correctly predict the two constituent propolis types in 14 of 15 
ﬁngerprints assessed with reasonable similarity scores (658/1000 to 820/1000); however 
errors in proportion were generally very large (table 22). An average error of percentage 
composition of approximately 30% was observed, with very large variance in error; this error 
ranged from 20% for F mixes up to 35% for PS mixes, but was not observed to be markedly 
different in magnitude or variance with varying sample composition. One error of 
identiﬁcation was observed: the CP:PS 50:50 mixed ﬁngerprint was identiﬁed by the 
calculator as CP 100%, although with the lowest similarity score recorded (653/1000). 
Type Sample Similarity score to average
S1 P466 802
S2 P912 781
KT P241 825
CP P494 797
PS P718 842
F P266 774
Representative propolis samples used
S1 S2 KT CP PS F
S1 32:68 81:19 45:55 92:8 63:37
S2 758 91:9 84:16 88:12 74:26
KT 664 806 11:89 71:29 49:51
CP 658 725 684 100:0 83:17
PS 715 820 712 653 26:74
F 774 807 743 744 801
S1 S2 KT CP PS F
S1 18 31 5 42 16
S2 41 34 38 24
KT 39 21 1
CP 50 33
PS 24
F
Calculated proportions at maximum observed similarity score
Absolute error from true (50:50)
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Table 22: Average error data from the accuracy testing process for the chloroform-d 1H-NMR 
propolis calculator. SD = standard deviation. 
 
Clearly, considering the ability of the calculator to determine the two constituents of each 
mixture (a feat, as established, not always possible by the traditional TLC identiﬁcation 
methods or by hierarchical clustering) the constituent propolis calculator was not without 
merit. Greater accuracy was obtained by the use of methanol-d4 ﬁngerprints. 
Mean SD (2 dp)
S1 22.4 14.33
S2 31.0 9.70
KT 26.6 16.33
CP 32.2 16.63
PS 35 12.25
F 20 12.01
Mean 27.8 13.5
Error data for samples containing each propolis
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4.3.2 Methanol-d4 1H-NMR propolis calculator 
 
Figure 48: Form of the methanol-d4 1H-NMR propolis calculator. Use of calculator is as per labels. 
Note shift range continues in the original to 13.99 ppm (not shown). Calculation of average propolis 
ﬁngerprints, performed automatically by the calculator, is not shown. 
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Figure 49: The improved ‘ready reckoner’ panel of the methanol-d4 1H-NMR propolis calculator 
Utilising all typed methanol-d4 ﬁngerprints produced and identiﬁed as from pure-source 
propolis samples, a similarity scoring calculator for estimation of composition of a new 
propolis sample was produced (ﬁgure 48). The mechanism of this calculator was generally as 
per 4.3.1. However, the binning schedule of the methanol-d4 1H-NMR spectra similarity 
calculator (4.2.2) was utilised and a newly-identiﬁed propolis type, TT, was included for 
calculations of new mixed ﬁngerprints. A new ‘ready reckoner’ to reﬂect this was produced 
(ﬁgure 49). Ease of use was increased with the addition of several new macros for clearing of 
entered data, as per the labelled buttons in ﬁgure 48. 
Assessment of the accuracy of the calculator was made as per the method described in 4.3.1. 
Not all samples used to assess the chloroform-d calculator were available as methanol-d4 
ﬁngerprints: in these cases, methanol-d4 ﬁngerprints of samples that were observed to cluster 
closely by hierarchical clustering of chloroform-d ﬁngerprints were substituted (table 23). 
Pure
Similarity 
Score
S1 
Dominant
Ratio
Similarity 
Score
KT 
Dominant
Ratio
Similarity 
Score
CP 
Dominant
Ratio
Similarity 
Score
Other 
Dominant
Ratio
Similarity 
Score
S1 0 S1:S2 50:50 0 KT:S1 50:50 0 CP:S1 50:50 0 PS:S1 75:25 0
S2 0 75:25 0 75:25 0 75:25 0 PS:S1 90:10 0
KT 0 90:10 0 90:10 0 90:10 0 PS:KT 75:25 0
CP 0 95:5 0 95:5 0 95:5 0 PS:KT 90:10 0
PS 0 S1:KT 50:50 0 KT:S2 50:50 0 CP:S2 50:50 0 PS:CP 75:25 0
F 0 75:25 0 75:25 0 75:25 0 PS:CP 90:10 0
TT 0 90:10 0 90:10 0 90:10 0 PS:F 75:25 0
95:5 0 95:5 0 95:5 0 PS:TT 75:25 0
S1:CP 50:50 0 KT:CP 50:50 0 CP:KT 50:50 0 F:S1 75:25 0
75:25 0 75:25 0 75:25 0 F:S1 90:10 0
90:10 0 90:10 0 90:10 0 F:KT 75:25 0
95:5 0 95:5 0 95:5 0 F:KT 90:10 0
S1:PS 50:50 0 KT:PS 50:50 0 CP:PS 50:50 0 F:CP 75:25 0
75:25 0 75:25 0 75:25 0 F:CP 90:10 0
90:10 0 90:10 0 90:10 0 F:PS 75:25 0
95:5 0 95:5 0 95:5 0 F:TT 75:25 0
S1:F 50:50 0 KT:F 50:50 0 CP:F 50:50 0 TT:S1 75:25 0
75:25 0 75:25 0 75:25 0 TT:S1 90:10 0
90:10 0 90:10 0 90:10 0 TT:KT 75:25 0
95:5 0 95:5 0 95:5 0 TT:KT 90:10 0
S1:TT 50:50 0 KT:TT 50:50 0 CP:TT 50:50 0 TT:CP 75:25 0
75:25 0 75:25 0 75:25 0 TT:CP 90:10 0
90:10 0 90:10 0 90:10 0 TT:PS 75:25 0
95:5 0 95:5 0 95:5 0 TT:F 75:25 0
(maximum score pre-
estimated by the 
ready reckoner)
0Max
3. ↓ using the READY RECKONER results below, refine proportions of propolis types in CALCULATED SPECTRUM ↓
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Table 23: Propolis samples used to calculate 50:50 mixed ﬁngerprints for assessment of the accuracy 
of the methanol-d4 1H-NMR propolis calculator 
 
Table 24: Estimated proportions by the methanol-d4 1H-NMR propolis calculator of produced 50:50 
spectra, with similarity score and error from true in percentage points 
 
Results were substantially better than those observed in 4.3.1. Correct constituent propolis 
types were estimated for all 21 ﬁngerprints tested with very high similarity scores (> 
780/1000 for all ﬁngerprints) (table 24). The average accuracy was within 5% of the correct 
range, with errors reasonably consistent between constituents, despite varying numbers of 
ﬁngerprints used to produce averages for each type (table 25). Only one ﬁngerprint returned 
an error of percentage > 10%; the KT:F 50:50 ﬁngerprint was estimated at 62:38, at the 
Type Sample Similarity score to average
S1 P28 838
S2 P912 778
KT P241 735
CP P493 817
PS P1009 768
F P266 751
TT P932 846
Representative propolis samples used
S1 S2 KT CP PS F TT
S1 49:51 51:49 50:50 52:48 55:45 44:56
S2 839 48:52 48:52 47:53 53:47 43:57
KT 830 812 50:50 45:55 62:38 45:55
CP 861 839 833 51:49 56:44 43:57
PS 829 828 799 853 58:42 44:56
F 829 802 783 826 806 44:56
TT 873 885 865 876 870 874
S1 S2 KT CP PS F TT
S1 1 1 0 2 5 6
S2 2 2 3 3 7
KT 0 5 12 5
CP 1 6 7
PS 8 6
F 6
TT
Calculated proportions at maximum observed similarity score
Absolute error from true (50:50)
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lowest similarity score recorded (783/1000). KT and F, as previously mentioned, have 
historically proven difﬁcult to differentiate in mixtures by any means so far utilised. Some 
further examples of the utility and accuracy of the methanol-d4 1H-NMR propolis calculator 
in estimating sample composition are shown in tables 1 and 11, with anomalous samples 
identiﬁed by hierarchical clustering and PCA. Here the calculator was observed to estimate 
composition of samples in general agreement with both those techniques and with new TLC 
results. 
Table 25: Average error data from the accuracy testing process for the methanol-d4 1H-NMR propolis 
calculator. SD = standard deviation. 
 
Table 26: Propolis samples used to calculate 50:50 mixed ﬁngerprints for assessment of the accuracy 
of the improved methanol-d4 1H-NMR propolis calculator, after removal of mixed samples identiﬁed 
in Chapter 3 
 
  
Mean (2 dp) SD (2 dp)
S1 2.50 2.43
S2 3.00 2.10
KT 4.17 4.36
CP 2.67 3.08
PS 4.17 2.64
F 6.67 3.08
TT 6.17 0.75
all 4.19 3.08
Error data for samples containing each propolis
Type Sample Similarity score to average
S1 P28 842
S2 P912 753
KT P241 762
CP P493 821
PS P1009 784
F P276 787
TT P932 1000
Representative propolis samples used
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Table 27: Estimated proportions by the improved methanol-d4 1H-NMR propolis calculator of 
produced 50:50 spectra, with similarity score and error from true in percentage points 
 
To conﬁrm the beneﬁt of hierarchical clustering and PCA in vetting samples for previously 
unidentiﬁed mixtures and subtypes, all samples newly identiﬁed as mixtures by these means 
(as per 3.2.3 and 3.4.8) were removed from the calculations of average ﬁngerprints in the 
calculator, and the accuracy of the calculator reassessed. Samples used to produce 50:50 
mixed ﬁngerprints to assess the accuracy of the calculator were identical to those used in 
table 23, with the exception that P276 was substituted for P266 as the F-type sample used 
(table 26). This was due to P266 showing poor similarity to average L. viscidum s.s. resin, in 
line with results of hierarchical clustering (Appendix II, ﬁgure 70) and PCA (3.4.4) 
suggesting P266 and P99 could be a new F-type propolis. Removal of Rf 0.7 samples left 
only one true TT sample, P932, accounting for the similarity score of 1000/1000. 
  
S1 S2 KT CP PS F TT
S1 53:47 55:45 51:49 52:48 56:44 50:50
S2 836 43:57 46:54 44:56 52:48 50:50
KT 832 830 48:52 45:55 56:44 50:50
CP 863 844 847 51:49 54:46 50:50
PS 837 813 814 863 59:41 51:49
F 856 805 794 849 813 50:50
TT 962 952 958 963 963 962
S1 S2 KT CP PS F TT
S1 3 5 1 2 6 0
S2 7 4 6 2 0
KT 2 5 6 0
CP 1 4 0
PS 9 1
F 0
TT
Calculated proportions at maximum observed similarity score
Absolute error from true (50:50)
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Table 28: Average error data from the accuracy testing process for the methanol-d4 1H-NMR propolis 
calculator. SD = standard deviation. 
  
Results showed a slight improvement in overall accuracy of the calculator, as expected (table 
27). Maximum error noted was now reduced to 9% (PS:F); average error and standard 
deviation of error was also reduced across samples (table 28). These results hold even when 
TT mixes are removed from the calculations: results for calculated TT mix ﬁngerprints are 
potentially artiﬁcially inﬂated due to the lack of samples available for averaging a ﬁngerprint 
of the TT class. Addition, over time, of more propolis sample ﬁngerprints for production of 
average ﬁngerprints, especially of rarer propolis types, should continue to increase the 
accuracy of the calculator tool. 
Mean (2 dp) SD (2 dp) Mean (2 dp) SD (2 dp)
S1 2.83 2.32 S1 3.40 2.07
S2 3.67 2.58 S2 4.40 2.07
KT 4.17 2.64 KT 5.00 1.87
CP 2.00 1.67 CP 2.40 1.52
PS 4.00 3.22 PS 4.60 3.21
F 4.50 3.21 F 5.40 2.61
TT 0.17 0.41 all 4.20 2.37
all 3.05 2.73
Error data for samples 
containing each propolis
Error data, excluding all TT 
combinations
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4.4 Plant resin similarity calculator 
 
Figure 50: Form of the plant resin similarity calculator. Use of calculator is as per labels. Note shift 
range continues in the original to 13.99 ppm (not shown). Calculation of average plant resin and 
propolis ﬁngerprints, performed automatically by the calculator, is not shown. 
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In the interests of improving speciﬁcity of the similarity score by removing any non-resin-
source spectral elements from the average ﬁngerprints utilised by the calculators, a calculator 
tool for the comparison of a new sample to calculated mixed plant resin ﬁngerprints was 
produced (ﬁgure 50). This calculator had the mechanism of 4.3.2, with the exception that the 
pure-source propolis sample ﬁngerprints utilised for calculation of average ﬁngerprints were 
replaced with ﬁngerprints of samples of the source plants. The resinous plant ﬁngerprints 
used are listed in table 3. For the case of CP propolis, where the plant resin source is as yet 
unknown, the set of CP propolis ﬁngerprints from 4.3.2 was maintained and utilised to 
produce an average ﬁngerprint. In addition, due to the erroneous belief that F. nodosa was the 
resin source of TT propolis (disproven above in 3.4.7), plant sample ﬁngerprints 131202-01, 
131202-02, 131202-03 and 160721-31 were used to produce an average plant resin 
ﬁngerprint representing TT. A ready reckoner as per ﬁgure 49 was included. 
Samples used to produce 50:50 mixed ﬁngerprints to assess the accuracy of the calculator 
were identical to those used in table 26 (table 29). P276 was again substituted for P266 as the 
F-type sample used, in line with the prior reasoning in 4.3.2. Very poor similarity (273/1000) 
was noted for the TT sample used, P932, to average F. nodosa in line with the ﬁndings of 
3.4.7. 
Table 29: Propolis samples used to calculate 50:50 mixed ﬁngerprints for assessment of the accuracy 
of the plant resin similarity calculator 
 
  
Type Sample Similarity score to average resin
S1 P28 666
S2 P912 662
KT P241 706
CP P493 817
PS P1009 764
F P276 637
TT P932 273
Representative propolis samples used
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Table 30: Estimated proportions by the plant resin similarity calculator of produced 50:50 spectra, 
with similarity score and error from true in percentage points 
   
Table 31: Average error data from the accuracy testing process for the plant resin similarity 
calculator. SD = standard deviation. 
 
With the exception of TT mixtures, the calculator correctly estimated the two constituents in 
all cases with high to very high similarity scores (671/1000 to 825/1000) and error from true 
percentage composition of no more than 16% and, on average, about 9% (tables 30 and 31). 
However, despite correct determination of constituents, the error for TT mixes was very 
S1 S2 KT CP PS F TT
S1 60:40 51:49 50:50 55:45 61:39 78:22
S2 727 34:66 41:59 38:62 51:49 44:56
KT 709 750 46:54 50:50 62:38 51:49
CP 770 801 800 54:46 58:42 70:30
PS 731 758 778 825 62:38 64:36
F 677 671 734 780 726 57:43
TT 454 425 390 487 457 471
S1 S2 KT CP PS F TT
S1 10 1 0 5 11 28
S2 16 9 12 1 6
KT 4 0 12 1
CP 4 8 20
PS 12 14
F 7
TT
Calculated proportions at maximum observed similarity score
Absolute error from true (50:50)
Mean (2 dp) SD (2 dp) Mean (2 dp) SD (2 dp)
S1 9.17 10.26 S1 5.40 5.03
S2 9.00 5.14 S2 9.60 5.50
KT 5.67 6.71 KT 6.60 7.06
CP 7.50 6.92 CP 5.00 3.61
PS 7.83 5.60 PS 6.60 5.27
F 8.50 4.23 F 8.80 4.66
TT 12.67 10.03 all 7.00 5.20
all 8.62 7.14
Error data for samples containing 
each propolis
Error data, excluding all TT 
combinations
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much higher, to a maximum of 28%, with consistently poor similarity scores (< 487/1000). 
Consistency of error was also lower for TT mixes. These results are unsurprising, given that 
incorrect resin sources were used to represent TT propolis in the calculator. Removing TT 
mixes from error calculations returned much better results (table 31). 
The results of the resin calculator, although somewhat poorer than those of the methanol-
d4 1H-NMR propolis calculator, are promising, given the low number of resin ﬁngerprints 
available for average ﬁngerprint calculation compared to the > 200 propolis ﬁngerprints. In 
the knowledge that wax, pollen and other hive detritus can contaminate propolis samples and, 
thus, extracts, ﬁngerprints and averages thereof, comparison to the chemistry of the source 
plant resins is much preferable. As more source resinous plant samples are collected and 
plant source identiﬁed for CP, TT, Rf 0.7 and other minor propolis types, it is projected that 
the plant resin similarity calculator will become the main tool for identiﬁcation of propolis 
where a 1H-NMR analysis facility is available. 
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4.5 Discussion 
Much work in beehive products analysis has been concerned with typing of pre-existing 
datasets of analytical data, generally by PCA means, to identify a small number (usually 2 to 
4) of distinct major propolis types. This is of rather less utility in an evolving dataset with 
many underlying major types and, additionally, is unable to conﬁdently assess mixed 
samples. As such, few studies have used similarity scoring methods. A 2008 study by Zhou et 
al. detailing use of similarity scoring methods on Chinese propolis HPLC chromatograms 
appears to be the only use of similarity scoring in propolis research (391). That study 
produced ﬁngerprints of RRT to RPA from chromatograms produced under standard 
conditions; average ﬁngerprints for geographical regions were produced. Fingerprints of new 
samples were then compared by correlation coefﬁcient to each average ﬁngerprint, with 
resulting similarity scores between 0-1 (391). These calculations were performed using 
software (Similarity Evaluation System for Chromatographic Fingerprint of Traditional 
Chinese Medicine v. 2004A) produced by the State Food and Drug Administration of China 
speciﬁcally for this purpose and available since at least 2000 (485), indicative of how far 
behind propolis research using similarity scoring is lagging compared to natural products 
research generally. 
By comparison, the 2016 study by Schievano et al. into honey typing by similarity scoring 
methods, already mentioned brieﬂy above, bears further expansion (427). This study used a 
dataset of 1103 1H-NMR spectra of Italian honey samples, split into a training set of 983 
samples and a testing set of 120 samples. Samples were prepared and the 1H-NMR spectra 
attained via a standardised process; a ﬁngerprint for each sample over shift range 2.16-13.00 
ppm, binned by 0.04 ppm increments, was produced and normalised by pareto scaling (a 
means of increasing the importance of middle-range features) and mean centring. PCA of the 
ﬁngerprints of the training set were used to identify pure samples to produce classiﬁcation 
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models for each honey type, previously determined by traditional sensory and 
melissopalynological means. Sixteen classiﬁcation models were produced for each pure 
honey using one-versus-all OPLS-DA, a special implementation of partial least squares 
analysis for measuring membership of groups. Testing set ﬁngerprints were submitted to this 
analysis for each model; with scoring in range 0-1 resulting, where increasing score indicated 
increasing proportion of the classiﬁcation model type in the tested sample. By this means, 
Schievano et al. were able to analyse primary, secondary and tertiary composition of mixed 
honey samples with good concordance with traditional typing means, even when honey 
samples had been initially misidentiﬁed (427). However, the inconvenience of submitting 
each new sample for testing to 16 different modelling processes remains with this technique.  
Schievano et al. noted that identiﬁcation of honey mixtures by traditional metabolomic means 
(hierarchical clustering, PCA) lacks capacity for identify of constituents of mixed samples 
(427); this certainly matches with the results obtained by our study. Although hierarchical 
clustering and PCA, as shown in Chapter 3, could identify most mixtures they were not able 
to identify conﬁdently the makeup of these mixed samples, except in the most egregious 
cases. Use of similarity scoring methods has demonstrated an accurate and quick means of 
identifying constituent propolis types, with high conﬁdence, within a mixed sample and 
specifying relative percentages to within at least ± 5% accuracy, as per table 28. This 
accuracy has, however, only been enabled by strong vetting of the propolis samples used to 
form the average ﬁngerprints by the means set out in Chapter 3: initial TLC, then 
metabolomic assessment of 1H-NMR spectra of each propolis sample. 
Results from 4.4, as per Chapter 3, clearly show that absolute consistency of ﬁngerprint 
production is required for accuracy of similarity scoring by the method used in this study. 
This would even appear to be more important than increasing sample size: note that more 
chloroform-d ﬁngerprints were available than methanol-d4 ﬁngerprints. This is particularly 
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clear from the results of the plant resin calculator, where accuracy within approximately ± 
10% was possible from a comparatively small total number (< 50) of plant resin ﬁngerprints 
(table 31). This is, however, not to say that increased number of ﬁngerprints are not beneﬁcial 
– average error as reported in table 28 would appear to imply better accuracy at prediction for 
those samples containing one of the propolis types where large numbers of ﬁngerprints are 
used to create the average ﬁngerprint (S1 and CP at approx. ± 2%) than those with low 
numbers of ﬁngerprints (KT, PS and F at approx. ± 4%). Even without reﬁnements of the 
datasets used (as per 4.3.1), the demonstrated capacity of similarity scoring calculator tools to 
successfully identify major components of mixtures suggests transfer of the method to other 
low-quality datasets could generate useful results. 
As such, the general method of the constituent propolis/plant resin calculators would appear 
to be readily applicable to any class of natural product where distinct chemotypes exist: most 
obviously and especially other propolis. Knowing that large datasets of 1H-NMR ﬁngerprints 
of propolis samples already exist for a number of geographical areas where multiple propolis 
types have been identiﬁed through metabolomic means, the calculator tools could, with 
minimal adjustments, be utilised almost immediately in much research. Easier accurate 
identiﬁcation of pure propolis samples, and likely botanic resin source, enables and informs 
better isolation and characterisation of pharmaceutically useful compounds from propolis. 
Several uses of these tools in this study informed the following chapters. 
  
 
 
 
 
 
Chapter Five 
Characterisation of general chemistry of 
C-prenyl-type Kangaroo Island propolis 
with isolation of diprenyl ﬂavonones 
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5.1 Fractionation and separation 
5.1.1 DK-1 
 
Figure 51: Abbreviated diagram of fractionation process of P410 initially yielding DK-1. Labelling of 
fractions is as per 2.3.11.2 (i.e by labbook page number then order of elution); solvent systems, 
fraction volumes and column diameters used in fractionation schedules listed to left of fractions. hex 
= hexane, EtOAc = ethyl acetate. 
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Table 32: Fractionation schedules used in initial fractionation of P410 yielding DK-1. EtOAc = ethyl 
acetate. 
 
Exploratory short-column fractionation was performed on a methanolic extract of a CP 
propolis sample, P410. P410, although not the most representative sample of CP (similarity 
score of 664/1000 to average CP) was available in large quantity (approx. 400 g) for 
separation of compounds. An abbreviated diagram of the fractionation process (ﬁgure 51) and 
table of the fractionation schedules (table 32) utilised is shown. This initial fractionation 
yielded 0.16 g of one fraction, observed to spontaneously crystallise, p.85-17 (DK-1). 
  
p.75 CHCl3 EtOAc p. 76 CHCl3 EtOAc p.78 CHCl3 hexane EtOAc
1 150 1 144 6 1 25 75
2 50 2 48 2 2 50
3 45 5 3 46 4 3 48 2
4 45 5 4 46 4 4 48 2
5 40 10 5 44 6 5 46 4
6 40 10 6 44 6 6 46 4
7 35 15 7 42 8 7 44 6
8 35 15 8 42 8 8 44 6
9 30 20 9 40 10 9 42 8
10 30 20 10 40 10 10 42 8
11 38 12 11 40 10
12 38 12 12 40 10
13 38 12
14 38 12
p.80 CHCl3 hexane EtOAc p.85 CHCl3 EtOAc 15 36 14
1 25 65 10 1 75 16 36 14
2 39 11 2 25 17 34 16
3 39 11 3 24.75 0.25 18 34 16
4 38 12 4 24.75 0.25
5 38 12 5 24.5 0.5
6 37 13 6 24.5 0.5
7 37 13 7 24.25 0.75
8 36 14 8 24.25 0.75
8 36 14 9 24 1
10 35 15 10 24 1
11 35 15 11 23 2
12 23 2
13 22 3
14 22 3
15 21 4
16 21 4
17 20 5
18 20 5
19 19 6
20 19 6
21 50
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Table 33: Fractionation schedules used in second fractionation of P410 yielding DK-1. EtOAc = ethyl 
acetate. 
 
Further fractionation was performed on a fresh methanolic extract of P410 to obtain DK-1 in 
greater quantity (ﬁgure 52 and table 33). Other compounds, previously isolated from S1 
propolis, were isolated by this process and identiﬁed by comparison to literature 1H-NMR: 
namely 2-prenylpiceatannol (p.20-6 and p.20-8) and 3-O-prenylpiceatannol (p.20-8) (133, 
406). Investigation by the calculator suggests that P410 may be a CP:S1 mix (similarity to 
average S1 402/1000; similarity to calculated CP:S1 90:10 669/1000). 2.49 g of DK-1, 
representing 13.46% w/w of the original extract weight of 18.49 g, was isolated and 
submitted to further characterisation (5.2.2). 
p. 20 CHCl3 EtOAc p. 23 CHCl3 EtOAc hexane
1 125 1 50 50
2 50 2 25 25
3 45 5 3 25 25
4 45 5 4 30 20
5 40 10 5 30 20
6 40 10 6 35 15
7 35 15 7 35 15
8 35 15 8 40 10
9 30 20 9 40 10
10 30 20 10 45 5
11 25 25 11 45 5
12 25 25 12 50
13 50
14 45 5
15 45 5
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Figure 52: Diagram of second fractionation process of P410 yielding DK-1. Labelling of fractions is 
as per 2.3.11.2; solvent systems, fraction volumes and column diameters used in fractionation 
schedules fractionation schedules listed to left of fractions. hex = hexane, EtOAc = ethyl acetate. 
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5.1.2 General chemistry and DK-7 
To explore in more detail the minor constituents of CP propolis, another methanolic extract 
of P410 was submitted to an exhaustive series of fractionations (ﬁgure 53). Many potential 
compounds and molecular subunits of interest were partially identiﬁed; ﬁndings of this 
process are described in 5.2.1. 
One fraction, p.3-(7-8), was observed to spontaneously crystallise after some weeks of sitting. 
This compound, DK-7, was obtained in sufﬁcient quantity (0.14 g) to allow characterisation 
(5.2.3). The schedule of fractionations arriving at DK-7 is listed in table 34. 
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Figure 53: Diagram of third fractionation process of P410. Labelling of fractions is as per 2.3.11.2; 
solvent systems, fraction volumes and column diameters used in fractionation schedules listed to left 
of fraction. hex = hexane, EtOAc = ethyl acetate, DCM = dichloromethane. 
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Table 34: Fractionation schedules used in third fractionation of P410 yielding DK-7. EtOAc = ethyl 
acetate, DCM = dichloromethane. 
 
  
p. 90 CHCl3 EtOAc EtOH p. 93 CHCl3 EtOAc p. 96 CHCl3 EtOAc
1 150 1 35 1 100
2 50 2 12.5 2 50
3 45 5 3 12.25 0.25 3 50
4 45 5 4 12.25 0.25 4 48 2
5 40 10 5 12 0.5 5 48 2
6 40 10 6 12 0.5 6 46 4
7 35 15 7 11.75 0.75 7 46 4
8 35 15 8 11.75 0.75 8 44 6
9 30 20 9 11.5 1 9 44 6
10 30 20 10 11.5 1 10 42 8
11 25 25 11 11.25 1.25 11 42 8
12 25 25 12 11.25 1.25 12 40 10
13 100 13 40 10
p. 106 CHCl3 EtOAc p. 113 DCM CHCl3 EtOAc p. 115 DCM CHCl3 EtOAc
1 100 1 25 1 25
2 48 2 2 12 2 12
3 48 2 3 12 3 12
4 47 3 4 6 6 4 11.5 0.5
5 47 3 5 6 6 5 11.5 0.5
6 46 4 6 12 6 11.5 0.5
7 46 4 7 12 7 11 1
8 45 5 8 11 1 8 11 1
9 45 5 9 11 1 9 11 1
10 44 6 10 10 2 10 10.5 1.5
11 44 6 11 10 2 11 10.5 1.5
12 43 7 12 9 3 12 10.5 1.5
13 43 7 13 9 3 13 10 2
14 8 4 14 10 2
15 8 4 15 10 2
p. 117 CHCl3 hexane EtOAc p. 3 CHCl3 hexane EtOAc
1 12 12 1 12 12
2 9 3 2 2 10 0.25
3 9 3 0.25 3 2 10 0.5
4 9 3 0.5 4 1.75 10.25 0.25
5 10 2 0.25 5 1.75 10.25 0.5
6 10 2 0.5 6 1.75 10.25 1
7 10 2 1 7 1.5 10.5 0.25
8 11 1 0.25 8 1.5 10.5 0.5
9 11 1 0.5 9 1.5 10.5 1
10 11 1 1 10 1.25 10.75 0.25
11 12 0.25 11 1.25 10.75 0.5
12 12 0.5 12 1.25 10.75 1
13 12 1 13 1 11 0.25
14 11 0.5 14 1 11 0.5
15 11 1 15 1 11 1
16 11 1
17 11 1
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5.2 Characterisation of compounds 
5.2.1 General chemistry of CP propolis 
Table 35: Tentative or partial identiﬁcation by 1H-NMR spectral signals of probable compounds in 
fractions of P410 from the third fractionation. Labelling of fractions is as per 2.3.11.2. 
 
Many fractions from the process shown in ﬁgure 53 returned 1H-NMR spectra allowing 
partial or tentative characterisation of probable constituent molecules by distinct spectral 
features with results summarised in table 35. Overall, CP propolis seems to be very rich in 
many structurally-similar C-prenylated ﬂavanones, especially 6,8-diprenylﬂavanones, 
potentially polyhydroxylated and/or polymethoxylated. Despite the large number of 
compounds, few appear to be in CP propolis in large quantity, with extracts dominated by 
DK-1. Obtaining these minor compounds in sufﬁcient purity or quantity for full and conﬁdent 
characterisation was not feasible, with co-chromatography of compounds very prevalent. 
Further work is required to conﬁdently assess and conﬁrm the general chemistry of DK-1. 
 Fraction Tentative or partial chemical identity
p.93-(4-5) 4′-methoxy-6,8-diprenylflavanone
p.96-2, p.99-1, p.101-2 4′-methoxy-6,8-diprenylflavanone; cinnamate; another flavanone
p.99-(6-13) a diprenylflavonoid
p.108-1 diprenylflavanone
p.108-2 a diprenyl, dimethyl 4,2′,4′-trihydroxychalcone
p.106-(9-13) unidentifiable flavanones
p.117-7 6,8-diprenyl-5,7,3′,4′-tetrahydroxyflavanone
p.3-(10-11) 6,8-diprenyl-5,7,3′,4′-tetrahydroxyflavanone; unidentifiable prenylflavanone
p.6-(8-10) methoxy-6,8-diprenylflavanone
p.6-(16-17) 6,8-diprenyl-2′,3′,5′,?,?-pentahydroxyflavanone
p.9-(10-11) a diprenylflavanone
p.9-(12-14), p.9-15 3,5-di-O -methyl piceatannol; diprenylflavanones
p.12-(8-11), p.12-(12-14) unidentifiable acetoxyflavanones
p.14-(7-8) an O-methylated derivative of 6,8-diprenyl-4’,5,7-trihydroxyflavanone; cinnamate
p.14-(10-11) unidentified cinnamates and flavanones
p.14-(12-15) mixture containing a compound with an allyl group and a 1,3,4-trisubstituted benzene moiety
p.14-6 6,8-diprenyl-4’,5,7-trihydroxyflavanone; unidentified lipid
p.14-9 mixture containing an unidentifiable cinnamate
p.17-6 unidentifiable terpenoids
p.17-(7-9), p.17-(10-12) a sesquiterpene or diterpene with a 1,2,4-trisubstituted benzene moiety
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5.2.2 DK-1 
 
Figure 54: Proposed structure of DK-1, 6,8-diprenyleriodictyol. Stereochemistry at C2 is as yet 
undetermined. 
Fractions p.85-17 and p.23-11 through to p.23-14 were identical by TLC and labelled DK-1. 
DK-1 was identiﬁed by comparison of spectral data of these fractions to literature values 
for 13C-NMR (table 36) and 1H-NMR (table 37) and identiﬁed as 6,8-diprenyleriodictyol, a 
known compound (ﬁgure 54) (486, 487). Mass spectrometry of DK-1 returned a positive 
sodium adduct molecular ion at m/z 447.18 [M + Na]+ and a deprotonated molecular ion at 
m/z 423.20 [M - H]−, consistent with literature molecular weight 424.1887 and molecular 
formula C25H28O6 (488). Stereochemistry at C2, although undetermined, is most likely (S), 
this being the only conﬁguration reported in the literature to date, including in the likely KI 
source family Fabaceae (487-489), as described in 5.3. Determination of melting point and 
absolute structure by x-ray diffraction was precluded by loss of crystalline material by 
dissolution. 
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Table 36: Comparative 13C-NMR results for DK-1 and literature results for 6,8-diprenyleriodictyol. 
Both experiments used chloroform-d as solvent. Shift in ppm at 125 MHz (Li et al.) or 100 MHz (DK-
1). 
 
  
assignment Li et al.  (2012) DK-1 (p.85-17)
2 79.5 78.4
3 44.2 43.2
4 197.8 196.8
5 160.4 159.3
6 108.5 107.4
7 162.8 162.7
8 106.5 106.6
9 158.8 157.8
10 103.7 102.8
1′ 131.7 131.6
2′ 113.8 113.3
3′ 144.8 143.8
4′ 145.6 144.0
5′ 116.2 115.4
6′ 119.3 118.9
1″ 21.9 21.9
2″ 122 121.8
3″ 134.9 134.7
4″ 17.9 17.9
5″ 25.8 25.8
1‴ 21.3 21.3
2‴ 121.6 121.7
3‴ 134.3 134.2
4‴ 17.9 17.8
5‴ 25.8 25.8
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Table 37: Comparative 1H-NMR results for DK-1 and literature results for 6,8-diprenyleriodictyol. 
Assignment of 4″, 5″, 4‴ and 5‴ was informed by Abu-Mellal et al. (2012) and Duke et al. (2017). Note 
that some signals, especially unresolved multiplets, may have multiple protons assigned to them, due 
to overlap or symmetry. All experiments used chloroform-d as solvent. Shift in ppm at 500 MHz (Li et 
al.), 400 MHz (DK-1) or unspeciﬁed (Harborne et al.), J values in Hz in brackets. s = singlet, d 
=doublet, dd = doublet of doublets, t = triplet, m = unresolved multiplet, br = broad. 
 
5.2.3 DK-7 
 
Figure 55: Proposed structure of DK-7, monotesone B. Stereochemistry at C2 is as yet undetermined. 
Fraction p.3-(7-8), labelled DK-7, was identiﬁed by 1H-NMR (table 38). Assigned spectral 
data showed good agreement with that of DK-1 for protons on the A and C rings and prenyl 
substituents, where structure between DK-1 and DK-7 are identical. Singlets at 6.79 ppm and 
6.92 ppm indicated a 2′,4′,6′ arrangement of protons on the B ring. No other major 
assignment Harborne et al.  (1993) Li et al.  (2012) DK-1 (p.85-17)
2 5.26-5.30 m 5.33 dd  (3.0, 13) 5.15-5.29 m
3 2.78 dd  (3, 17.1) 2.79 dd  (3.0, 17.0) 2.77 dd  (2.7, 17.2)
3 3.00 dd  (12.51, 17.1) 3.05 dd  (12.5, 17.0) 2.99 dd  (12.7, 17)
2′ 6.88-6.99 m 7.20 d  (2.5) 6.80-6.98 m
5′ 6.88-6.99 m 6.84 d  (8.0) 6.80-6.98 m
6′ 6.88-6.99 m 7.20 dd  (2.0, 8.0) 6.80-6.98 m
1″ 3.29-3.35 m 3.31 d  (7.0) 3.29 d  (7.0)
2″ 5.26-5.30 m 5.22 t  (7.0) 5.15-5.29 m
4″ 1.71 s 1.73 s 1.81 s
5″ 1.75 s 1.73 s 1.74 s
1‴ 3.29-3.35 m 3.38 d  (7.0) 3.33 d  (7.0)
2‴ 5.26-5.30 m 5.33 t  (7.0) 5.15-5.29 m
4‴ 1.81 s 1.79 s 1.81 s
5‴ 1.81 s 1.79 s 1.70 s
B ring-OH 5.97 br s 5.68 br s
6.02 br s 5.85 br s
5-OH 12.3 s 12.3 s
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unassigned signals were noted, suggesting 5,7,3′,5′ tetrahydroxylation. As such, DK-7 was 
identiﬁed as monotesone B, a known compound (ﬁgure 55). Literature 1H-NMR results are 
included for comparison in table 38 (490); despite different solvent systems, results appear to 
match well. 13C-NMR results were not available in the literature. Mass spectrometry of DK-7 
returned a positive sodium adduct molecular ion at m/z 447.16 [M + Na]+ and a deprotonated 
molecular ion at m/z 423.14 [M - H]−, consistent with literature molecular weight 42418 and 
molecular formula C25H28O6 (490). Stereochemistry at C2 is as yet undetermined, but also 
likely (S) as per Versiani et al. (2011) (491). 
Table 38: Comparative 1H-NMR results for DK-7 and literature results for monotesone B. Assignment 
of 4″, 5″, 4‴ and 5‴ was informed by Abu-Mellal et al. (2012) and Duke et al. (2017). Note that some 
signals, especially unresolved multiplets, may have multiple protons assigned to them, due to overlap 
or symmetry. Shift in ppm at 500 MHz (Garo et al.) or 400 MHz (DK-7), J values in Hz in brackets. s 
= singlet, d =doublet, dd = doublet of doublets, t = triplet, m = unresolved multiplet, br = broad. 
 
  
                                                 
18 HREIMS data was unavailable in the literature. 
assignment Garo et al.  (1998), DMSO-d 6 Garo et al.  (1998), CDCl3 DK-7 (p.3-(7-8)), methanol-d 4
2 5.28 dd  (3.0, 12.2) 5.25 m 5.21 dd  (2.9, 12.7)
3 2.66 dd  (3.0, 17.1) 2.79 br d (16.6) 2.69 dd  (3.0, 17.1)
3 3.06 dd  (12.2, 17.1) 3.00 dd  (6.2, 16.6) 3.03 dd  (12.7, 17.0)
2′ 6.73 s 6.88 m 6.79 s
4′ 6.86 s 6.98 m 6.92 s
6′ 6.73 s 6.88 m 6.79 s
1″ 3.16 dd  (7.9, 11.7) 3.31 dd  (6.4, 19.5) 3.23 d  (7.6)
2″ 5.07 m 5.25 m 5.12 t  (7.0)
4″ 1.55 s 1.72 s 1.63 s
5″ 1.59 s 1.72 s 1.58 s
1‴ 3.16 dd  (7.9, 11.7) 3.31 dd  (6.4, 19.5) 3.26 d  (7.6)
2‴ 5.07 m 5.25 m 5.15 t  (7.0)
4‴ 1.61 s 1.75 s 1.76 s
5‴ 1.70 s 1.81 s 1.66 s
5-OH 12.44 s 12.31 s
B ring-OH 8.96 s
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5.3 Assessment of possible botanical source of CP propolis 
Table 39: Harvesting data for all pure CP propolis samples (by TLC) for years 2012 to 2014. HBS = 
Hanson Bay Sanctuary. 
 
Sample Harvesting Date Location Harvested
P-410 10/12/12 Kelly Hill
P-471 27/12/12 HBS Southern Alleyway
P-472 27/12/12 HBS Southern Alleyway
P-473 27/12/12 HBS Southern Alleyway
P-474 27/12/12 HBS Southern Alleyway
P-475 27/12/12 HBS Southern Alleyway
P-476 27/12/12 HBS Southern Alleyway
P-477 27/12/12 HBS Southern Alleyway
P-478 27/12/12 HBS Southern Alleyway
P-480 27/12/12 HBS Southern Alleyway
P-481 27/12/12 HBS Southern Alleyway
P-482 27/12/12 HBS Southern Alleyway
P-483 27/12/12 HBS Southern Alleyway
P-488 27/12/12 HBS Southern Alleyway
P-489 27/12/12 HBS Southern Alleyway
P-493 07/01/13 HBS Southern Alleyway
P-494 07/01/13 HBS Southern Alleyway
P-645 29/01/13 HBS Southern Alleyway
P-646 29/01/13 HBS Southern Alleyway
P-647 29/01/13 HBS Southern Alleyway
P-649 29/01/13 HBS Southern Alleyway
P-705 20/02/13 HBS site 1
P-706 20/02/13 HBS site 1
P-707 20/02/13 HBS site 1
P-719 18/03/13 HBS site 1
P-720 18/03/13 HBS site 1
P-721 18/03/13 HBS site 1
P-744 16/06/13 HBS site 1
P-798 Nov-13 Stephen Heatley
P-808 Nov-13 Stephen Heatley
P-834 18/10/13 HBS (unspecified)
P-835 18/10/13 HBS site 1
P-841 01/12/13 HBS site 1
P-842 01/12/13 Hanson Beach
P-876 26/12/13 Hanson Beach
P-877 26/12/13 Hanson Beach
P-878 26/12/13 HBS Southern Alleyway
P-923 27/01/14 HBS Southern Alleyway
  180 
 
 
Figure 56: Map of Hanson Bay Sanctuary (HBS). Main recorded CP collection sites are marked by 
blue boxes. Dark green = national parks and other reserves, light green = uncleared land, generally 
dominated by mallee gums. For scale, HBS is approx. 8 km wide. Map credit: Government of South 
Australia, Dept. of Environment, Water and Natural Resources 
To inform potential plant source of CP propolis, data on harvesting date and harvesting site 
for all CP propolis samples, assessed as pure or CP dominant by TLC, collected in years 
2012-2014 were tabulated. Table 39 shows all pure samples, showing a usual harvest time of 
late spring to early autumn, and a focus of collection sites around Hanson Bay Sanctuary, 
located in the south-west of KI (Chapter 1, ﬁgure 8), and close to uncleared Flinders Chase 
National Park (ﬁgure 56). Allowing for delay between collection of resins by bees and 
collection of propolis of bees (a minor beekeeping activity on KI), this would suggest the 
source resin is foraged by bees in spring. Although a bias in collection data must be noted, as 
Hanson Bay Sanctuary (HBS) are a partner in our KI propolis studies and a major source of 
propolis samples for assessment, other sites of collection by other beekeepers are also 
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concentrated along the south coast of the island, such as Kelly Hill and Stephen Heatley 
noted in table 39. Broadening data tabulation to include mixed CP samples during these 
harvest seasons returned similar collection times and locations on the south coast, with the 
notable exception of a CP:PS sample harvested from Island Beach, a location on the Dudley 
Peninsula of KI, in the east. The resin source must be a common plant, producing resin in 
quantity during season, as L. sp. ‘Montebello’, the source of S1 propolis, is common on the 
south coast and produces resin year-round. Many of the hives at HBS have been recorded as 
producing S1 propolis at other times, suggesting the resin source of CP is not a ‘desperation’ 
source for bees but actively preferred when available. 
Literature results for DK-1, 6,8-diprenyleriodictyol, have shown its isolation from plants of 
the family Fabaceae (487-489). With this knowledge, a list of likely plants of this family for 
assessment was assembled from lists of known species on KI from botanic surveys (129, 
492). Plants considered extremely rare or limited to geographic areas outside the south and 
west of the island were generally eliminated, in line with major distribution of recorded CP 
propolis harvesting sites (table 40). Three plants in particular were considered more likely 
resin sources; Acacia dodonaeifolia, Acacia retinodes and Pultenaea viscidula. 
A. dodonaeifolia, although listed as ‘not common’ except on the north coast of KI by local 
botanists and enthusiasts (452-454), was considered a possibility due to its common name of 
Sticky Wattle and its known hybridisation with A. paradoxa, the established source of KT 
propolis (454). A stronger possibility was A. retinodes, a very common species on KI (27/172 
species by the 1989 survey) especially along the lower watercourses of the south of KI where 
CP propolis is produced in abundance (129). Most promising was P. viscidula. Both binomial 
and common names were supportive: viscid means ‘sticky’ and Karatta is a locality on the 
south coast of KI near to HBS, the central locus of CP propolis production. The suggestive 
nomenclature is further supported by Prescott, who states it is often found with ‘young stems 
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sticky’ (454). It is common on KI (34/172 species by the 1989 survey) (129), all authors had 
noted its presence in the south-west of the island (452-454). In addition, it ﬂowers ‘late 
winter to spring’ (452), which matches with the postulated collection times of CP propolis by 
bees. 
Table 40: Shortlist of more common and widespread species of family Fabaceae on KI, as the most 
likely resin sources for CP propolis. The three species mentioned in the text are highlighted. Higher 
ﬁgures for ‘Total % of known distribution accounted for by KI’ implies greater speciﬁcity of the 
species to KI only. ‘Last attested’ lists last date of plant collection in the botanic literature, as of 
2011. 
 
  
Binomial name Common name Common on KI?
Total % of known 
distibution 
accounted for by KI
Last attested
Acacia baileyana Cootamundra Wattle <1 1992
Acacia calamifolia Wallowa 2 1995
Acacia cupularis Coastal Umbrella Bush 4 1996
Acacia cyclops Western Coastal Wattle 1 1995
Acacia dodonaeifolia Sticky Wattle not common, north coast 23 2002
Acacia euthycarpa Wattle 2 2003
Acacia longifolia Sydney Golden Wattle widespread 2 1996
Acacia myrtifolia Myrtle Wattle widespread 4 2008
Acacia pycnantha Golden Wattle 3 2005
Acacia retinodes Wirilda dune sands 15 2005
Acacia simmonsiana Wattle 14 2005
Acacia sophorae Coast Wattle 2 2005
Acacia spinescens Spiny Wattle 5 2005
Acacia triquetra Wattle 19 2005
Acacia verticillata Prickly Moses 2 2003
Daviesia asperula Bitter-pea widespread 51 2004
Daviesia benthamii Bitter-pea 1 1997
Daviesia brevifolia Bitter-pea 9 2006
Dillwynia hispida Parrot-pea 3 2006
Glycine clandestina Widespread Glycine <1 1997
Gompholobium ecostatum Wedge-pea 15 2006
Goodia medicaginea Native Clover widespread, mallee 7 1995
Hardenbergia violacea Happy Wanderer widespread, mallee woodland <1 2001
Kennedia prostrata Running Postman widespread 3 1997
Lotus australis Australian Trefoil 2 1996
Phyllota pleurandroides Bush-pea 13 2004
Phyllota remota Bush-pea 5 1990
Platylobium obtusangulum Native Pea 8 2008
Pultenaea dentata Bacon and Eggs <1 1991
Pultenaea graveolens Bacon and Eggs 3
Pultenaea largiflorens Large Flowered Bacon and Eggs 1 1996
Pultenaea pedunculata Matted Bush Pea 2 2005
Pultenaea prostrata Prostrate Bacon and Eggs <1 1999
Pultenaea viscidula Karatta Bacon and Eggs, Dark Bush-Pea 87 2003
Swainsona lessertiifolia Darling Pea 15 2000
Templetonia retusa Mallee-pea 4 2004
Trifolium stellatum Introduced Clover 12 1998
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Table 41: All plants collected on KI to date assessed by TLC as potential resin source of CP propolis 
 
  
Binomial name Common name Family Notes
Acacia cupularis coast umbrella bush Fabaceae
Acacia longifolia coastal wattle Fabaceae
Acacia paradoxa kangaroo thorn Fabaceae
Acacia paradoxa kangaroo thorn Fabaceae possible hybrid
Acacia pycnantha golden wattle Fabaceae
Acacia retinoides swamp wattle, wirilda Fabaceae
Acacia spinescens spiny wattle Fabaceae
Adenonthus macropodiana Kangaroo Island silver bush Proteaceae
Arctotheca calendula capeweed Compositae
Asterolasia muricata starbush Rutaceae
Astroloma conostephioides flame heath Epacridaceae
Beyeria subtecta ♀ turpentine bush Euphorbiaceae
Beyeria subtecta ♂ turpentine bush Euphorbiaceae
Bursaria spinosa sweet bursaria, christmas bush Pittosporaceae
Calytrix glaberrima smooth fringe-myrtle Myrtaceae
Conospermum patens slender smopke-bush Proteaceae
Dampiera lanceolata Kangaroo Island dampiera Goodeniaceae
Darwinia micropetala small darwinia Myrtaceae
Daviesia arenaria sand-hill bitter-pea Fabaceae very rare
Daviesia brevifolia leaf-less bitter-pea Fabaceae
Daviesia genistifolia broom bitter-pea Fabaceae rare on KI
Daviesia leptophylla bitter-pea Fabaceae
Dillwynia hispida red parrot-pea Fabaceae
Eutaxia microphylla mallee bush-pea Fabaceae
Goodenia varia sticky goodenia Goodeniaceae
Grevillea rogersii Rogers grevillea Proteaceae
Hakea vittata striped hakea Proteaceae
Haloragis acutangula raspwort Haloragaceae
Hibbertia acicularis prickly Guinea-flower Dilleniaceae
Hibbertia prostrata bundled Guinea-flower Dilleniaceae
Hibbertia sericea silky Guinea-flower Dilleniaceae
Hibbertia sp. 'B' Guinea-flower Dilleniaceae
Hibbertia sp. simple-haired Guinea-flower Dilleniaceae
Isopogon ceratophyllus conebush Proteaceae
Leucopogon costatus twiggy bearded-heath Epacridaceae
Muehlenbeck ia adpressa climbing lignum Polygonaceae
Myoporum insulare boobialla Scrophulariaceae
Oxalis pes-caprae soursob Oxalidaceae
Phyllanthus australis pointed spurge Euphorbiaceae
Pimelea phylicoides heath rice-flower Thymelaeaceae
Pimelea serpyllifolia thyme riceflower Thymelaeaceae
Platylobium obtusangulum common flat-pea Fabaceae
Prostanthera serpyllifolia small-leafed mintbush Labiatae
Prostanthera spinosa spiny mint-bush Labiatae
Pultenaea canaliculata coast-bush-pea Fabaceae
Pultenaea daphnoides large-leafed bush-pea Fabaceae
Pultenaea dentata clustered bush-pea Fabaceae
Pultenaea teretifolia needle-leaf bush-pea Fabaceae
Rhagodia candolleana seaberry saltbush Chenopodiaceae
Scaevola crassifolia cushion fan-flower Goodeniaceae
Swainsona lessertifolia coast swainson pea Fabaceae
Wahlenbergia multicaulis Tadgel bluebell Campanulaceae
Description
grass-like plant unknown unknown
purple six petal flower with dark purple stamens and stigma, grass-like stem unknown unknown
round sedge unknown Cyperaceae
white five petals, small flower unknown unknown
yellow cluster flowers, wire-like stem and leaves unknown unknown
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Table 41 lists all plants assessed to date by TLC from KI as potential sources of CP propolis; 
duplicate collections are not noted. Plant material was harvested over the years 2013-2016 
from road edges and private property on the south coast of KI, with an especial focus on 
Fabaceae and plants obviously sticky to the touch or shiny in appearance. Lack of permits 
precluded collection from nature reserves. Plant samples were provisionally identiﬁed in-
house using KI botany resources (452-454); several plants were unable to be identiﬁed and a 
description of these plants is given. 
The swamp wattle, A. retinodes, was quickly ruled out as a potential source proving broadly 
non-resinous, although producing marked quantities of gum. Numerous other acacias were 
tested, with few being obviously resinous and none producing chromatogram images 
comparable to CP propolis. A. dodonaeifolia was unable to be collected, in line with the 
noted distribution. Beyeria subtecta, the turpentine bush, another promising potential source 
being resinous and widespread on the island, was also ruled out. Despite repeated attempts, 
the supposedly common P. viscidula was unable to be collected; many closely related bush-
peas of genus Pultenaea were noted and assessed but none showed similarity by TLC to CP 
propolis or, indeed, any particular ‘stickiness’. 
The resinous coating of the ﬂower buds of Scaevola crassifolia, the cushion fan-ﬂower, did 
show some CP-like chromatographic features. Further investigation of the 1H-NMR spectra 
of samples of the resin of this species, and of related Scaevola spp. harvested at several 
locations around Narooma, far south coast NSW, returned spectra with poor similarity to CP 
propolis (< 300/1000). 
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5.4 Discussion 
It would appear that the limits of vacuum short column chromatography have been reached 
for CP propolis. Despite repeated chromatography under a variety of schedules, only two 
compounds were able to be puriﬁed to a state where structure could be conﬁdently assessed: 
6,8-diprenyleriodictyol and monotesone B. Certainly, suggestive results for other fractions 
were obtained, but lack of purity precluded conﬁdence in assessment. Attempts were made to 
follow lead signals in TLC chromatograms when choosing fractions to combine and 
fractionate, but these signals often proved illusory and made up of several compounds upon 
this further chromatography. Given the large number of prenylated ﬂavanones, of equal 
hydroxylation, present within CP propolis, it is fair to comment that any other separation 
technique would be likely to run into similar problems with co-chromatography. In addition, 
means such as semi-preparative HPLC or standard column chromatography could prove 
problematic when dealing with the quantity of extract assessed in this study and certainly 
prove very much slower. At any rate, 6,8-diprenyleriodictyol solidly dominates CP propolis, 
being observed to make up approx. 14% of methanol extract (ﬁgure 52). Considering that 
P410, the CP sample used in this chapter, would appear to be a minor S1 mixed sample, this 
percentage could be somewhat higher. 
6,8-Diprenyleriodictyol has been previously isolated from four botanic families; 
Dipterocarpaceae (Monotes engleri) (493), Fabaceae (Derris laxiﬂora (488), Derris 
ferruginea (489), Flemingia philippinenesis (487)), Velloziaceae (Vellozia coronata and 
Vellozia nanazae) (486) and, most commonly, Moraceae (Dorstenia mannii) (494-502). 
Notably, of these families, only the Fabaceae are found on KI (492). The compound has been 
isolated from many parts of the plants listed, including twigs (494, 499-501), leaves (494), 
leaf surfaces (486) and roots (487). Certain of these plants have known traditional use; 
Dorstenia mannii for cough, headache, stomach pain, gout and skin disease (498, 502), 
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Derris ferruginea as an insecticide and ﬁsh poison (489). As would be expected,  
6,8-diprenyleriodictyol has shown wide-ranging activity in many cellular assays, notably 
showing good antibacterial, antiparasitic and anticancer activity against speciﬁc cell lines 
(489, 495, 497, 498). In addition, anti-inﬂammatory action through several pathways has 
been demonstrated (494, 496). A fuller listing of the biological activity of  
6,8-diprenyleriodictyol, alongside the results of epigenetic and other assays, is expounded in 
Chapter 7. 
Monotesone B was initially isolated from dichloromethane extract of leaves of Monotes 
engleri, traditionally used for treating of leprosy in Zimbabwe (490). It was observed to have 
a minor inhibitory action against C. albicans in a dilution assay using solid media (MIC 50 
µg/mL) (490). The authors of this study also observed difﬁculties in use of chromatography 
for separating prenylated ﬂavanones and observed that 1D and 2D NMR were more useful 
methods of structure analysis than UV or MS methods (133). Interestingly, Monotes engleri 
is also a known source of 6,8-diprenyleriodictyol (493). Monotesone B has since been 
additionally isolated from Macaranga conifera (Euphorbiaceae) collected in Borneo (491). 
Monotesone B was observed to inhibit ABCG2 (IC50 4.1 μM), a drug-efﬂux membrane-
bound protein known to be overexpressed in many tumours that increases drug resistance 
(491). Macaranga spp. are native to Australia (122); Macaranga tanarius is a known resin 
source for Paciﬁc-type propolis, a propolis type rich in prenylated compounds (81), and a 
suspected resin-source for propolis from South East Queensland (122). Two prominent 
species of family Euphorbiaceae on KI were tested as sources of CP propolis (Beyeria 
subtecta, Phyllanthus australis), with no match. 
Given the circumstantial evidence detailed in 5.3, alongside the known sources of  
6,8-diprenyleriodictyol and structurally similar prenylﬂavanones, such as monotesone B, it 
may still be considered that the Karatta Bacon and Eggs, Pultenaea viscidula, is the best 
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candidate for resin source of CP propolis. The failure to collect a sample of the plant over the 
last four years should not be considered an absolute counter-indication to this: the resin 
source for S1 propolis, Lepidosperma sp. ‘Montebello’, took four years to be identiﬁed 
despite S1-type being a the main propolis on KI and the plant source growing in abundance 
within human eyesight of beehives19 (133). A similar delay occurred between identiﬁcation 
of KT propolis and identiﬁcation of A. paradoxa as resin source (133). Further ﬁeldwork is 
required, with a focus on Pultenaea spp., ideally with permits for harvesting in national parks 
and other reserves secured beforehand. In addition, to increase resin collection, hives should 
be depleted of propolis beforehand in line with past KI studies (131-133, 406). 
C-prenyl-type propolis, in line with the provisional label, appears to be a very rich source of a 
large number of C-prenylated compounds, particularly 6,8-diprenylated ﬂavanones. Of these, 
6,8-diprenyleriodictyol is the most prominent. Prenylated ﬂavonoids have shown wide-
ranging pharmaceutical interest as antimicrobials, antiparisitics, immunomodulators, and 
anticancer compounds, as detailed in Chapter 1. Further investigation of this propolis type, 
and the plant source once identiﬁed, should readily identify and purify a number of 
‘variations on a theme’ antioxidant molecules with broad biological activity, allowing better 
SAR elucidation of these important secondary metabolites. 
  
                                                 
19 Speciﬁcally, S1-type propolis was initially noted in June 2006, and L. sp. ‘Montebello’ only identiﬁed as resin 
source in February 2010. Once again, the superior capacity of bees to identify and locate pharmaceutically-
interesting resinous plants compared to PhD students must be noted. 
 
 
 
 
 
Chapter Six 
Isolation and characterisation of methyl 
ﬂavanones and novel terminally-
hydroxylated prenyldihydrochalcones from 
Lepidosperma viscidum sensu stricto plant 
resin   
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6.1 Fractionation and separation 
6.1.1 DK-2, DK-3 
 
Figure 57: Diagram of fractionation process of 160722-01 yielding DK-2 and DK-3. Labelling of 
fractions is as per 2.3.11.2; solvent systems, fraction volumes and column diameters used in 
fractionation schedules listed to left of fractions. EtOAc = ethyl acetate. 
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Table 42: Fractionation schedules used in fractionation of 160722-01 yielding DK-2 and DK-3. 
EtOAc = ethyl acetate. 
 
Short-column fractionation was performed on a methanolic extract of the resinous base of a 
L. visicidum s.s. plant sample, 160722-01. Figure 57 shows the fractionation process utilised. 
Fractions appearing near pure by TLC were submitted to 1H-NMR; two fractions were 
assessed as near pure from these spectra. These two fractions, p.45-13 and p.52-(6-7), were 
designated DK-2 and DK-3 respectively and submitted to further characterisation (6.2.1). 
17.2 mg of DK-2 and 4.8 mg of DK-3 were obtained. Table 42 shows the fractionation 
schedules yielding these compounds. 
p. 45 CHCl3 EtOAc p. 52 CHCl3 EtOAc
1 25 1 15
2 10 2 7.3 2.7
3 9 1 3 7.3 2.7
4 9 1 4 7.3 2.7
5 8 2 5 7 3
6 8 2 6 7 3
7 7 3 7 7 3
8 7 3 8 6.6 3.4
9 6 4 9 6.6 3.4
10 6 4 10 6.6 3.4
11 5 5
12 5 5
13 4 6
14 4 6
15 2 8
16 20
  191 
 
6.1.2 DK-4, DK-5, DK-6 
 
Figure 58: Diagram of fractionation process of grouped L. viscidum s.s. extracts yielding DK-4,  
DK-5 and DK-6. Labelling of fractions is as per 2.3.11.2; solvent systems, fraction volumes and 
column diameters used in fractionation schedules to left of fractions. DCM = dichloromethane; 
EtOAc = ethyl acetate. Note the division of p.59-9 into the precipitate ‘p.59-9-crystal’ and the dried 
supernatant ‘p.59-9-liquid’. 
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Table 43: Fractionation schedules used in fractionation of grouped L. viscidum s.s. extracts yielding 
DK-4, DK-5 and DK-6. DCM = dichloromethane; EtOAc = ethyl acetate. 
 
Resinous plant bases of four L. visicidum s.s. samples (141222-01, 141222-02, 141222-03 
and 141223-01) were extracted with ethanol and the dry extracts combined. Short-column 
fractionation was then performed on this combined dry extract (ﬁgure 58). One fraction, p.57-
9, was observed to produce a crystallised product prior to drying; this crystal was ﬁltered and 
analysed separately, yielding 46.2 mg of a pale yellow crystal. This compound, labelled p.57-
9-crystal, was found by TLC to be identical to p.57-1 (23.4 mg) and designated DK-4. Two 
other fractions, p.57-14 (47.9 mg) and p.57-15 (27.9 mg), were found to be near-pure and 
designated DK-5 and DK-6. Further characterisation was performed on these compounds 
(6.2.2, 6.2.3). Table 43 shows the fractionation schedules yielding these fractions. 
p. 54 CHCl3 EtOAc EtOH p. 57 DCM EtOAc
1 50 1 50
2 25 2 12 0.5
3 22.5 2.5 3 12 0.5
4 22.5 2.5 4 12 0.5
5 20 5 5 12 0.5
6 20 5 6 11.5 1
7 17.5 7.5 7 11.5 1
8 17.5 7.5 8 11.5 1
9 15 10 9 11.5 1
10 15 10 10 10 2
11 12.5 12.5 11 10 2
12 12.5 12.5 12 9 3
13 10 15 13 9 3
14 10 15 14 8 4
15 7.5 17.5 15 8 4
16 7.5 17.5 16 7 5
17 50 17 7 5
18 12 12
19 6 18
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6.2 Characterisation of compounds 
6.2.1 DK-2 and DK-3 
 
Figure 59: Proposed structure of DK-2, 5′-(4″-hydroxyprenyl)-4,2′,4′-trihydroxydihydrochalcone 
 
Figure 60: Proposed structure of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy- 
4,2′-dihydroxydihydrochalcone 
DK-2 (p.45-13) and DK-3 (p.52-(6-7)) were submitted to several NMR experiments, with 
spectra compared to literature results for 4,2′,4′-trihydroxydihydrochalcone (davidigenin) 
(503), 4,2′-dihydroxy-4′-methoxydihydrochalcone (504), and 3′-prenyl-4,2′-dihydroxy- 
4′-methoxydihydrochalcone (505) (ﬁgure 61). Consistency of spectral solvent utilised was 
not possible across all experiments and literature results. Nevertheless, 13C-NMR spectral 
results showed good concordance between davidigenin and p.15-13, and 4,2′-dihydroxy- 
4′-methoxydihydrochalcone and p.52-(6-7), suggesting these two dihydrochalcones formed 
the basic structure of these fractions (table 44). Other peaks noted in the 13C-NMR, along 
with the increase in attributed shift for C5′, were consistent with prenylation at C5′. 
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Figure 61: Structures of compounds compared in this study to DK-2 and DK-3. 
A: 4,2′,4′-trihydroxydihydrochalcone (davidigenin) (Jensen et al. (1977)), B: 4,2′-dihydroxy- 
4′-methoxydihydrochalcone (Kostrzewa-Susłow and Janeczko (2012)), C: 3′-prenyl-4,2′-dihydroxy- 
4′-methoxydihydrochalcone (Awouafack et al. (2010)). 
Table 44: Comparative 13C-NMR results for DK-2 and DK-3 with literature results for davidigenin 
(Jensen et al.) and 4,2′-dihydroxy-4′-methoxydihydrochalcone (Kostrzewa-Susłow and Janeczko). 
Note that some signals have multiple carbons assigned to them due to symmetry. Shift in ppm at 100 
MHz (DK-2 and DK-3); unstated for other studies. 
 
assignment
Jensen et al . 
(1977), acetone-d 6
Kostrzewa-Susłow 
and Janeczko 
(2012), CDCl3
DK-2 (p.45-13), 
methanol-d 4
DK-3 (p.52-(6-7)), 
methanol-d 4
1 132.1 133.0 132.7 133.3
2 129.6 129.5 130.5 130.5
3 115.4 115.7 116.3 116.4
4 155.8 151.5 156.8 156.9
5 115.4 115.7 116.3 116.4
6 129.6 129.5 130.5 130.5
α 39.7 40.1 41.2 41.3
β 29.5 29.9 31.5 28.5
1′ 113.3 114.0 113.8 114.1
2′ 165.6 166.7 164.9 165.6
3′ 103.0 101.2 103.2 100.1
4′ 164.7 166.7 164.4 165.4
5′ 108.1 107.5 121.5 122.5
6′ 133.0 131.3 133.3 131.9
1″ 28.4 31.4
2″ 124.8 124.5
3″ 137.0 137.2
4″ 68.9 68.9
5″ 14.0 13.9
C=O 200.7 191.5 205.8 206.1
4′-OMe 55.6 56.4
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Table 45: Comparative 1H-NMR results for DK-2 and DK-3 with literature results for davidigenin 
(Jensen et al.), 4,2′-dihydroxy-4′-methoxydihydrochalcone (Kostrzewa-Susłow and Janeczko) and 
3′-prenyl-4,2′-dihydroxy-4′-methoxydihydrochalcone (Awouafack et al.). Note that some signals, 
especially unresolved multiplets, may have multiple protons assigned to the due to overlap or 
symmetry. Shift in ppm at 400 MHz (DK-2, DK-3, Awouafack et al.) unstated for others, J values in 
Hz in brackets. s = singlet, d =doublet, dd = doublet of doublets, ddd = doublet of doublets of 
doublets, t = triplet, m = unresolved multiplet, br = broad. Multiplicity of signals was not available 
for Jensen et al. 
 
1H-NMR spectra also demonstrated good concordance with literature values for davidigenin, 
4,2′-dihydroxy-4′-methoxydihydrochalcone and 3′-prenyl-4,2′-dihydroxy- 
4′-methoxydihydrochalcone, the latter values giving further evidence for prenylation. Lack of 
singlet peak at approx. 1.65 ppm, attributed to C4″ in Awouafack et al., observed doublet of 
doublets of doublets at approx. 5.5 ppm instead of triplet at 5.17 ppm and otherwise 
unassigned singlets at approx. 3.9 ppm, with two proton integral, strongly suggested 4″ 
hydroxylation of both p.45-13 and p.52-(6-7) (table 45). This (E) conﬁguration is 
predominant in terminally-hydroxylated prenyl groups in natural products (506-508). To 
conﬁrm 5′-prenylation and terminal hydroxylation in both compounds, as well as  
4′-methoxylation of p.52-(6-7), 2D experiments were performed on both samples. HMBC 
assignment
Jensen et al . 
(1977), 
acetone-d 6
Kostrzewa-Susłow 
and Janeczko 
(2012), CDCl3
Awouafack et al. 
(2010), CDCl3
DK-2 (p.45-13), 
methanol-d 4
DK-3 (p.52-(6-7)), 
methanol-d 4
2 7.22 7.11 d  (8.5) 7.15-7.25 m 7.04 d  (8.6) 7.04 d  (8.6)
3 6.83 6.77 d  (8.5) 7.15-7.25 m 6.69 d  (8.6) 6.69 d  (8.6)
5 6.83 6.77 d  (8.5) 7.15-7.25 m 6.69 d  (8.6) 6.69 d  (8.6)
6 7.22 7.11 d  (8.5) 7.15-7.25 m 7.04 d  (8.6) 7.04 d  (8.6)
α 3.21 3.19 t  (7.8) 3.22 t  (7.3) 3.13 t  (7.7) 3.16 t  (7.2)
β 2.95 2.98 t  (7.5) 3.02 t  (7.3) 2.89 t  (7.7) 2.90 t  (7.6)
3′ 6.39 6.40 d  (2.5) 6.25 s 6.43 s
5′ 6.47 6.42 dd  (2.4, 9.0) 6.41 d  (9.0)
6′ 7.79 7.63 d  (9.0) 7.59 d  (9.0) 7.47 s 7.51 s
1″ 3.33 d  (7.0) 3.26 d  (7.2) 3.26 d  (7.2)
2″ 5.17 t  (7.0) 5.56 ddd  (1.2, 6.0, 8.7) 5.51 ddd  (1.3, 6.1, 7.4)
4″ 1.65 s 3.96 s 3.95 s
5″ 1.76 s 1.74 s 1.73 s
4-OH 5.38 s
2′-OH 12.60 s 12.76 br s
4′-OMe 3.83 s 3.86 s 3.86 s
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results, as per table 46, were consistent with these proposed structural features. Full COSY, 
HMBC and HSQC 2D spectra for DK-2 and DK-3 are attached in Appendix V. 
High-resolution electrospray ionisation mass spectrometry (HRESIMS) of DK-2 returned a 
positive sodium adduct molecular ion at m/z 365.13583 [M + Na]+ (calculated 365.13594), 
consistent with molecular formula C20H22O5. DK-2 was thus identiﬁed as  
5′-(4″-hydroxyprenyl)-4,2′,4′-trihydroxydihydrochalcone (ﬁgure 59). HRESIMS of DK-3 
returned a positive sodium adduct molecular ion at m/z 379.15141 [M + Na]+ (calculated 
379.15160), consistent with molecular formula C21H24O5. DK-3 was thus identiﬁed as  
5′-(4″-hydroxyprenyl)-4′-methoxy-4,2′-dihydroxydihydrochalcone (ﬁgure 60). Thorough 
investigation of the literature suggests both of these compounds are novel. 
Table 46: Selected HMBC correlation results for DK-2 and DK-3. Shift in ppm at 400 MHz (1H) and 
100 MHZ (13C) 
 
  
H C
1″ (3.26) 4′ (164.4), 5′ (121.5), 6′ (133.3), 2″ (124.8), 3″ (137.0)
4″ (3.96) 2″ (124.8), 3″ (137.0), 5″ (14.0)
5″ (1.74) 2″ (124.8), 3″ (137.0), 4″ (68.9)
H C
1″ (3.26) 4′ (165.4), 5′ (122.5), 6′ (131.9), 2″ (124.5), 3″ (137.2)
4″ (3.95) 2″ (124.5), 3″ (137.2), 5″ (13.9)
5″ (1.73) 2″ (124.5), 3″ (137.2), 4″ (68.9)
4′-OMe (3.86) 4′ (165.4)
DK-2 (p.45-13)
DK-3 (p.52-(6-7))
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6.2.2 DK-4 and DK-5 
 
Figure 62: Proposed structure of DK-4, farrerol. Stereochemistry at C2 is as yet undetermined. 
 
Figure 63: Proposed structure of DK-5, 5,7,3′,5′-tetrahydroxy-6,8-dimethylﬂavanone. 
Stereochemistry at C2 is as yet undetermined. 
DK-4 (p.57-1, p.57-9-crystal) was identiﬁed by comparison of spectral data of these fractions 
to literature values for 13C-NMR (table 47) and 1H-NMR (table 48) and identiﬁed as farrerol, 
a commonly isolated ﬂavanone (ﬁgure 62) (509). Mass spectrometry of DK-4 returned a 
deprotonated molecular ion at m/z 299.02 [M - H]−, consistent with literature result m/z 
299.3062 [M - H]− and molecular formula C17H16O5 (510). Stereochemistry at C2 is as yet 
undetermined, but is most likely (S), this being near universal in the extensive literature. 
DK-5 (p.57-14) was identiﬁed by comparison of 13C-NMR (table 47) and 1H-NMR (table 48) 
spectra to those of farrerol. C and H assignations for the A and C rings matched literature 
values of farrerol very closely; observed remaining signals in the 1H-NMR spectrum of DK-5 
were consistent with dihydroxylation at 3′ and 5′. As such, DK-5 was identiﬁed as  
5,7,3′,5′-tetrahydroxy-6,8-dimethylﬂavanone, a compound previously identiﬁed by HPLC-
MS from Rhododendron dauricum with (S) stereochemistry (ﬁgure 63) (510). Mass 
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spectrometry of DK-5 returned a deprotonated molecular ion at m/z 315.05 [M - H]−, 
consistent with literature result m/z 315.0728 [M - H]− and molecular formula C17H16O6 
(510). 
Table 47: Comparative 13C-NMR results for DK-4 and DK-5 with literature results for farrerol. Note 
that some signals may have multiple carbons assigned to them due to symmetry. All experiments used 
methanol-d4 as solvent. Shift in ppm at 100 MHz, except Devkota et al. (unstated). 
 
Table 48: Comparative 1H-NMR results for DK-4 and DK-5 with literature results for farrerol. Note 
that some signals may have multiple protons assigned to them due to symmetry. All experiments used 
methanol-d4 as solvent. Shift in ppm at 400 MHz, except Devkota et al. (unstated), J values in Hz in 
brackets. s = singlet, d =doublet, dd = doublet of doublets, br = broad. 
 
assignment Lai et al.  (2016) Devkota et al.  (2012) DK-4 (p.57-9-crystal) DK-5 (p.57-14)
2 80.1 80.1 80.2 80.2
3 44.1 44.1 44.2 44.3
4 198.4 198.4 198.5 198.5
5 160.3 159.4 160.4 160.4
6 104.8 104.8 104.9 104.9
7 164.2 164.2 164.3 164.3
8 104.1 104.1 104.2 104.2
9 159.3 160.3 159.5 159.4
10 103.2 103.3 103.4 103.4
1′ 131.5 131.6 131.7 132.4
2′ 128.8 128.8 129.0 119.1
3′ 116.3 116.4 116.5 146.8
4′ 158.8 158.8 159.0 116.4
5′ 116.3 116.4 116.5 146.6
6′ 128.8 128.8 129.0 114.7
6-Me 7.4 7.4 7.6 7.6
8-Me 8.1 8.2 8.3 8.5
assignment Lai et al.  (2016) Devkota et al.  (2012) DK-4 (p.57-9-crystal) DK-4 (p.57-1) DK-5 (p.57-14)
2 5.29 dd  (2.9, 12.8) 5.29 br d  (12.8) 5.28 br d (12.9) 5.41 dd  (2.8, 12.8) 5.21 dd  (2.2, 12.6)
3a 2.71 dd  (2.9, 17.1) 2.71 br d  (17.1) 2.69 br d  (17.0) 2.82 dd  (3.0, 17.1) 2.68 dd  (3.0, 17.1)
3b 3.05 dd  (12.8, 17.1) 3.05 dd  (12.8, 17.1) 3.04 dd  (13.1, 16.8) 3.14 dd  (12.8, 17.1) 3.05 dd  (12.6, 17.1)
2′ 7.32 d  (8.5) 7.31 d  (8.8) 7.31 d  (8.0) 7.43 d  (8.6) 6.79 s
3′ 6.83 d  (8.5) 6.82 d  (8.8) 6.82 d  (8.6) 6.97 d  (8.8)
4′ 6.94 s
5′ 6.83 d  (8.5) 6.82 d  (8.8) 6.82 d  (8.6) 6.97 d  (8.8)
6′ 7.32 d  (8.5) 7.31 d  (8.8) 7.31 d  (8.0) 7.43 d  (8.6) 6.79 s
6-Me 2.00 s 1.98 s 1.98 s 2.05 s 1.98 s
8-Me 1.99 s 1.99 s 1.99 s 2.06 s 1.99 s
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6.2.3 DK-6 
 
Figure 64: Proposed structure of DK-6, 5,7,3′,5′-tetrahydroxy-6-methylﬂavanone. Stereochemistry at 
C2 is as yet undetermined. 
DK-6 (p.57-15) was identiﬁed by comparison of spectral data to literature values for  
13C-NMR (table 49), 1H-NMR (table 50) and HMBC (table 51), and identiﬁed as  
5,7,3′,5′-tetrahydroxy-6-methylﬂavanone, a compound isolated previously from the conifer 
Pseudotsuga sinensis with (S) stereochemistry (ﬁgure 64) (511). Lack of available sample 
precluded determination of mass spectrum. 
Table 49: Comparative 13C-NMR results for DK-6 and literature results for 5,7,3′,5′-tetrahydroxy- 
6-methylﬂavanone. Note that some signals have multiple carbons assigned to them due to symmetry. 
Shift in ppm at 100 MHz (DK-6), unspeciﬁed for Yi et al. 
 
  
assignment Yi et al.  (2002), DMSO-d 6 DK-6 (p.57-15), methanol-d 4
2 78.4 80.2
3 42.2 44.1
4 196.4 198.3
5 160.7 163.1
6 103.2 104.8
7 164.5 166.5
8 94.2 96.3
9 160.3 161.8
10 101.5 102.8
1′ 129.6 132.4
2′ 115.3 114.7
3′ 145.7 146.9
4′ 114.3 116.4
5′ 145.2 146.6
6′ 117.9 119.1
6-Me 6.9 7.9
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Table 50: Comparative 1H-NMR results for DK-6 and literature results for 5,7,3′,5′-tetrahydroxy- 
6-methylﬂavanone. Note that some signals have multiple protons assigned to them due to symmetry. 
Shift in ppm at 400 MHz (DK-6), unspeciﬁed for Yi et al., J values in Hz in brackets. s = singlet, dd = 
doublet of doublets.  
 
Table 51: Comparative HMBC correlation results for DK-6 and literature results for 
5,7,3′,5′-tetrahydroxy-6-methylﬂavanone. Shift in ppm at 100 MHz (13C) and 400 MHz (1H) (DK-6), 
unspeciﬁed for Yi et al. 
 
  
assignment Yi et al.  (2002), DMSO-d 6 DK-6 (p.57-15), methanol-d 4
2 5.34 dd  (3, 12) 5.26 dd  (3.0, 12.4)
3a 2.68 dd  (3, 17) 2.71 dd  (3.1, 17.0)
3b 3.18 dd  (12, 17) 3.01 dd  (12.5, 17)
8 5.99 s 5.92 s
2′ 6.75 s 6.79 s
4′ 6.89 s 6.95 s
6′ 6.75 s 6.79 s
6-Me 1.89 s 1.95 s
H C
2 (5.34) 1′ (129.6),  2′ (115.3) , 6′ (117.9)
3 (2.68, 3.18) 2 (78.4), 1′ (129.6), 10 (101.5)
8 (5.99) 6 (103.2), 7 (164.5), 9 (160.3)
5-OH (12.42) 6 (103.2)
6-Me (1.89) 5 (160.7), 7 (164.5)
H C
2 (5.26) 1′ (132.4), 2′ (114.7), 6′ (119.1) 
3 (2.71, 3.18) 4 (198.3), 2 (80.2), 1′ (132.4), 10 (102.8)
8 (5.92) 6 (104.8), 7 (166.5), 9 (161.8), 10 (102.8)
6-Me (1.95) 5 (163.1), 6 (104.8), 7 (166.5)
Yi et al.  (2002), DMSO-d 6
DK-6 (p.57-15), methanol-d 4
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6.3 Discussion 
Chemistry of L. viscidum s.s. resin is markedly different from that previously observed in 
other propolis resin sources of genus Lepidosperma on KI. Isolation of compounds found in 
this chapter from F-type propolis is pending, but the statistical identiﬁcation of this plant 
resin as source of F-type propolis, and the general chemical identity between source resins 
and resulting propolis suggests very strongly these unique compounds will be present in this 
propolis.  
The predominant propolis isolated on KI, S1-type, has resin source species L. sp. 
‘Montebello’, whose chemistry has been extensively investigated by our group (131, 133, 
406). The compounds isolated from resins of that species are predominantly C- and  
O-prenylated hydroxystilbenes or derivatives thereof, many with piceatannol as base 
structure (131, 406), with small amounts of prenylated p-coumarate ester, farrerol and a  
4′-methoxylated derivative also isolated (131). By comparison, L. viscidum s.s. resin appears 
to be predominantly 6- or 8-methyl or dimethyl polyhydroxyﬂavanones of the type DK-4, 
DK-5 and DK-6; 1H-NMR spectra of less pure fractions also suggests the presence of some  
O-methylated ﬂavanones. Notably, prenylation appears to be uncommon in L. viscidum s.s. 
resin compounds, with the exception of the two dihydrochalcones isolated, and no evidence 
of stilbenes of any description were encountered during this study. 
DK-2 and DK-3 are apparently novel in structure: a number of 3′-prenyl 
hydroxydihydrochalcones have been reported from natural sources, but, unexpectedly, no  
5′-prenylated structures to date. These 3′-prenyl hydroxydihydrochalcones have been isolated 
from genera Angelica (512), Artocarpus (513), Bacopa (514), Broussonetia (515), Eriosema 
(505, 516) and Lonchocarpus (517), none of these genera being closely related to the 
Cyperaceae. Limited information on biological activity of these compounds exists, but one is 
a reported strong free radical scavenger by the DPPH assay (513) and another has been 
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observed to inhibit aromatase (515). By comparison, both 3′- and 5′-prenylated 
hydroxychalcones have been reported from genera Angelica (518), Artocarpus (508, 519), 
Glycyrrhiza (507, 520), and Hypericum (521). Again, biological activity reports are limited, 
but one study demonstrated antifungal activity against C. albicans for 3′-prenyl- 
4,2′,4′-trihydroxychalcone with MIC 2 µg/mL; unfortunately, botanic source (if any) was not 
mentioned (522). 5′-prenylation appears to be more common where hydroxy- or keto- 
moieties are found at Cα or Cβ (523-525). 
In addition, the hydroxylation of prenyl moieties is very unusual across all natural products, 
especially terminally at C4 (506-508) or C5 (519), with C2 or C3 proving more usual 
hydroxylation sites (526, 527). Previous evidence of terminal hydroxylation of prenyl groups 
in Lepidosperma spp. exists: a terminally-hydroxylated O-prenyl cinnamate has been isolated 
from L. sp. ‘Montebello’ (131, 406). Nevertheless, the extremely unusual structure of 
compounds DK-2 and DK-3 suggests the possibility of their use as marker compounds for  
F-type propolis. Investigation of biological activity, if any, is required; hydroxylation of 
prenyl groups appears to reduce the activity of prenylated compounds (508, 527) and, as 
such, is more commonly encountered in metabolites of ingested prenylated compounds, 
especially xanthohumol and isoxanthohumol from hops20 (528, 529). However, at least one 
study has noted no difference in antibacterial activity between terminally-hydroxylated and 
non-hydroxylated prenylﬂavonoids (506). 
Farrerol (DK-4) has a long history in the literature. It was contemporaneously identiﬁed and 
reported in 1956 from Japanese ferns of genus Cyrtomium under the name ‘cyrtopterinetin’ 
(530) and in 1955 from Rhododendron farrerae under the current trivial name (531). 
                                                 
20 Interestingly, resin extracts of L. viscidum s.s were observed to have a strong hoppy odour comparable to an 
American-style India Pale Ale. 
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Isolation from Rhododendron spp., especially Rhododendron dauricum, has been ongoing 
since (509). In an Australian context, farrerol was ﬁrst isolated from Angophora costata in 
1960 (532). It has since been isolated from plants from an extremely widespread number of 
genera: Bauhinia (533), Chingia (534), Cordyline (535), Daphne (536), Hildegardia (537), 
Hymenocallis (538), Miconia (539), Narcissus (540), Pancratium (541), Scadoxus (542), 
Sterculia (543) and Wikstroemia (544, 545). In addition, farrerol has previously been isolated 
by this group from Lepidosperma sp. ‘Montebello’ (131, 406). 
Farrerol, in the form of dry Rhododendron dauricum leaves, has a long history of use in TCM 
as a constituent of two preparations: qin-bao-hong (546) and man-shan-hong (547). The latter 
was historically used as an expectorant and antitussive, in line with the demonstrated strong 
expectorant action of farrerol (548). Research into this antitussive activity of man-shan-hong 
by Chinese researchers in the 70s and 80s demonstrated broad anti-inﬂammatory activity, 
leading to more widespread investigations. A variety of anti-inﬂammatory and 
immunomodulatory activities have since been demonstrated: inhibition of vascular smooth 
muscle cell proliferation via estrogen receptor-β (547); inhibition of various interleukin and 
NF-κB pathways (549-551); inhibition of heme oxygenase-1 (552); inhibition of murine T 
cells, both in vitro and in vivo (553); dose-dependent vasorelaxation on rat aorta (554); 
reduction of aortic lesions through upregulation of endothelial nitric oxide synthase (555); 
and protection against hydrogen-peroxide-induced apoptosis in human endothelium-derived 
EA.hy926 cells via regulation of occludin expression, associated with atherosclerosis (556, 
557). Some anticancer activity has been shown; with apoptosis of human gastric cancer  
SGC-7901 cells at 40.4 μM via a mitochondrial pathway observed (558), as well as 
reductions in angiogenesis (559). Strong activity against 35 strains of S. aureus (MIC 4-16 
µg/mL), including methicillin-resistant strains, has been noted; lower concentrations 
demonstrated dose-dependent reduction in α-toxin production by S. aureus (560). A potential 
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difﬁculty in use of farrerol derivatives in human therapy should be noted: farrerol is observed 
to strongly bind to bovine and human serum albumin (561, 562), probably attributable to its 
observed interactions with lysozymes (563).  
DK-5 has previously been isolated from Rhododendron dauricum (510) as per farrerol, and 
DK-6 from the conifer Pseudotsuga sinensis (511). Neither species is closely related to the 
Cyperaceae. No biological assays for these compounds have been reported21 (510, 511) but, 
given the broad structural similarity of both to farrerol, biological activity can be assumed to 
be, correspondingly, broadly similar and probably anti-inﬂammatory. 
F-type propolis and its resin source L. viscidum s.s. are a promising source of a diverse range 
of ﬂavanones of likely biological activity, and of farrerol, a compound of intense 
pharmaceutical interest and long-term traditional use. In addition, a number of unique 
dihydrochalcones have been isolated from the resin. Given the demonstrated wide variance in 
F-type propolis chemistry, further work is needed to determine if these dihydrochalcones, or 
structurally-related compounds, are common to all F-type propolis. In addition, given the 
paucity of literature, investigation as to the anti-inﬂammatory or immunomodulant properties 
of these novel compounds is certainly warranted.  
  
                                                 
21 With the caveat that Yi et al. (2002) was, with the exception of structure names and tables, entirely in 
Mandarin and absolute translation of the paper was, thus, unavailable. 
 
 
 
 
 
Chapter Seven 
Biological activity of 
6,8-diprenyleriodictyol  
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7.1 Introduction 
7.1.1 Known botanic sources of 6,8-diprenyleriodictyol 
The ﬁrst mention of 6,8-diprenyleriodictyol is in Harborne et al. (1993). This paper reported 
its isolation from the leaf washings of Vellozia coronata and V. nanuzae, tropical 
monocotyledons from South America of the Velloziaceae family (486). The authors noted 
that similar prenylated ﬂavanones had previously been isolated from plants of the Asteraceae 
(Compositae), Platanaceae and particularly the Fabaceae (486). Within that latter family, 
other prenylated eriodictyols are known from Erythrina sigmoidia and the 7-methyl ether of 
6,8-diprenyleriodictyol known from Amorpha fruticosa (486). 6,8-Diprenyleriodictyol has 
since been isolated from other species of family Fabaceae: Derris ferruginea (489), Derris 
laxiﬂora (488) Flemingia phillippinensis (487), and Pseudarthria hookeri (564). Two 
additional non-Fabaceae species produce 6,8-diprenyleriodictyol: Dorstenia mannii (494-
496, 498-500, 502) and Monotes engleri (493). 
7.1.2 Antibiotic activity of 6,8-diprenyleriodictyol 
6,8-Diprenyleriodictyol-rich species have a long traditional use in equatorial Africa: Derris 
spp. as insecticides and ﬁsh poisons (488, 489), and Pseudarthria hookeri for coughs, 
diarrhoea, malaria and tuberculosis (564), indicating a long history of known biocidal 
potential. However, the antibiotic potential of 6,8-diprenyleriodictyol varies greatly across 
pathogens: Mbaveng et al. (2012) recorded reasonable minimum inhibitory concentration 
(MIC) of 32 μg/mL only against Enterobacter aerogenes ATCC 13048 and Candida albicans 
ATCC 9002; the latter also demonstrated a minimum bactericidal concentration (MBC) of 64 
μg/mL (498). A low degree of antitrichomonal activity against Trichomonas gallinarum has 
also been shown in one study, with a minimum lethal concentration (MLC) at both 24 and 48 
h of 31.25 µg/mL (502). 
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By comparison, Dzoyem et al. (2013) demonstrated MIC of ≤ 4 μg/mL against multiple 
strains of S. aureus, both MSSA and MRSA, as well as Crytococcus neoformans H99 (495). 
Various mechanisms were observed by this study, including increased membrane 
permeability and decreased DNA, RNA and protein synthesis, comparable to reference 
antibiotics (495). In addition, a very high LD50 in silkworms of >625 μg/mL was estimated, 
with no obvious toxicity observed at 625 μg/mL (495). Good activity against at least three 
species of parasites are also known: Plasmodium falciparum (IC50 = 5.8 ± 0.8 µM), 
Leishmania major (IC50 = 3.7 ± 0.2 µM) (489) and Leishmania amazonas (IC50 = 12.38 ± 
3.39 µM) (565). 
7.1.3 Anti-inﬂammatory and immunomodulant activity of  
6,8-diprenyleriodictyol 
Dorstenia spp. has historical use in West Africa for rheumatism and stomach upset (498, 
499), as well as cough, headache, gout and skin disease (502). Investigation of these 
properties by West African researchers has shown that 6,8-diprenyleriodictyol is a potent 
scavenger of free radicals by the DPPH assay (EC50 = 32.12 ± 2.15 µg/mL), proving more 
potent than butylated hydroxytoluene, a historically-common antioxidant food additive, but 
with mixed results in ORAC and AGEs assays (489, 494, 502). Prenylation was not observed 
to increase general antioxidant capacity compared with base ﬂavanones (489). 
Speciﬁc inhibition of inﬂammatory pathways has been shown. Inhibition of Cu2+-mediated 
oxidation of LDL (IC50 < 1 µM), a pathway to atherosclerosis, has been noted, without 
binding copper ions and with no pro-oxidant activity at higher dose (494). Notably, > 90% 
inhibition of NO production in a soybean lipoxygenase inhibition study at 25 µg/mL, 
attributed to partial cytotoxicity against macrophages, has been shown by Dzoyem et al. 
(2015), with appreciable NO inhibitory activity (84.65%) at concentrations as low as 3.12 
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µg/mL (496). This study also showed broad anticholinesterase activity (IC50 = 6.38 ± 0.13 
µg/mL) and speciﬁc inhibition of soybean 15-lipoxygenase (IC50 = 57.19 µg/mL) (496). 
7.1.4 Anticancer activity of 6,8-diprenyleriodictyol 
Broad cytotoxicity against a wide range of tumour cell lines has been noted in two studies on 
6,8-diprenyleriodictyol: an ED50 of less than 20 µg/mL (47.11 µM) was noted for 786-0 renal 
cell adenocarcinoma, A431 and KB epidermoid carcinomas, A549 alveolar basal epithelial 
cell adenocarcinoma, CaSki and HeLa cervical carcinoma, CEM/ADR5000 and PF-382  
T-cell leukaemia, Colo-38 and Mel2 melanoma, HL-60 promyelocytic leukemia , HT 
ﬁbrosarcoma, Lul lung cancer, and U87MG glioblastoma (493, 497). 
Lower ED50 at ≤ 5 µg/mL (11.78 µM), was noted for some cell lines: BCl breast cancer, 
CCRF‑CEM T-cell leukaemia, Co12 colon cancer, KB-VI multidrug-resistant oral 
epidermoid carcinoma, MiaPaCa-2 pancreatic carcinoma, U373 glioma and ZR-75-l 
hormone-dependent breast cancer (493, 497). Most notably, a ED50 of ≤ 2 µg/mL (4.71 µM) 
for LNCaP prostate cancer cells was demonstrated (493), and a ED50 of 0.6 µg/mL (1.41 µM) 
observed for MCF-7 breast adenocarcinoma (497). Non-prenylated isologues were generally 
observed to have lesser cytotoxicity; hydroxylation was also observed to increase cytotoxicity 
(493, 497). Low hepatotoxicity was observed with IC50 > 20 µg/mL (47.11 µM) for AML12 
normal hepatocytes (497). An apoptotic mechanism, partially through induction of caspase 
3/7, was observed, partially explaining the observed cytotoxic activity (497). More recent 
studies qualify this observed cytotoxic potential, noting non-speciﬁcity with strong 
cytotoxicity against non-cancerous MRC-5 ﬁbroblast cells (IC50 = 8 µM) (489). 
Apart from its cytotoxic activity, a degree of angiogenesis inhibition has been noted for  
6,8-diprenyleriodictyol: 34.8% inhibition of vasculation at 20 μg/mL (approx. half that of the 
standard, captopril) by the chicken-chorioallantoic-membrane assay (497). 
  209 
 
7.1.5 Choice of assays in this study 
Biological screening of the two new compounds isolated by this study, DK-2 and DK-3, was 
precluded due to both their late isolation and insufﬁcient quantity available for analysis. In 
addition, terminal hydroxylation of prenylated compounds has generally been associated with 
lowered therapeutic activity in the literature (508, 527). As such, focus was made on a more 
detailed investigation of the activity of DK-1, available in quantity at good purity, despite 
some concerns over the catechol structure of DK-1 returning potentially-overinﬂated and 
imprecise assay results22 (566, 567). Against this was contrasted the obvious innate biological 
activity, as demonstrated by the use of DK-1-rich CP propolis by KI bees and the studies 
summarised above. 
In line with the known activity of 6,8-diprenyleriodictyol, DK-1 was submitted to additional 
experiments on cancer cell lines in this study, as well as a wide range of anti-inﬂammatory 
assays. Mixed antibiotic results suggested against further antibiotic assessment. The 
prenylﬂavonoid structure of DK-1 was observed to be broadly similar to other compounds 
isolated by this group from KI propolis with potential melatonergic activity speciﬁc to MT3 
(ML2) receptors; as such DK-1 was submitted to this assay. 
The majority of assays performed were to assess the epigenetic activity of DK-1. The known 
broad immunomodulant and anticancer activity of 6,8-diprenyleriodictyol is, to date, lacking 
elucidation of potential pathways. Increased induction of pro-immune genes by stimulus of 
DNA-modifying enzymes is commonly shown to lie behind much immune activity; 
exploration of this epigenetic activity as a probable source of some of the observed action of 
6,8-diprenyleriodictyol was deemed a potentially-rewarding area of study. 
                                                 
22 Catechols are a noted Pan Assay Interference Compounds (PAINS) moiety, as described by Baell and 
Holloway (2010), noted for often returning false positive results in assays through non-speciﬁc actions such as 
redox cycling and metal chelation. 
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7.2 Results and discussion 
7.2.1 Cancer cell line assays 
Table 52: Selected cell proliferation assay results at 10 days, showing where EC50, IC50 or GI50 below 
10 µm DK-1 were calculated. EC50 =concentration at inﬂection point of curve of concentration to cell 
count (half effective response); IC50 = concentration producing half observed maximal response; 
GI50 = concentration at half observed maximal cell volume. Barretina et al. (2012) lists controls. 
 
Cell Line Cell Line Type EC50 (µM) IC50 (µM) GI50 (µM)
MDA-MB-436 breast adenocarcinoma 9.82 9.87 9.82
NCI-H661 lung carcinoma 6.31 6.31 6.25
SW872 connective tissue liposarcoma 9.24 9.24 9.20
A204 muscle rhadomyosarcoma 1.72 1.72 1.65
A427 lung carcinoma 6.09 6.09 6.05
AU565 lung adenocarcinoma 5.05 5.05 4.93
BPH1 benign prostatic hyperplasia 4.44 13.70 13.30
CA46 Burkitt's lymphoma (B lymphocytes) 4.74 4.74 4.73
CEM-C1 acute lymphoblastic leukaemia 4.36 4.37 4.36
ChaGoK1 bronchogenic carcinoma 8.21 8.21 8.12
CML-T1 chronic myeloid leukaemia 7.64 7.64 7.63
COR-L105 lung adenocarcinoma 9.36 9.46 9.39
Capan-2 pancreatic adenocarcinoma 8.65 8.69 8.65
DoTc2 4510 cervical adenocarcinoma 5.78 5.78 5.54
DMS53 lung carcinoma 3.32 3.39 3.32
Daoy desmoplastic cerebellar medulloblastoma 3.84 3.84 3.82
Daudi Burkitt's lymphoma 3.58 3.58 3.57
DOHH-2 B cell lymphoma 1.24 1.24 1.24
EFM-19 breast carcinoma 3.78 3.78 3.65
SKMES1 lung squamous carcinoma 6.88 6.88 6.74
GA-10 Burkitt's lymphoma 2.64 2.64 2.64
HEL-92.1-7 bone marrow erythroleukaemia 8.82 8.82 8.78
HT-1080 fibrosarcoma 4.48 4.49 4.48
JeKo-1 mantle cell lymphoma 4.03 4.03 4.02
KPL-1 breast carcinoma 4.07 4.07 4.05
L-428 Hodgkin's lymphoma 5.34 5.34 5.32
MOLT-16 T cell acute lymphoblastic leukaemia 4.04 4.05 4.04
MDA MB 231 breast adenocarcinoma 6.99 7.04 6.99
SK-MEL-28 dermal malignant melanoma 9.14 9.14 8.96
MDA MB 453 breast carcinoma 3.17 3.17 3.09
MDA MB 468 breast adenocarcinoma 3.06 3.07 3.04
MC116 B cell lymphoma 8.95 8.95 8.93
Mia PaCa-2 pancreatic carcinoma 9.79 9.79 9.77
MV-4-11 acute monocytic leukaemia 3.88 3.88 3.87
PANC-1 pancreas ductal adenocarcinoma 5.40 5.40 5.36
Raji Burkitt's lymphoma 9.69 9.69 9.68
RS4;11 acute lymphoblastic leukaemia 4.53 4.55 4.52
SK-N-AS neuroblastoma 6.52 6.52 6.43
SU-DHL-8 large cell lymphoma (B lymphoctyes) 4.78 4.78 4.78
SJRH30 muscle rhadomyosarcoma 6.16 6.16 6.11
SR large cell immunoblastic lymphoma 4.70 4.71 4.70
ST486 Burkitt's lymphoma 3.16 3.16 3.14
TE 381.T rhadomyosarcoma 5.78 5.78 5.66
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Table 53: Results of cell viability assays for DK-1 and a sample of unmixed CP-type propolis (P1166) 
at 3 days. ‘Cell Viability’ = percentage of control cell count. Where cell viability < 0%, cell count is 
less than that observed at t = 0. Estimated molar concentration of P1166 propolis was calculated 
using a nominal molecular weight of 350. HUVEC normal umbilical vein endothelium cells were used 
as control cell line. Other controls were as per Barretina et al. (2012). 
 
Cell Line Cell Line Type
Cell Viability (%), 
DK-1 (10 µM)
Cell Viability (%), 
P1166 (30 µM)
4T1 BALB/cfC3H mouse mammary gland adenocarcinoma 91 56
A375 malignant melanoma 84 26
A-431 epidermoid carcinoma 83 30
A-498 kidney carcinoma 95 45
A549 lung carcinoma 100 31
ACHN kidney adenocarcinoma 84 28
B16-F0 C57BL/6J mouse melanoma, skin 73 17
BT474 breast carcinoma, mammary gland ductal carcinoma 102 46
CT26.WT BALB/c mouse colon carcinoma 60 2
DLD-1 colon adenocarcinoma 59 39
H33HJ-JA1 Jurkat derivative lymphoma 42 -64
HC-4 liver carcinoma 98 74
HCT-116 colon carcinoma 90 12
HCT-15 colon adenocarcinoma 72 35
Hep3B hepatocellular carcinoma 53 10
HepG2 hepatocellular carcinoma 70 32
HL-60 acute promyelocytic leukemia 66 -2
HT-29 colon adenocarcinoma 83 2
HUVEC normal umbilical vein endothelium 61 19
K562 chronic myelogenous leukemia 88 3
KATO III gastric carcinoma 57 7
LL/2 C57BL mouse lung carcinoma 94 24
LNCaP prostatic carcinoma 108 -41
MCF-7 breast adenocarcinoma, mammary gland 69 -19
MCF-7 AdrR breast adenocarcinoma, mammary gland 97 -15
MDA-MB-231 breast adenocarcinoma, mammary gland 98 25
MDA-MB-468 breast adenocarcinoma, mammary gland 5 -23
MES-SA uterine sarcoma 75 -15
MIA PaCa-2 pancreatic carcinoma 94 28
MOLT-4 lymphoblastic leukemia 59 -19
MV-411 biphenotypic B myelomonocytic leukemia -75 -96
NCI-H460 lung carcinoma, large cell lung cancer 89 22
OVCAR-3 ovarian adenocarcinoma 65 4
PANC-1 pancreas/duct epithelioid carcinoma 93 40
PC-3 prostatic adenocarcinoma 75 17
PC-6 lung carcinoma 34 20
Ramos Burkitt's Lymphoma (B cell) 8 -92
SK-MEL-5 malignant melanoma 91 5
SK-N-MC neuroepithelioma 52 2
SK-OV-3 ovarian adenocarcinoma 58 -6
SW-620 colon adenocarcinoma 45 -60
T47D breast ductal carcinoma 88 60
U-87 MG brain glioblastoma, astrocytoma 100 29
U937 histiocytic lymphoma, lymphocyte, Myeloid 96 4
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Results of both cell proliferation and cell viability assays on DK-1 conﬁrm the wide-ranging 
cytotoxic activity of 6,8-diprenyleriodictyol. Non-cancerous control cell lines and positive 
control agents used were as Fallahi-Sichani et al. (2013) (456) and Barretina et al. (2012) 
(457). Of 90 cell lines tested in the cell proliferation assays, all but four returned an EC50, 
IC50 or GI50 below 20 µM at 10 days (Appendix VI, table 59) and 43 demonstrated an EC50, 
IC50 or GI50 below 10 µM at 10 days (table 52). Within these 43, some patterns are apparent: 
approximately half of the cell lines (18/43) are leukaemias or lymphomata (BPH1, CA46, 
CEM-C1, CML-T1, Daudi, DOHH-2, GA-10, JeKo-1, L-428, MC116, MV-4-11, Raji, 
RS4;11, SU-DHL-8, SR and ST486). Of these blood cancers, ﬁve of the cell lines are 
representative of one disease state alone: Burkitt’s lymphoma, a rare non-Hodgkin’s 
lymphoma that affects B-lymphocytes (CA46, Daudi, GA-10, Raji, ST486). Two other B cell 
lymphoma cell lines returned EC50 < 10 µM (MC116, DOHH-2); the lowest EC50 noted in 
the cell proliferation assays overall was for DOHH-2 B-cell lymphoma at 1.24 µM. The 
second lowest EC50, 1.72 µM, was observed for A204 muscle rhadomyosarcoma; two other 
cell lines for this disease (SJRH30 and TE 381.T) returned low EC50. Lung and breast cancer 
cell lines also were well represented in the results, with 6 and 5 cell lines, respectively, 
returning EC50 < 10 µM. 
Unsurprisingly, assay results for cell viability at three days (table 53) showed strongest 
results for cell lines representing some of the cancers mentioned above. Notably, after 
treatment with DK-1 at 10 µM, PC-6 lung carcinoma returned a cell mass 34% of control (i.e. 
cell viability = 34%), Ramos Burkitt’s lymphoma had cell viability of 8%, and MDA-MB-
468 breast adenocarcinoma had cell viability of 5%. The latter cell line was also tested in the 
cell proliferation study, with EC50 = 3.06 µM at 10 days. Most notably, cell viability of -75% 
was returned for MV-411 biphenotypic B myelomonocytic leukaemia. This represents a 
reduction in cell mass of 75% compared to the time of initial treatment with DK-1. These 
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results broadly match those in the literature, where EC50 at 2-3 days of approximately 10 µM 
or less is noted against a number of leukaemia and breast cancer cell lines (493, 497). Direct 
comparison with literature results is possible for three speciﬁc cell lines. MCF-7 breast cancer 
has a low reported ED50 of 1.41 µM at 48 hours, broadly in line with the cell viability of 69% 
at 10 µM noted in this study (493). However, MiaPaCa-2 pancreatic carcinoma and LNCaP 
prostatic cancer have low reported ED50 (10.3 µM at 48h and 3.5 µM at 3 days, respectively) 
(493, 497) which does not match well with the cell viability at 10 µM recorded in this study 
(94% and 108%, effectively equal to control). These results are most likely due to variant 
assay conditions in these studies potentiating action against these cell lines; especially given 
that DK-1 demonstrated a low EC50 at 10 days for MiaPaCa-2 (9.79 µM) and for BPH1 
benign prostatic hyperplasia (4.44 µM) (table 52). Although problematic lowered cell 
viability (61% at three days) is noted against HUVEC normal umbilical vein endothelium 
cells, inidicative of excessive cytotoxicity, the use of this common control was perhaps not 
ideal given the strong activity of DK-1 in blood and vascular cancers and low reduction of 
cellular viability on other cancer lines. Assays with a broader range of controls are required to 
more fully assess the general cytotoxicity of DK-1. 
Despite this caveat, further research into the anticancer activity of 6,8-diprenyleriodictyol or 
derivatives is certainly warranted by the results of these two experiments, most particularly 
for breast and blood cancers but especially for Burkitt’s lymphoma. This non-Hodgkin’s 
lymphoma is rare but deadly in adults, representing < 5% of all lymphoma cases and with 
ﬁve-year overall survival rates of 50-65% (568). Due to its rarity, studies to conﬁrm standard 
treatment protocols are generally lacking (187 to June 2015, of which none were phase 3). 
Current treatment protocols are noted for use of cyclophosphamide, vincristine, and 
prednisolone initially and ongoing treatment with fractionated cyclophosphamide, 
adriamycin, high-dose methotrexate, prednisone, and vincristine. Ribrag et al. (2016), in a 
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recent phase 3 study, have advocated addition of rituximab (568). 6,8-Diprenyleriodictyol 
derivatives could prove a worthy addition or partial replacement to these protocols. 
CP propolis extract (P1166) was observed to return non-speciﬁc strong growth inhibition at 3 
days on most cell lines, with the notable exception of HC-4 liver carcinoma (table 53). These 
results suggest that, despite the difﬁculties encountered in Chapter 5, further efforts in 
purifying compounds from CP propolis could also prove fruitful. The broad reduction in cell 
viability observed for P1166 suggests there are a host of other minor cytotoxic compounds in 
CP propolis contributing to its activity. Whilst not discounting the possibility of synergistic 
action of active compounds, anecdotally common and occasionally observed in cytotoxic 
natural products (569), we can assume these compounds are relatively speciﬁc in their action. 
DK-1 makes up approximately 13% of the total weight of CP propolis (Chapter 5, ﬁgure 52), 
dominating other compounds, yet is not observed to share the broad growth inhibition at 3 
days of CP propolis as a whole. One caveat is that P1166 was assessed at triple the calculated 
nominal molar concentration: given the very broad antiproliferative results of DK-1 at 10 
days, it is possible the results at 3 days for P1166 are purely related to higher concentration. 
7.2.2 Melatonin assay 
DK-1 was observed to inhibit MT3 (ML2) receptors, at 69.9% inhibition of control-speciﬁc 
binding of melatonin. This inhibition, although signiﬁcant, was rather less marked than that 
observed for other ﬂavonoid compounds tested. Further testing of DK-1 against MT1 and 
MT2 receptors are required: if inhibition of these is poor, 6,8-diprenyleriodictyol could prove 
a useful research tool for investigation of MT3-mediated pathways, where speciﬁc ligands are 
rare (570). The purpose of MT3 receptors in the body is currently very much less than clear, 
although a number of pro-inﬂammatory actions appear to be linked to it and the receptors 
appear to be induced in inﬂamed tissues (571); this would match well with the observed anti-
inﬂammatory action detailed in 7.2.3.  
  215 
 
7.2.3 Anti-inﬂammatory assays 
Table 54: Results of anti-inﬂammatory and antioxidant assays. Concentration of DK-1 was 10 µM for 
all assays. IC = inhibitory response, where IC0 = control and IC100 = full inhibition. 
 
Anti-inflammatory Assay Tissue Source IC (%)
5-Lipoxygenase human 76
Aldose Reductase rat 42
Catechol-O-Methyl Transferase (COMT) pig 31
Cyclooxygenase COX-1 human 27
Cyclooxygenase COX-2 human 100
Deacetylase, Histone 1 human -13
Deacetylase, Histone 2 human 2
Free Radical Scavenger, ABTS Radical 20
Free Radical Scavenger, DPPH Radical 16
Free Radical Scavenger, SOD Mimetic bovine 46
HMG-CoA Reductase human 13
Lipid Peroxidase guinea pig 37
Lipoxygenase 12-LO human 97
Lipoxygenase 15-LO human 7
Monoamine Oxidase MAO-A human 59
Monoamine Oxidase MAO-B human 22
Myeloperoxidase human 61
Peptidase, Angiotensin Converting Enzyme rabbit 2
Phospholipase sPLA2-V human -1
Protein Tyrosine Phosphatase, PTPN1 (PTP1B) human -9
Steroid 5α-Reductase rat -1
Thioredoxin Reductase E. coli 11
Tyrosine Hydroxylase rat 1
Xanthine Oxidase bovine 26
Angiotensin AT2 human 12
Chemokine CCR1 human -6
Chemokine CCR2B human -12
Chemokine CX3CR1 human 6
Chemokine CXCR1/2 (IL-8, Non-Selective) human -11
Chemokine CXCR2 (IL-8RB) human 2
Chemokine CXCR4 human -23
CysLT2 (LTC4) human 14
Epidermal Growth Factor (EGF) human -9
Histamine H1 human 78
Histamine H2 human 86
Histamine H3 human 10
Histamine H4 human 29
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Table 55: Further results of anti-inﬂammatory and antioxidant assays. IC = inhibitory response, 
where IC0 = control and IC100 = full inhibition. Note two assays for AT1/ACE receptor; one testing 
for antagonist and the other testing for agonist activity. 
 
DK-1 demonstrated a range of anti-inﬂammatory activity (tables 54 and 55), but by no means 
universal activity across all assays: this discussion will only touch upon assays showing 
inhibition rates > 50%. In line with literature ﬁndings, mixed-to-poor results were observed 
over free radical scavenger assays, with a highest inhibition of 46% by the superoxide (SOD) 
mimetic assay. 
Instead, inhibition was particularly demonstrated against cyclooxygenase-2 (COX-2, 100%), 
5-lipoxygenase (76%) and lipoxygenase-12 (97%) although not lipoxygenase-15 (15-LO, 
7%). Inhibition against COX-2 appears to be reasonably speciﬁc, with inhibition against 
COX-1 comparatively low (27%). All of these enzymes are notable for being induced in 
injured tissue, converting arachidonic acid to various pro-inﬂammatory cytokines; most 
commercial anti-inﬂammatories act via inhibition of these enzymes (572). This matches well 
with the traditional use of 6,8-diprenyleriodictyol-containing plants for headache, gout and 
Anti-inflammatory Assay Tissue Source Concentration IC (%)
Adhesion, ICAM-1-Mediated human 10 μM 6
human 1 μM -1
human 0.1 μM -6
human 10 nM -2
human 1 nM -3
Adhesion, VCAM-1-Mediated human 10 μM 44
human 1 μM 37
human 0.1 μM 19
human 10 nM 13
human 1 nM 0
Transcription Response, NF-κB human 10 μM 50
human 1 μM 13
human 0.1 μM -7
human 10 nM -12
human 1 nM -20
Angiotensin, AT1/ACE guinea pig ileum 10 μM 13
Angiotensin, AT1/ACE guinea pig ileum 10 μM 4 (agonist)
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rheumatism (499, 502) as well as literature ﬁndings for LDL oxidation inhibition and weak 
15-LO inhibition (EC50 > 50 µM) (494, 496). 
Good inhibition against two classes of histamine receptors was shown: H1 (78%) and H2 
(86%). H1 receptors are the receptors that classic antihistamines inhibit; inhibition decreases 
transcription of NF-κB, which was also demonstrated in this study (50% at 10 µM) (573). H2 
receptor antagonists are primarily known as antacids (574); this matches with traditional use 
in stomach upset (498). In addition, recent work suggests that H2 receptor antagonists can, by 
reducing ﬁbrosis and apoptosis, improve symptoms in heart failure and prevent exercise-
induced muscle soreness (575, 576). 
Myeloperoxidase (MPO) inhibition was noted (61%); this enzyme is utilised by neutrophil 
granulocytes to produce cytotoxic oxidants to kill pathogens (577). However, the non-speciﬁc 
nature of these oxidants can also cause damage to host tissue: overexpression of MPO has 
been linked with heart disease (578) and atherosclerosis (579), amongst other conditions. 
Inhibition of monoamine oxidase A (MAO-A, 59%), although largely known for its 
regulatory effect on the proper functioning of the brain, is also expressed in tissue as a 
response to stress and inﬂammation (580). In addition, inhibition of MAO-A has been shown 
to prevent apoptosis of cardiac cells during ischaemia (581). Inhibition of MAO is known to 
create possibilities for numerous drug interactions and CNS effects (582), a point of caution 
for further research. 
Overall, further research into the potential of 6,8-diprenyleriodictyol, particularly against 
COX-2 and the lipoxygenases, is needed. Performance of those assays in particular at lower 
molar concentration is needed, to both avoid the known cytotoxicity of the compound and 
determine the dose-activity relationship. Certainly for COX-2, at least, a rather lower molar 
concentration should still produce marked inhibition. 
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7.2.4 Epigenetic assays 
Table 56: Selected results of epigenetic assays, showing where IC > 40% or < 0% was observed and 
results for reference compounds, where available. Concentration of DK-1 was 10 µM for all assays. 
IC = inhibitory response, where IC0 = control and IC100 = full inhibition. 
 
Of the 143 assays for activity against enzymes modulating genetic expression (‘epigenetic 
assays’) performed (Appendix VI, table 60) 19 returned an inhibitory response (IC) greater 
than 40% at 10 µM DK-1, the majority of these being for histone acetyltransferases or 
histone deacetylases (table 56). In addition, one assay (HAT1) returned a stimulant response 
(IC = -52%). Abbreviated known or inferred results of inhibiting the action of these enzymes, 
forming potential pathways for the observed activity of 6,8-diprenyleriodictyol, follow: 
Epigenetic Assay % Inhibition of Control Values (10 µM) Reference Compound Reference IC50 (µM)
Bromodomains
ASH1L 44 JQ-1 32
Chromodomains
CBX4 42
CBX6 54
MBT domains
L3MBTL1 53
L3MBTL3 49
PHD domains
UHRF1(108-286) 52
Histone acetyltransferases
CREBBP 87 Garcinol 1.5
HAT1 -52 Garcinol 1.5
MYST4 45 Curcumin 11
Histone deacetylases
G9a 40 SAH 2.1
hSMYD2 51 SAH 0.16
PRMT1 48 SAH 0.094
PRMT3 77 SAH 0.86
PRMT4 67 SAH 0.025
PRMT6 56 SAH 0.053
WHSC1 (NSD2) 45 Chaetocin 0.48
Kinases
IKK alpha 66 staurosporine 0.03
MSK1 67 staurosporine 0.015
MSK2 59 staurosporine 0.58
Small molecule methyltransferases
Thiopurine S-methyltransferase 44 SAH-d4 2.3
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• ASH1L23 – reduces angiogenesis, cell motility, apoptosis and cellular signalling 
during haematopoiesis (583). 
• CBX4 – suppresses hepatic cancer (584); inhibits T-cell proliferation via thymus 
(585). 
• CBX6 – suppresses hepatic cancer (586). 
• L3MBTL1 – suppresses cancer, particularly breast; potentially anti-aging (587). 
• L3MBTL3 – reduces risk of colorectal, overall breast, estrogen receptor (ER)-
negative breast, clear cell ovarian, and overall and aggressive prostate cancer (588). 
• UHRF1(108-286) – suppresses hepatic cancer (589); suppresses cancer generally 
(590). 
• CREBBP – suppresses acute myeloid leukaemia (591). 
• HAT1 – Increased activation of this acetyltransferase (as seen in our study) would be 
associated with an increase in general cancerous activity, but also an increase in stem 
cell activity (592). 
• MYST4 – suppresses acute myeloid leukaemia (593). 
• G9a – stimulates foetal haemoglobin production in adult erythrocytes, reducing 
severity of sickle-cell disease and thalassaemia (594). 
• hSMYD2 – changes expression of oestrogen receptor α (595). 
• PRMT1 – suppresses cancers, particularly breast cancers (596) and lung cancers 
(597).  
• PRMT3 – supresses cancer generally (596) and fatty liver disease (597). 
• PRMT4 – suppresses prostate and breast cancers (596). 
                                                 
23 In the interests of brevity and sanity, full names of these enzymes will be omitted. The full names are 
generally fairly arbitrary and (at least for natural products doctoral candidates) quite meaningless: e.g. ASH1L = 
‘absent, small and homeotic disks protein 1-like’. Further muddying the waters, multiple names for the enzymes 
are common: e.g. MYST4, alias MOZ-related factor (MORF) or Querkopf. 
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• PRMT6 – suppresses bladder and lung cancers (596). 
• WHSC1 (NSD2) – suppresses prostate cancer (598), glioma (599) and carcinoma 
(600). 
• IKK alpha – anti-inﬂammatory via suppression of NF-κB pathway (601). 
• MSK1 – anti-inﬂammatory via suppression of NF-κB pathway (602); suppresses skin 
cancers (603). 
• MSK2 – anti-inﬂammatory via suppression of NF-κB pathway (604); supresses skin 
cancers (603). 
• thiopurine S-methyltransferase – no particular disease states modulated by this 
enzyme, however proper functioning is required to metabolise some drugs, including 
6-mercaptopurine, 6-thioguanine and azathioprine (605). 
Even from this abbreviated list, it would certainly seem the strong inhibitory effect of DK-1 
on the histone acetyltransferases and histone deacetylases mentioned is largely responsible 
for the pronounced anticancer activity and the strong inhibitory effect on kinases mentioned 
responsible for observed anti-inﬂammatory activity, with suppression of NF-κB transcription 
already noted (table 55). Anticancer activity though epigenetic pathways, which take some 
time for downstream effects to present, would also match with the large difference between 
observed anticancer activity at 3 days compared to 10 days. Further experimentation at lower 
concentration for these particular assays, especially CREBBP as the most probable pathway 
of much of the observed blood cancer activity in 7.2.1, would more strongly identify the most 
important targets for therapeutic research of 6,8-diprenyleriodictyol derivatives. 
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7.3 Conclusion 
6,8-Diprenyleriodictyol has had its already-demonstrated cellular activity reﬁned through this 
study. The compound has promising anticancer and anti-inﬂammatory activity, despite the 
possibility of excessive cytotoxicity, most particularly as a lead compound for Burkitt’s 
lymphoma and as a COX-2 and lipoxygenase inhibitor. Likely epigenetic inhibition routes 
resulting in these newly-observed activities have been elucidated in addition. Further research 
into the therapeutic use of 6,8-diprenyleriodictyol derivatives, building from this strong base, 
is needed. Furthermore, the promise of other strongly-anticancer compounds from CP 
propolis, hinted at by the 3-day cell viability assay, strongly encourages further exploration 
and characterisation of this novel KI propolis. 
  
 
 
 
 
 
Chapter Eight 
Summary and future work  
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ropolis is produced by bees from a variety of plant resins with therapeutically-
interesting biological properties. Bees selectively collect plant resins, generally 
from trees of genus Populus. Where these resin sources are unavailable, other 
resinous plants are sourced. Propolis in general, whatever its source, displays an appreciable 
range of antibacterial, anti-inﬂammatory, immunomodulatory and anticancer activities. As 
such, research into propolis and source plant resins is ongoing within the discipline of natural 
products chemistry. 
The chemistry of Australian propolis where Populus spp. are unavailable is largely unknown, 
with the exception of an early study from Western Australia and some more recent studies 
from South East Queensland. These studies have demonstrated markedly different chemistry 
from standard Populus spp. sourced temperate propolis. Our ongoing research into the 
propolis of Kangaroo Island, South Australia, has already isolated a methoxychalcone- and 
ﬂavonoid-rich propolis from the wattle Acacia paradoxa and several propolis types from the 
Lepidosperma viscidum s.l. complex, notable for C- and O-prenylated tetrahydroxystilbenes. 
The diterpene chemistry of a propolis from the leaf surface of the coastal shrub Myoporum 
insulare was also recently identiﬁed. 
The increasing number of propolis types found of Kangaroo Island by our group necessitated 
a standard and expandable analysis schedule. This study has utilised 1D 1H-NMR 
metabolomics to successfully identify and assess propolis. A schedule of initial TLC 
assessment in the ﬁeld, to inform 1H-NMR results, was developed and utilised. A standard 
method of propolis and resinous plant extraction and ﬁngerprint generation, using methanol 
as extraction solvent and methanol-d4 as spectrographic solvent, was developed. Speciﬁc use 
of 1D 1H-NMR ﬁngerprints was observed to be sufﬁcient to be used alone, with HPLC 
ﬁngerprints quickly abandoned. Metabolomic assessment of ﬁngerprints from the 1D  
1H-NMR process was performed using hierarchical clustering and principal component 
P 
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analysis. Previously identiﬁed KI propolis types and subtypes were conﬁrmed by this method, 
and three previously-unidentiﬁed subtypes of Acacia paradoxa (KT) propolis noted. 
Previously identiﬁed plant resin sources were also conﬁrmed by this process. Capacity to 
identify and reassign propolis samples misidentiﬁed by TLC was noted with these methods, 
but not capacity to determine mixed-source samples beyond primary propolis component. 
Domination of ﬁngerprint dataset by Lepidosperma sp. ‘Montebello’ (S1) propolis and plant 
resin was not observed to reduce accuracy of metabolomic classiﬁcation. 
Conﬁdent identiﬁcation of pure-source Kangaroo Island propolis samples enabled 
programming of a range of similarity-scoring calculator tools. Calibration of the similarity-
scoring mechanism was performed, informed by closeness of clustering between different 
propolis types observed in the metabolomic analyses. A binning system using the innate 
primary binning (0.01 ppm) from the spectrum processing software and a moving overlap 
secondary binning (2 values, 1 overlap) was observed to maximise spread of similarity score. 
Average spectra using pure-source propolis samples and conﬁdently-assigned plant resin 
samples were produced, informed by results of metabolomic analysis. These average spectra 
were used to create calculator tools to estimate composition of new propolis samples, with 
accuracy of approximately ± 5% observed for the ﬁnal calculator tool using average propolis 
spectra and approximately ± 10% observed for that using average plant source resin spectra. 
Three previously provisionally-identiﬁed distinct Kangaroo Island propolis types, C-prenyl-
type (CP), ‘triterpene’-type (TT) and Lepidosperma viscidum s.s. (F), were conﬁrmed by 
statistical analysis, and the plant source for the latter conﬁrmed through the same process. 
The chemistry of CP propolis and L. viscidum s.s. resin was assessed through vacuum short 
column chromatography and 1D and 2D 1H-NMR, with CP propolis dominated by  
6,8-diprenylﬂavanones and L. viscidum s.s. dominated by 6- or 8-methyl or dimethyl 
ﬂavanones.  
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CP propolis yielded two compounds in sufﬁcient purity for characterisation; these were 
identiﬁed as known compounds 6,8-diprenyleriodictyol and monotesone B, the former 
accounting for approximately 14% by weight of CP propolis dry methanolic extract. Directed 
by literature attestations of these compounds investigation of resinous plants native to 
Kangaroo Island was performed, with a likely source plant, Pultenaea viscidula (Fabaceae), 
identiﬁed. Conﬁrmation awaits collection of this plant. 
L. viscidum s.s. resin yielded ﬁve compounds in sufﬁcient purity for characterisation, three of 
which are known to literature: farrerol, 5,7,3′,5′-tetrahydroxy-6,8-dimethylﬂavanone and 
5,7,3′,5′-tetrahydroxy-6-methylﬂavanone. The other two compounds, 5′-(4″-hydroxyprenyl)-
4,2′,4′-trihydroxydihydrochalcone and 5′-(4″-hydroxyprenyl)-4′-methoxy-4,2′-
dihydroxydihydrochalcone, are new to the literature and are described in this study for the 
ﬁrst time. 
The biological activity of 6,8-diprenyleriodictyol was assessed by cell viability, cell 
proliferation and anti-inﬂammatory assays: 6,8-diprenyleriodictyol was found to be a strong 
COX-2 and lipoxygenase inhibitor at 10 µM. Anticancer results in line with the literature 
were returned, with marked reduction in cell proliferation after 10 days (EC50 < 10 µM) 
noted in 43 of 90 cancer cell lines, particularly breast and blood cancer cell lines. Of these, 
ﬁve cell lines were for one disease state, Burkitt’s lymphoma. In line with 10 day results, 
markedly reduced cell viability at 3 days at 10 µM was observed for three cell lines: PC-6 
lung carcinoma (34%), Ramos Burkitt’s lymphoma (8%), MDA-MB-468 breast 
adenocarcinoma (5%) and MV-411 biphenotypic B myelomonocytic leukaemia (-75%). 
Investigation of possible pathways by epigenetic inhibition of 143 enzymes modulating 
genetic expression was performed. These epigenetic assays, the ﬁrst performed for 6,8-
diprenyleriodictyol, demonstrated strong inhibition of a range of histone acetyltransferases 
and histone deacetylases, most notably CREBBP (87% inhibition). 
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A number of future areas of research, to further the project aim of chemical and 
pharmaceutical evaluation of novel Australian propolis types, present themselves from this 
study’s ﬁndings. Collection and processing of propolis samples and plant resins by this 
study’s schedule is ongoing. Continually increasing the size of datasets, apart from improving 
the accuracy of the calculator tools, will allow readier identiﬁcation of subtypes by 
hierarchical clustering and principal component analysis; especially in the case of plant resins 
and minor propolis types, where the datasets utilised in this study were, overall, insufﬁciently 
large for conﬁdence in observations. Expansion to mainland propolis samples, already 
performed at an exploratory level, could be considered, as well as the possibility of using 
other statistical tools on the ﬁngerprint information. A number of King Island, Tasmania, 
propolis samples are currently available as an immediate source of ﬁngerprints. Utilisation of 
the methods developed by this study to other propolis research, as well as natural products 
with identiﬁable subtypes more generally, is also a possibility. 
NMR metabolomics has proved itself a highly useful means of assessing novel propolis 
types, but requires access to an NMR facility. This has necessitated the use of TLC as an 
initial ﬁeld assessment; a less-than-ideal solution. Permanent-magnet NMR spectrometer use 
could combine the portability of TLC with the utility of NMR. Despite reduced dispersion 
(1350 Hz at 90 MHz vs 6000 Hz at 400 MHz) and resolution of signals, maintenance of 
consistent extraction and preparation of propolis samples would still return ﬁngerprints 
suitable for metabolomics by statistical means and would remove the human element inherent 
in visual classiﬁcation by TLC. In addition, as J-coupling patterns and distances are constant 
over ﬁeld strength, statistical collation of low-ﬁeld 1H-NMR ﬁngerprints, obtained in the 
ﬁeld, with high-ﬁeld ﬁngerprints obtained by an NMR facility could yield data-enhanced 2D 
ﬁngerprints. Another alternative is research into the use of multidimensional HPLC or 
HPTLC techniques, possibly alongside an NMR schedule, with the caveat that the HPLC 
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method utilised in this study at an exploratory level was inadequate for useful ﬁngerprint 
generation. 
Further exploration of the chemistry of CP, TT, Rf 0.7 and F type propolis, or their plant 
source resins (where identiﬁed), is required beyond that performed in this study. CP propolis, 
in particular, appears to have a very large number of minor prenylated compounds that would 
most likely prove, from the results seen for 6,8-diprenyleriodictyol, biologically active as 
immunomodulators and anticancer agents. A separation method other than vacuum short 
column chromatography would most likely need to be utilised; extensive work done in this 
study proving this technique insufﬁcient for sufﬁcient separation. Investigation of a greater 
number of F propolis samples to conﬁrm presence of terminally-hydroxylated 
prenyldihydrochalcones is required, as these compounds are very rare in natural products and 
biological activity data is lacking. Establishing the range of the chemistry of L. viscidum s.s. 
would also beneﬁt the ongoing reassessment of the taxonomy of the L. viscidum s.l. complex. 
TT propolis is yet to have its chemistry assessed beyond a very basic level, but possibly 
contains steroid-like molecules that would certainly be worthy of assessment. Further 
exploration of the KT subtypes identiﬁed in this study and their major chemical differences is 
also required, especially as one of the major propolis types encountered on Kangaroo Island. 
6,8-Diprenyleriodictyol requires further biological assays, initially to determine absolute 
cytoxicity with certainty then, pending results, with a strong focus on Burkitt’s lymphoma 
cell lines and the potentially-identiﬁed epigenetic pathways behind its marked cytotoxicity in 
this rare, but deadly, disease. Deeper assessment of the other lymphoma and leukaemia cell 
lines would be of interest. Speciﬁcally, assays performed across a range of concentrations to 
assess dose-response are the most clearly required; this would also provide a point of 
reference for other, similar molecules awaiting isolation from CP propolis. 
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Overall, the 1D 1H-NMR metabolomic and similarity-scoring methods developed in this 
study have proven successful, predictive and expandable. Two pure-source Kangaroo Island 
propolis types have been partially chemically characterised, and one compound isolated,  
6,8-diprenyleriodictyol, has been extensively biologically assayed with promising results. 
Research continues into Kangaroo Island propolis, and Australian propolis more generally. 
The bees of Kangaroo Island continue to surprise and delight the researcher in their choices 
of native plant resins for propolis: one can only envisage the additional as-yet undiscovered 
potential pharmaceutics hidden throughout this nation in that fragrant treasure of beehives –  
propolis. 
⁂ 
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Appendix I: Examples of the ﬁngerprint generation 
processes 
 
Figure 65: Raw chromatogram for P410, obtained as per 2.3.6.2. Note the uneven baseline, a 
consistent problem observed over several HPLC systems used, and the reference peak at 8.441 min. 
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Table 57: HPLC ﬁngerprint calculations for P410. Raw retention times were divided by an 
adjustment factor of 1.01223 (obtained as per 2.3.11.2) to produce a table of relative retention time to 
area under curve (AUC). These last two columns form the HPLC ‘ﬁngerprint’ for P410, utilised in the 
statistical and calculator methods described in the thesis. 
 
Raw retention 
time (min)
Relative retention 
time (min)
AUC
2.118 2.092 2458
2.228 2.201 1233
2.417 2.388 28902
2.586 2.555 13913
2.801 2.767 88276
3.376 3.335 58223
3.644 3.600 17886
3.885 3.838 95949
4.081 4.032 34290
4.296 4.244 5763
4.381 4.328 5822
4.556 4.501 21843
4.848 4.789 219981
5.019 4.958 85685
5.341 5.276 89514
5.679 5.610 13668
5.833 5.763 53906
6.197 6.122 13868
6.399 6.322 46403
6.58 6.500 59427
6.728 6.647 8775
6.857 6.774 9561
7.042 6.957 32856
7.327 7.238 17109
7.584 7.492 24901
7.769 7.675 24306
8.103 8.005 31005
8.441 8.339 91517
8.58 8.476 17284
8.711 8.606 25789
8.979 8.870 8209
9.183 9.072 16328
9.368 9.255 31645
9.562 9.446 6932
9.765 9.647 15285
9.931 9.811 4175
10.143 10.020 8743
10.376 10.251 4228
10.68 10.551 3930
10.765 10.635 2709
11.071 10.937 15351
11.286 11.150 4287
11.994 11.849 5989
P410 HPLC fingerprint
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Figure 66: Raw methanol-d4 1H-NMR spectrum for P410 (0-8 ppm), obtained as per 2.3.7.3. Note 
domination of spectrum by strong signals at approx. 1.8 ppm, 4.8 ppm (H2O) and 3.3 ppm 
(MeOH/methanol-d4). 
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Figure 67: Methanol-d4 1H-NMR spectrum for P410 (0-8 ppm) after processing as per 2.3.7.3. The 
dominant signals from the previous ﬁgure have been removed, and signals of interest marked. 
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Table 58: Relative peak height to shift for signals of interest from the methanol-d4 1H-NMR spectrum 
of P410, as generated by ACD Labs 1D-NMR Processor. The second and fourth columns form the 1H-
NMR ‘ﬁngerprint’ for P410, utilised in the statistical and calculator methods described in the thesis. 
 
  
Signal number Shift (ppm) Shift (Hz) Relative peak height Signal number Shift (ppm) Shift (Hz) Relative peak height
1 1.5 599.8 0.0677 55 3.38 1350.5 0.0694
2 1.51 604.3 0.0813 56 3.46 1384.7 0.0913
3 1.52 607.3 0.0619 57 3.47 1388.2 0.1958
4 1.53 610.2 0.0541 58 3.49 1395.7 0.1178
5 1.57 625.7 0.3343 59 3.53 1412.3 0.0543
6 1.58 632.7 0.8154 60 3.54 1415.2 0.054
7 1.62 646.4 0.4677 61 3.54 1417 0.0522
8 1.63 652.1 0.8537 62 3.55 1420.9 0.0621
9 1.67 666.4 0.9801 63 3.58 1430.5 0.0559
10 1.69 675.4 0.1253 64 3.6 1440.9 0.0817
11 1.71 683.6 0.2265 65 3.61 1442.8 0.076
12 1.73 690.2 0.1757 66 3.64 1453.2 0.1025
13 1.74 696.1 0.1452 67 3.64 1455.1 0.1149
14 1.77 706.1 1 68 3.64 1456.5 0.1176
15 1.79 717.4 0.3507 69 3.65 1458.5 0.055
16 1.81 724.7 0.0898 70 3.67 1467.7 0.1305
17 1.96 781.8 0.0599 71 3.71 1484.5 0.4143
18 2 797.6 0.0675 72 3.73 1489.8 0.0757
19 2 801 0.0756 73 3.74 1493.9 0.0902
20 2.01 803.1 0.0602 74 3.74 1495.4 0.0741
21 2.02 805.7 0.0837 75 3.76 1501.5 0.1197
22 2.02 809.2 0.0806 76 3.76 1502.1 0.12
23 2.03 813.1 0.0784 77 3.77 1505.2 0.3764
24 2.04 814.8 0.0891 78 3.77 1508.9 0.1334
25 2.06 822.3 0.0711 79 3.78 1510.9 0.2654
26 2.07 827.4 0.0537 80 3.79 1513.4 0.1493
27 2.25 899.8 0.0592 81 3.8 1517.4 0.4062
28 2.27 907.4 0.1025 82 3.81 1524.2 0.2817
29 2.28 910.3 0.0553 83 3.82 1525.2 0.2531
30 2.29 914.8 0.0698 84 3.83 1531.2 0.109
31 2.33 929.9 0.0647 85 3.83 1532.2 0.1061
32 2.34 934.4 0.0773 86 3.86 1541.4 0.0597
33 2.35 938.9 0.0734 87 3.86 1544.7 0.0951
34 2.36 941.8 0.1004 88 3.87 1546.7 0.1118
35 2.67 1068.6 0.0908 89 3.87 1547.7 0.0828
36 2.68 1071.7 0.115 90 3.88 1549.6 0.109
37 2.72 1085.6 0.1283 91 3.89 1555.9 0.1847
38 2.72 1088.7 0.1333 92 3.9 1560.4 0.1646
39 2.73 1092.6 0.0527 93 3.99 1594.2 0.0716
40 3 1200.2 0.1107 94 4.01 1601.1 0.0963
41 3.03 1213 0.1169 95 4.01 1602.5 0.0762
42 3.04 1215.7 0.0788 96 4.04 1613.6 0.0854
43 3.05 1217.3 0.0949 97 4.04 1615 0.0986
44 3.07 1228.6 0.0669 98 4.07 1625.7 0.0528
45 3.08 1230 0.0922 99 4.08 1632 0.0554
46 3.17 1268.5 0.0554 100 4.46 1782.8 0.0555
47 3.19 1274.4 0.0858 101 4.48 1790.7 0.0533
48 3.21 1282.6 0.0684 102 4.5 1799.9 0.0589
49 3.24 1293.4 0.1647 103 4.52 1806.1 0.057
50 3.25 1299.4 0.165 104 4.53 1812.2 0.0086
51 3.26 1303.1 0.1974 105 4.56 1822.7 0.0109
52 3.35 1338.6 0.1607 106 4.58 1829.8 0.0131
53 3.36 1342.5 0.0825 107 4.65 1860.5 0.0317
54 3.37 1346.6 0.0619
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Table 58 (cont.): Relative peak height to shift for signals of interest from the methanol-d4 1H-NMR 
spectrum of P410 
  
Signal number Shift (ppm) Shift (Hz) Relative peak height Signal number Shift (ppm) Shift (Hz) Relative peak height
108 4.67 1867 0.0321 161 5.7 2280.3 0.0095
109 4.69 1874.6 0.0106 162 5.71 2283.3 0.0108
110 4.7 1880.1 0.0179 163 5.72 2286.8 0.0133
111 4.71 1882.6 0.0164 164 5.72 2288.1 0.0123
112 4.73 1891.6 0.009 165 5.73 2289.9 0.0099
113 4.9 1960.3 0.1294 166 5.74 2294.8 0.0178
114 4.91 1961.6 0.1194 167 5.77 2306.1 0.01
115 4.93 1970.4 0.0269 168 5.8 2316.9 0.0109
116 4.93 1972.2 0.0269 169 5.92 2366 0.059
117 4.95 1977.9 0.0294 170 6.5 2600 0.0665
118 4.95 1979.2 0.0245 171 6.53 2610.7 0.0593
119 4.96 1982.4 0.0119 172 6.54 2612.9 0.0568
120 5.03 2010.4 0.0039 173 6.54 2616 0.0724
121 5.06 2021.3 0.0108 174 6.72 2687.4 0.0627
122 5.06 2022.7 0.0107 175 6.73 2688.8 0.0764
123 5.1 2037.9 0.1052 176 6.73 2690.8 0.0652
124 5.11 2041.3 0.1037 177 6.74 2692.7 0.0663
125 5.11 2044 0.0901 178 6.74 2695.5 0.098
126 5.12 2045.4 0.1122 179 6.75 2696.8 0.1098
127 5.12 2046.7 0.1159 180 6.75 2699 0.0869
128 5.12 2048.1 0.0916 181 6.76 2702.1 0.1186
129 5.14 2054.2 0.1026 182 6.77 2705.8 0.1394
130 5.15 2060 0.0901 183 6.78 2710.5 0.1219
131 5.16 2061.4 0.0974 184 6.79 2714 0.4207
132 5.17 2067.1 0.0366 185 6.79 2714.4 0.4218
133 5.17 2068.5 0.0375 186 6.8 2716.8 0.1969
134 5.21 2081.6 0.0794 187 6.81 2720.3 0.0589
135 5.22 2084.7 0.0788 188 6.82 2725.2 0.052
136 5.24 2094.3 0.0941 189 6.83 2728.9 0.0789
137 5.25 2097.2 0.082 190 6.84 2732.6 0.0518
138 5.27 2106 0.0325 191 6.84 2735.2 0.0512
139 5.28 2108.8 0.0383 192 6.9 2758.4 0.062
140 5.3 2118.9 0.0741 193 6.92 2766.3 0.1135
141 5.31 2124 0.0863 194 6.93 2768.8 0.2246
142 5.32 2125.4 0.0645 195 6.93 2770.4 0.1881
143 5.32 2126.9 0.0794 196 6.94 2772.7 0.0929
144 5.33 2131.8 0.0808 197 6.94 2775.9 0.0832
145 5.34 2135.6 0.087 198 6.95 2778.2 0.0848
146 5.35 2140.3 0.0427 199 6.95 2780 0.0766
147 5.37 2145.7 0.0299 200 6.96 2781.7 0.1097
148 5.38 2151.4 0.0251 201 6.97 2784.3 0.0914
149 5.39 2156.5 0.0174 202 6.97 2787 0.0591
150 5.43 2170 0.0103 203 7.27 2906.9 0.0514
151 5.45 2176.8 0.0153 204 7.29 2913.4 0.1298
152 5.46 2180.7 0.0161 205 7.29 2915 0.1463
153 5.46 2182.1 0.0182 206 7.31 2920.6 0.1287
154 5.46 2183.5 0.0201 207 7.31 2921.8 0.0927
155 5.47 2187 0.0128 208 7.33 2929 0.1058
156 5.48 2190.3 0.0106 209 7.4 2958.6 0.0876
157 5.53 2209.5 0.0028 210 7.4 2959.8 0.0739
158 5.55 2218.7 0.0027 211 7.41 2962.1 0.1053
159 5.57 2228.3 0.0022 212 7.42 2965 0.0785
160 5.69 2272.9 0.0051 213 12.27 4903.3 0.0045
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Appendix II: Dendrograms from hierarchical clustering of 
large datasets 
 
Figure 68: Dendrogram by hierarchical clustering of chloroform-d 1H-NMR propolis ﬁngerprints. 
Clusters of pure-type propolis types and dominant mixtures are marked and labelled in red. 
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Figure 68 (cont.): Dendrogram by hierarchical clustering of chloroform-d 1H-NMR propolis 
ﬁngerprints 
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Figure 68 (cont.): Dendrogram by hierarchical clustering of chloroform-d 1H-NMR propolis 
ﬁngerprints 
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Figure 69: Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis ﬁngerprints. 
Clusters of pure-type propolis types and dominant mixtures are marked and labelled in red. Note the 
much improved clustering due to standardisation and reﬁnement of ﬁngerprint production method. 
  269 
 
 
Figure 69 (cont.): Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis 
ﬁngerprints 
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Figure 69 (cont.): Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis 
ﬁngerprints 
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Figure 70: Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis and resinous 
plant ﬁngerprints. Pure propolis types are observed to cluster with plant resin sources, as per 
Chapter 3, table 2 (not marked). 
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Figure 70 (cont.): Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis and 
resinous plant ﬁngerprints 
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Figure 70 (cont.): Dendrogram by hierarchical clustering of methanol-d4 1H-NMR propolis and 
resinous plant ﬁngerprints 
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Appendix III: Biplots from principal component analysis 
on small datasets 
 
Figure 71: Biplot of PC1 to PC2 for the S2 propolis dataset. S2 samples in red. 
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Figure 72: Biplot of PC1 to PC3 for the S2 propolis dataset. S2 samples in red. 
  276 
 
 
Figure 73: Biplot of PC2 to PC3 for the S2 propolis dataset. S2 samples in red. 
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Figure 74: Biplot of PC1 to PC2 for the F propolis dataset. F samples in red. 
  278 
 
 
Figure 75: Biplot of PC1 to PC3 for the F propolis dataset. F samples in red. 
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Figure 76: Biplot of PC2 to PC3 for the F propolis dataset. F samples in red. 
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Figure 77: Biplot of PC1 to PC2 for the L. sp. ‘Flinders Chase’ dataset 
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Figure 78: Biplot of PC1 to PC2 for the L. viscidum dataset 
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Appendix IV: 1D NMR spectra of identiﬁed compounds 
 
Figure 79: 13C-NMR of DK-1, 6,8-diprenyleriodictyol 
  283 
 
 
 
Figure 80: 1H-NMR of DK-1, 6,8-diprenyleriodictyol 
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Figure 81: 1H-NMR of DK-7, monotesone B 
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Figure 82: 13C-NMR of DK-2, 5′-(4″-hydroxyprenyl)-4,2′,4′-trihydroxydihydrochalcone 
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Figure 83: 1H-NMR of DK-2, 5′-(4″-hydroxyprenyl)-4,2′,4′-trihydroxydihydrochalcone 
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Figure 84: 13C-NMR of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy-4,2′-dihydroxydihydrochalcone 
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Figure 85: 1H-NMR of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy-4,2′-dihydroxydihydrochalcone 
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Figure 86: 13C-NMR of DK-4, farrerol 
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Figure 87: 1H-NMR of DK-4, farrerol 
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Figure 88: 13C-NMR of DK-5, 5,7,3′,5′-tetrahydroxy-6,8-dimethylﬂavanone 
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Figure 89: 1H-NMR of DK-5, 5,7,3′,5′-tetrahydroxy-6,8-dimethylﬂavanone 
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Figure 90: 13C-NMR of DK-6, 5,7,3′,5′-tetrahydroxy-6-methylﬂavanone 
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Figure 91: 1H-NMR of DK-6, 5,7,3′,5′-tetrahydroxy-6-methylﬂavanone  
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Appendix V: 2D NMR spectra of DK-2 and DK-3 
 
Figure 92: 2D NMR COSY spectrum of DK-2, 5′-(4″-hydroxyprenyl)- 
4,2′,4′-trihydroxydihydrochalcone 
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Figure 93: 2D NMR HMBC spectrum of DK-2, 5′-(4″-hydroxyprenyl)- 
4,2′,4′-trihydroxydihydrochalcone 
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Figure 94: 2D NMR HSQC spectrum of DK-2, 5′-(4″-hydroxyprenyl)- 
4,2′,4′-trihydroxydihydrochalcone 
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Figure 95: 2D NMR COSY spectrum of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy- 
4,2′-dihydroxydihydrochalcone 
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Figure 96: 2D NMR HMBC spectrum of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy- 
4,2′-dihydroxydihydrochalcone 
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Figure 97: 2D NMR HSQC spectrum of DK-3, 5′-(4″-hydroxyprenyl)-4′-methoxy- 
4,2′-dihydroxydihydrochalcone 
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Appendix VI: Full cellular assay results 
Table 59: Full cell proliferation assay results at 10 days. EC50 =concentration at inﬂection point of 
curve of concentration to cell count (half effective response); IC50 = concentration producing half 
observed maximal response; GI50 = concentration at half observed maximal cell volume. 
 
Cell Line EC50 (µM) IC50 (µM) GI50 (µM) Cell Line EC50 (µM) IC50 (µM) GI50 (µM)
NCI-H292 10.40 10.40 10.40 EFM-19 3.78 3.78 3.65
NCI-H295R > 30 > 30 > 30 EM-2 13.50 13.50 13.40
MDA-MB-415 11.40 11.40 10.40 SKMES1 6.88 6.88 6.74
MDA-MB-436 9.82 9.87 9.82 GA-10 2.64 2.64 2.64
NCIH441 13.90 13.90 12.50 HEC-1-A 14.20 14.20 14.20
BT-549 17.20 17.20 16.90 Hs 229.T 19.20 19.20 11.90
5637 25.10 25.10 25.00 NCI-H460 15.30 15.30 15.20
Hs 578T 18.10 18.10 17.90 NCI-H520 14.90 14.90 14.80
NCI-H661 6.31 6.31 6.25 NCI-H596 > 30 > 30 > 30
Hs 766T 14.70 14.70 14.40 NCI-H69 12.40 12.40 11.40
SW872 9.24 9.24 9.20 HEL-92-1-7 8.82 8.82 8.78
A204 1.72 1.72 1.65 HS 746T 16.40 16.40 13.80
A427 6.09 6.09 6.05 HT-1080 4.48 4.49 4.48
A431 24.40 24.40 24.40 HT-29 11.40 11.40 11.40
ACHN 10.20 10.20 10.10 JeKo-1 4.03 4.03 4.02
CRO-AP2 18.50 18.50 18.40 Jiyoye 10.00 10.00 10.00
ARH-77 10.00 10.10 10.00 K562 18.80 25.00 24.90
AsPC-1 18.60 18.60 18.20 KPL-1 4.07 4.07 4.05
AU565 5.05 5.05 4.93 L-428 5.34 5.34 5.32
BC-1 13.10 13.10 13.10 MOLT-16 4.04 4.05 4.04
BCP-1 13.70 13.70 13.60 MDA MB 231 6.99 7.04 6.99
BPH1 4.44 13.70 13.30 SK-MEL-28 9.14 9.14 8.96
BT474 13.00 13.00 12.20 MDA MB 453 3.17 3.17 3.09
BxPC-3 12.30 12.30 12.30 MDA MB 468 3.06 3.07 3.04
CAL-62 12.70 12.70 12.70 MC116 8.95 8.95 8.93
Calu1 17.50 17.50 17.40 MEG01 11.60 11.60 11.50
CA46 4.74 4.74 4.73 MG-63 13.00 13.00 12.90
CAMA-1 14.20 14.20 13.80 Mia PaCa-2 9.79 9.79 9.77
CCRFCEM 13.70 13.70 13.50 MT-3 12.60 12.60 12.50
CEM-C1 4.36 4.37 4.36 MV-4-11 3.88 3.88 3.87
CFPAC-1 12.20 12.20 12.20 PANC-1 5.40 5.40 5.36
ChaGoK1 8.21 8.21 8.12 PC-3 11.60 11.60 11.50
Caki-2 13.90 13.90 13.70 Raji 9.69 9.69 9.68
CML-T1 7.64 7.64 7.63 RS4;11 4.53 4.55 4.52
COR-L105 9.36 9.46 9.39 SK-N-AS 6.52 6.52 6.43
Capan-2 8.65 8.69 8.65 SU-DHL-10 12.10 12.10 12.10
Ca Ski 17.80 17.80 17.60 SU-DHL-8 4.78 4.78 4.78
DoTc2 4510 5.78 5.78 5.54 SJRH30 6.16 6.16 6.11
DMS53 3.32 3.39 3.32 SR 4.70 4.71 4.70
Daoy 3.84 3.84 3.82 ST486 3.16 3.16 3.14
Daudi 3.58 3.58 3.57 SUP-T1 13.60 13.60 13.60
DOHH-2 1.24 1.24 1.24 T24 12.30 12.30 12.30
DLD-1 11.00 11.00 11.00 TE 381.T 5.78 5.78 5.66
DU145 14.60 14.60 14.40 Thp1 16.20 16.20 16.00
EB2 13.60 13.60 13.50 YAPC 15.40 15.40 15.30
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Table 60: Results of all epigenetic assays, with results for reference compounds, where available. 
Concentration of DK-1 was 10 µM for all assays. IC = inhibitory response, where IC0 = control and 
IC100 = full inhibition. IC < 0% represents an increase in activity relative to control. 
 
 
Epigenetic Assay IC (%) Reference Compound
Reference 
IC50 (µM)
Bromodomains
ATAD2B 35 Ischemin sodium salt 96
ASH1L 44 JQ-1 32
BAZ2A 24 GSK2801 6.3
BRPF1-1 8 Bromosporine 0.26
CECR2 26 Bromosporine 0.18
EP300 30 SGC-CBP30 0.1
KAT2A (GCN5L2) 22 JQ-1 100
PCAF 4 JQ-1 84
PB1(2) 25 PFI-3 150
PB1(3) 23 JQ-1 47
PB1(4) 16 Ischemin sodium salt 6.8
PHIP(2) 24 SGC-CBP30 50
SP140 23 JQ-1 37
SMARCA2 32 PFI-3 0.54
TAF1(1) 19 GSK2801 6.8
SMARCA4 23 PFI-3 8.2
TAF1(2) 30 GSK2801 7.8
BAZ2B 26 GSK2801 6.5
ATAD2A 18 JQ-1 24
BRD2(1) 27 JQ1 0.43
BRD2(2) 28 JQ-1 0.1
BRD3(1) 17 JQ-1 0.65
BRD3(2) 21 PFI-1 0.79
BRD4(1) 14 JQ1 0.64
BRD4(2) 21 PFI-1 2.8
BRDT(1) 20 JQ-1 0.75
CREBBP 8 SGC-CBP30 0.089
FALZ 23 I-CBP112 10
Chromodomains
CBX1 5
CBX2 3
CBX4 42
CBX6 54
CBX5 29
CBX7 36
CBX8 36
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Table 60 (cont.): Results of all epigenetic assays, with results for reference compounds, where 
available 
 
Epigenetic Assay IC (%) Reference Compound
Reference 
IC50 (µM)
MBT domains
L3MBTL1 53
L3MBTL3 49
PHD domains
SP140 3
TRIM 33 -6
UHRF1(108-286) 52
Tudor domains
PHF20 3
Cell-based detection methyl modifications
H3K27 ac -17
H3K27 me2-1 0
H3K27 me3 10
H3K36 me2 5
H3K4 me2 -3
H3K79 me2 1
H3K9 ac 7
H3K9 me2 10
Demethylases
FBXL10 27 2,4 PDCA 0.61
FBXL11 14 2,4 PDCA 1.5
JARID1A 9 2,4 PDCA 0.18
JARID1B 26 2,4 PDCA 0.15
JARID1C 25 2,4 PDCA 0.23
JMJD1A 38 2,4 PDCA 0.76
JMJD2A 15 2,4 PDCA 0.083
JMJD2B 9 2,4 PDCA 0.14
JMJD2C 3 2,4 PDCA 0.091
JMJD2D 15 2,4 PDCA 0.091
JMJD2E 9 2,4 PDCA 0.061
JMJD3 16 2,4 PDCA 52
LSD1 25 Tranylcypromine 22
PHF8 26 Daminozide 0.28
UTX 9 IOX1 0.15
DNA methyltransferases
DNMT1 11 SAH 0.23
DNMT3b -5 SAH 0.094
DNMT3B/DNMT3L 7 SAH 0.045
hDNMT3a -1 SAH 0.052
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Table 60 (cont.): Results of all epigenetic assays, with results for reference compounds, where 
available 
 
Epigenetic Assay IC (%) Reference Compound
Reference 
IC50 (µM)
Histone acetyltransferases
CREBBP 87 Garcinol 1.5
GCN5L2 8 Anacardic Acid 4.7
HAT1 -52 Garcinol 1.5
MYST3 22 Garcinol 1.8
MYST4 45 Curcumin 11
pCAF -21 Garcinol 2.9
TIP60 6 Garcinol 1.5
Histone deacetylase
HDAC1 1 trichostatin A 0.0052
HDAC10 7 trichostatin A 0.009
HDAC11 -20 scriptaid 8.9
HDAC2 -4 trichostatin A 0.024
HDAC3 -3 trichostatin A 0.0068
HDAC4 -1 trichostatin A 4
HDAC5 -3 trichostatin A 1
HDAC6 -15 trichostatin A 0.0074
HDAC7 11 trichostatin A 1.8
HDAC8 1 trichostatin A 0.41
HDAC9 -4 trichostatin A 9.1
sirtuin 1 (inhibitor effect) -6 suramin 7.9
sirtuin 2 (inhibitor effect) -2 suramin 21
sirtuin 3 (inhibitor effect) -3 niacinamide 21
Sirtuin 6 15 EX-527 550
Sirtuin 7 -5 JFD00244 1300
Histone methyltransferases
ASH1L -1 SAH 9.1
DOT1L 7 SAH 0.14
EHMT1 -12 SAH 0.18
EZH1/EED/SUZ12 1 SAH 8.4
EZH2/EED/SUZ12 (PRC2 complex) 15 SAH 22
G9a 40 SAH 2.1
hSMYD2 51 SAH 0.16
MLL complex 3 SAH 0.97
MLL2 complex 24 SAH 24
MLL3 complex 20 SAH 9
MLL4 complex 3 SAH 0.55
NSD1 -7 chaetocin 0.13
NSD3 / WHSC1L1 -42 Suramin 1.5
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Table 60 (cont.): Results of all epigenetic assays, with results for reference compounds, where 
available 
Epigenetic Assay IC (%) Reference Compound
Reference 
IC50 (µM)
Histone methyltransferases
PRDM9 17 SAH 370
PRMT1 48 SAH 0.094
PRMT3 77 SAH 0.86
PRMT4 67 SAH 0.025
PRMT5 complex 25 SAH 0.65
PRMT6 56 SAH 0.053
PRMT7 33 SAH 0.86
PRMT8 -2 SAH 0.14
SETD2 3 SAH 1.2
SETD7 -1 SAH 24
SETD8 7 mercurochrome 2.4
SETDB1 22 SAH 1.8
SUV39H2 30 SAH 24
SUV4-20H2 4 SAH 4.7
WHSC1  (NSD2) 45 Chaetocin 0.48
Kinases
Aurora B 29 staurosporine 0.038
DAPK3/ZIP 28 staurosporine 0.0073
Haspin 30 staurosporine 0.032
IKK alpha 66 staurosporine 0.03
MSK1 67 staurosporine 0.015
MSK2 59 staurosporine 0.58
PIM1 36 staurosporine 0.025
PKBalpha/AKT1 29 staurosporine 0.0073
PKBbeta/AKT2 22 staurosporine 0.021
PKBgamma/AKT3 21 staurosporine 0.03
Rsk2 23 staurosporine 0.007
Small molecule methyltransferases
Catechol O-methyltransferase -25 SAH-d4 14
Glycine N-methyltransferase 1 SAH-d4 17
Guanidinoacetate N-methyltransferase 10 SAH-d4 2.3
Histamine N-methyltransferase 23 SAH-d4 13
Nicotinamide N-methyltransferase 10 SAH-d4 13
Phenylethanolamine N-methyltransferase 19 SAH-d4 3.9
Thiopurine S-methyltransferase 44 SAH-d4 2.3
Ubiquitin modifying enzymes
BAP1 18 Ubiquitin Aldehyde 0.23
USP 10 -4 N-Methylmaleimide 1000
USP 14 20 Ubiquitin Aldehyde 0.004
USP 16 10 Iodoacetamide 3.5
USP 21 -6 Ubiquitin aldehyde 0.17
USP 7 1 Ubiquitin Aldehyde 0.11
 
 
 
 
 
 
 
 
 
 
 
⁂ 
KENT — Is this the promised end? 
EDGAR — Or image of that horror? 
ALBANY — Fall and cease.  
  (King Lear V.iii.271-3) 
 
 
 
 
 
 
 
 
 
 
 
⁂ 
Douglas King, The University of Sydney, August MMXVII 
